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Executive Summary
A.

Background to the CBD invitation to UNCTAD

In 2002, the Conference of the Parties (COP) of the Convention on Biological Diversity
(CBD) at its Sixth Meeting adopted the Bonn Guidelines to address access to genetic
resources and fair and equitable benefit-sharing arising from use of those resources. In
the Bonn Guidelines, the CBD COP invited Parties and governments to encourage
disclosure of the country of origin of genetic resources and of associated traditional
knowledge in applications for intellectual property where the subject matter of the
application concerns or makes use of such knowledge in its development. Since 2002,
various proposals to facilitate or to mandate such “disclosure of origin” requirements
within the world intellectual property law system have been submitted by countries to
intergovernmental organizations, notably the World Trade Organization (WTO) and the
World Intellectual Property Organization (WIPO). In 2004, at its Seventh Meeting, the
CBD COP, in Decision VII/19, invited WIPO and the United Nations Conference on
Trade and Development (UNCTAD) to analyse issues relating to implementation of
disclosure of origin requirements in the intellectual property law system.
Specifically, the CBD COP identified for analysis five distinct topics relating to
disclosure of origin requirements. These are:
•
•
•
•
•

Options for model provisions on proposed disclosure requirements;
Practical options for intellectual property application procedures with
regard to the triggers of disclosure requirements;
Options for incentive measures for applicants;
Identification of the implications for the functioning of disclosure
requirements in various WIPO-administered treaties; and
Intellectual property-related issues raised by proposed international
certificates of origin/source/legal provenance.

This analysis has been commissioned by the UNCTAD secretariat as a contribution to its
response to the CBD COP’s invitation. However, the views in this document are solely
those of the authors and do not necessarily reflect the views of UNCTAD or the authors’
institutions. The analysis is intended to make a thorough, practical, and substantive
contribution to discussions on the topics identified above. It builds upon prior analyses of
these issues by the authors, by WIPO, by various countries, and in a growing body of
literature.
The analysis begins with an introduction, which provides additional background on the
CBD COP invitation, identifies the need for and features of an international system of
mandatory disclosure of origin requirements, and defines the scope of the analysis and
the terminology used therein. The discussion of terminology is important, both to assure a
common understanding and to achieve clarity.
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The introduction is followed by a five additional sections that address the topics
identified by the CBD COP. Part II discusses the basic choices for “model provisions,”
focusing on an international regime of mandatory disclosure requirements, triggers for
disclosure requirements and the consequences of disclosure failures, as well as the choice
of treaty regime in which to adopt disclosure requirements. Part III examines in greater
depth the options relating to substantive and procedural triggers for disclosure
requirements. Part IV addresses incentives for enforcement of disclosure obligations that
are internal to the intellectual property law system. Part V discusses practical issues in
implementing disclosure of origin requirements within existing WIPO-administered
treaties, focusing on WIPO patent law treaties. These practical considerations apply
beyond the specific context of patent applications and have relevance for other
intellectual property treaty regimes, such as the WTO’s Agreement on Trade-Related
Aspects of Intellectual Property Rights (the TRIPS Agreement), the Union for the
Protection of New Varieties of Plants (UPOV), and the International Treaty on Plant
Genetic Resources for Food and Agriculture (ITPGRFA). Finally, Part VI analyses
intellectual property law issues raised by international certificates of origin when such
certificates are used to effectuate disclosure of origin requirements.
B.

Summary of principal findings

The remainder of this executive summary provides a brief overview of the most
significant issues and conclusions of the analysis. It briefly reviews the issues addressed
and the conclusions of the introduction and of parts II to VI, with a view to facilitating an
understanding of the detailed text.
Introduction
There is a need for an international system of mandatory disclosure of origin
requirements.
An international system of mandatory disclosure of origin requirements is needed to
prevent misappropriation of genetic resources and associated traditional knowledge, to
promote compliance with CBD access and benefit-sharing requirements, and to prevent
misuse of the intellectual property system. As recognized by the Bonn Guidelines,
disclosure of origin requirements for intellectual property applications are an important
element of the CBD access and benefit-sharing regime, reflecting the interconnection of
the CBD regime with the international intellectual property law system. Although
national legislation imposing disclosure of origin requirements already exists in some
countries, in many others where intellectual property may be sought such requirements
have yet to be adopted. Thus new international treaty provisions are required to assure
worldwide implementation of disclosure of origin requirements.
Objections raised to mandating adoption of disclosure of origin requirements through
new international treaty provisions either do not stand up to analysis or do not outweigh
the benefits to be obtained. Specifically, disclosure of origin requirements:
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(a)

(b)

(c)
(d)

(e)

May be useful in improving substantive examinations and in
assuring the integrity of determinations under traditional
intellectual property legal requirements, in providing greater
certainty as to the validity of granted rights or privileges, and in
reducing the need for revocation of improperly granted intellectual
property;
May assist in identifying situations and facilitating corrective
actions where intellectual property is improperly granted, or where
access to genetic resources and associated traditional knowledge
has been obtained without concluding contracts establishing prior
informed consent and equitable benefit-sharing;
Are necessary to prevent misappropriation of commercial benefits
that are improperly obtained as a consequence of applying for,
owning or transferring intellectual property;
May help to make more coherent existing and future national laws
regarding misappropriation that affect the validity of intellectual
property or the entitlement to own or retain benefits from
intellectual property; and
May reduce uncertainties of and make more transparent an
international system of national access and benefit-sharing, and
intellectual property laws.

Suggested outline for an international system of mandatory disclosure of origin
requirements.
To be effective in deterring violations of access and benefit-sharing requirements and in
preventing misappropriation, disclosure of origin requirements must provide authority to
deny entitlements to apply for, own or enforce intellectual property. Similarly, they must
provide authority to permit national intellectual property offices to delay processing of
intellectual property applications or to consider such applications withdrawn when
required information is not provided in a timely manner. Disclosures of origin should be
required at the earliest stage of intellectual property applications, and should obligate
applicants to disclose:
(a)
(b)
(c)
(d)

The source of genetic resources and associated traditional
knowledge;
The country providing genetic resources and associated
traditional knowledge;
Available documentary information regarding compliance with
access and benefit-sharing requirements; and
Information known to the applicant (following a specified level
of effort for inquiry) regarding persons involved in the subject
matter of the application and the country of origin of genetic
resources and associated traditional knowledge.

These disclosures should be based on a broad set of substantive triggers that relate the
subject matter of the application to the genetic resources and associated traditional

4

knowledge. Required disclosures should be reviewed at the international and national
stages of application proceedings for completeness and for formal compliance with
specified procedures, but should not ordinarily be reviewed for substantive validity or
legality (unless such review already is required). In contrast, substantive reviews of
disclosures should occur principally in a judicial action, or in a pre-grant or post-grant
administrative challenge proceeding. In the absence of bad faith, opportunities to rectify
disclosure failures should be provided, and remedies tailored to the scope and nature of
the disclosure failures.
Scope of the analysis.
This analysis focuses on the concerns raised by the CBD with regard to disclosure of
origin requirements in intellectual property applications. Although the Convention
broadly concerns genetic resources, biological materials and biological diversity, the
access and benefit-sharing requirements of Article 15 address only genetic resources.
Accordingly, this analysis focuses on disclosure of origin requirements for genetic
resources, and explores a wide variety of substantive and procedural relationships
between the genetic resources and the subject matter of intellectual property applications.
Similarly, the CBD’s Article 8(j) directly addresses for purposes of equitable benefitsharing only that body of traditional knowledge that is relevant for the conservation and
sustainable use of biological diversity. Traditional knowledge, innovation and practices,
however, encompass a much wider array of information. As has the CBD COP, this
analysis focuses on traditional knowledge that is associated with genetic resources.
Nevertheless, the principles discussed here may have relevance for biological materials
other than genetic resources and for other forms of traditional knowledge that relate to the
subject matter of intellectual property applications.
Terminology.
Many of the terms associated with disclosure of origin requirements relating to genetic
resources and traditional knowledge have no standard definitions. Yet the scope of and
burdens in complying with required disclosures will depend on the definitions of relevant
terms and how they relate to the various substantive and procedural triggers adopted. In
order to provide greater clarity, this analysis defines several key terms using definitions
that are derived from or supplement those adopted by the CBD.
(a)
(b)

(c)
(d)

Genetic resources means “genetic material of actual or potential
value,” i.e. valuable “material of plant, animal, microbial or other
origin containing functional units of heredity.”
The country of origin means the country that possesses the
relevant genetic resources in in-situ conditions, even if a country
of origin is not the country where the genetic resources
historically originated. There may be many countries of origin.
The country providing genetic resources means the country
from which genetic resources relevant to an intellectual property
application have been supplied.
The source of genetic resources means the person or entity
directly providing access to genetic resources. A source may
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(e)

(f)
(g)
(h)
(i)
(j)

(k)
(l)

(m)

either possess or lack authority to provide access under specified
conditions of use and of equitable benefit-sharing.
Authority refers to the ability of the source to legally provide
access on specified conditions of use, and to establish conditions
to ensure that the source or other relevant persons involved will
receive an equitable share of benefits arising from the use of
genetic resources. Authority is used here to define a legal
condition, rather than to refer to a government entity
(administrative or judicial) that determines whether access under
specified conditions is permitted or prohibited.
Legal provenance means possession of or other access to
genetic resources for use under specified conditions, pursuant to
authority.
Biopiracy means obtaining access to genetic resources without
authority.
Misappropriation means using genetic resources in violation of
access conditions or deriving benefits without equitable benefitsharing.
Traditional knowledge means knowledge, innovations and
practices of indigenous or local communities associated with
genetic resources.
Intellectual property applications means applications relating
to intangible subject matter that require some government action
(such as registration or examination) before rights or privileges
will vest.
The applicant for intellectual property means any and all
persons entitled or required to apply for the relevant intellectual
property.
Persons involved means all persons who were involved in the
development of the subject matter of or the application for
intellectual property, or whose involvement may have a bearing
on the entitlement of the applicant to apply for or receive benefits
of intellectual property.
Certificate of origin means a document issued by a competent
entity that identifies the source of genetic resources and
associated traditional knowledge, attests to the authority of the
source to provide access under specified conditions of use, and
attests to ex-ante compliance with applicable benefit-sharing
requirements. Certificates of origin thus differ from declarations
(typically under oath) made by applicants for intellectual
property, and from other common uses of the term to denote
certificates that identify the country of origin. By certifying
authority to use genetic resources and associated traditional
knowledge, certificates of origin document the legal provenance
of genetic resources and associated traditional knowledge under
specified conditions and in the absence of misappropriation.
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Certificate of origin thus corresponds to common uses of the
terms certificate of source and certificate of legal provenance.
Monitoring may be needed to assure ex-post compliance with
certificates of origin once they are issued.
Options for model provisions for disclosure of origin requirements
Principles relating to the recognition and enforcement of foreign laws may already
impose mandatory disclosure of origin requirements.
Disclosure of origin requirements already exist under the national laws of many
countries, and contracts for access and benefit-sharing may impose requirements to make
such disclosures in intellectual property applications wherever filed, even when not
required by such national laws. Mandatory disclosure requirements thus already exist to
the extent that national disclosure of origin laws and contracts requiring such disclosures
are recognized and enforced under legal principles such as comity in the various
jurisdictions where intellectual property is sought. However, the principles governing
recognition and enforcement of national disclosure of origin requirements (including
choice of law and jurisdictional principles) are not well established or understood. New
international treaty provisions may help to make the recognition and enforcement of such
national laws and contractual provisions more coherent.
Disclosure of origin requirements should be consistent with international
intellectual property treaties.
Prior analyses have established that most of the proposed forms of national disclosure of
origin requirements are consistent with WIPO-administered patent law treaties, as well as
with the TRIPS Agreement and the UPOV Convention. In particular, existing intellectual
property law treaties do not preclude disclosure of origin requirements, as they relate to
substantive entitlements to apply for and to own intellectual property. Permissible
consequences of failing to comply with disclosure of origin requirements may include
refusing to grant intellectual property, or invalidation of intellectual property when
required information was accidentally or intentionally omitted or when false or fraudulent
documentation was submitted. Therefore, proposals to facilitate such disclosures that
seek, for example, to amend the Rules of the Patent Cooperation Treaty (PCT) may not
be needed.
Mandatory disclosure of origin requirements are needed, and may provide greater
coherence to the international system.
As noted by many developing countries, although mandatory disclosure of origin
requirements exist pursuant to the national legislation of some countries, there are good
reasons to adopt new international treaty provisions requiring mandatory disclosure of
origin obligations. Without mandatory obligations, national disclosure of origin
requirements may not be recognized and enforced by other countries in which intellectual
property is applied for, and information provided pursuant to such requirements may not
be employed to prevent improper issuance of intellectual property. On the other hand,
mandatory disclosure of origin requirements will provide numerous benefits for both the
CBD regime and the intellectual property law system, including greater coherence in
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recognition and enforcement of existing disclosure of origin obligations. In addition,
mandatory requirements may: improve determinations of inventorship or other
relationship to the subject matter, thereby assisting in the identification of persons
involved who should participate in equitable benefit-sharing; facilitate abilities to use the
subject matter of the intellectual property; promote compliance with access and benefitsharing legislation; and help to track commercialization of intellectual property so as to
promote more effective benefit-sharing.
Numerous options for mandatory disclosure of origin requirements and compliance
consequences should be evaluated.
Disclosure of origin obligations must be evaluated in terms of the nature and timing of
the information to be disclosed, and the consequent administrative burdens and costs
associated with providing and reviewing disclosed information. Issues to be considered
include:
(a)

(b)

(c)

(d)

The substantive and procedural triggers for information to be
provided and evaluated, including specifying the relevant
relationships between genetic resources and associated
traditional knowledge and the subject matter of intellectual
property at the international and national stage of application
procedures, in pre-grant and post-grant administrative challenges
and in judicial proceedings;
The form, prescribed formats and timing of the information and
documentation to be submitted, and whether and when it should
be supplemented or corrected, including disclosures of
information only, disclosures accompanied by declarations of
applicants, disclosures accompanied by documentary information
regarding access and benefit-sharing, and disclosures
accompanied by international certificates of origin;
The degree to which information and documentation is reviewed
for sufficiency and validity, including completeness, substantive
adequacy of information, accuracy of declarations and
documents, and validity of international certificates of origin;
and
The degree to which disclosure failures of varying types should
be sanctioned, including: leaving decisions to the discretion of
contracting States; relying on sanctions that do not affect the
validity or ownership of intellectual property; imposing civil
liability or criminal penalties; using unfair competition or other
legal regimes in addition to the intellectual property system;
imposing administrative fines or criminal penalties for omissions
or false or fraudulent statements; requiring revocation or
invalidation of intellectual property; requiring full or partial
transfer of rights or privileges; and requiring the return of
unjustified benefits.
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The TRIPS Agreement is the most appropriate treaty regime in which to adopt
mandatory disclosure of origin requirements.
The choice of treaty regime in which to mandate disclosure of origin requirements
requires careful attention, so as to ensure that the obligations will apply to all intellectual
property for which applications are made and that there will be continuing coordination
between CBD obligations and the intellectual property law system. Particularly in light of
the broad membership of the WTO and its existing dispute settlement procedures, the
TRIPS Agreement is the most appropriate treaty regime in which to include mandatory
disclosure of origin requirements.
Practical options for intellectual property application procedures
Substantive triggers.
Substantive triggers for disclosures of origin must define the relationships between
genetic resources and associated traditional knowledge and applications for intellectual
property that require disclosures in various procedural contexts. Substantive triggers
should reflect the purposes to be accomplished by disclosure obligations. Disclosures of
origin may assist in making determinations: within the intellectual property law system;
regarding entitlements to apply for and own intellectual property and to receive an
equitable share of the benefits under other laws; and of compliance with CBD access and
benefit-sharing legislation and contracts. Substantive triggers will need to be broad (i.e.
addressing many types of inputs into the process of discovery of and application for the
subject matter, as well as of its use) to assure the proper recognition and enforcement of
entitlements to apply for and own intellectual property and to ensure that benefit-sharing
is equitable. Mandatory disclosure obligations should also specify the types of required
disclosures, such as disclosures of information only, disclosures accompanied by
declarations of applicants, and disclosures accompanied by documentary information.
Different disclosure obligations may apply to various substantive and procedural triggers.
Substantive triggers may address:
(a)

(b)
(c)
(d)
(e)

The relationship of the source of genetic resources and associated
traditional knowledge to the subject matter of the intellectual
property application (e.g. by forming part of the subject matter,
by use during its development, by use as a necessary prerequisite
or background, or to facilitate development, or by forming part
of the prior art);
The relationship of the source to the applicant for intellectual
property under intellectual property and other laws;
The relationship of the applicant to persons involved;
Disclosure of the country of origin; and
Disclosure of documentary information regarding compliance
with prior informed consent for access and equitable benefitsharing requirements.
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Mandatory disclosure obligations may also need to specify the manner in which
applicants must provide required information. Options for disclosures may include:
(a)
(b)
(c)
(d)
(e)

Presenting information on standardized forms using standardized
terms;
Addressing specified mandatory contents;
Describing specified levels of effort and documenting
investigations performed;
Reaching a specified set of conclusions and explaining the bases
thereof; and
Providing indications of levels of confidence.

Procedural triggers.
Procedural triggers for disclosures of origin must define the opportunities for required
disclosures and evaluations, the format in which information is to be submitted and the
types of evaluations that are to be made. Procedural triggers may be imposed by national
access and benefit-sharing legislation, by contracts or by new treaty requirements. In
specifying mandatory procedural triggers, consideration must be given not only to
evaluations that are made by international and national intellectual property offices, but
also to other uses to which required disclosures may be put during and after the
application process. Application disclosure requirements thus may include information
that may not be evaluated during the application process. Consideration must also be
given to whether and when to require or permit applicants or owners to supplement or
correct disclosures during or after the application process.
Opportunities for required disclosures and evaluations may include:
(a)
(b)
(c)
(d)

The international stage of application processing (in a coordinated
international system of national intellectual property application
procedures);
The national stage of application processing;
Pre-grant and post-grant administrative challenge proceedings; and
Judicial proceedings.

Evaluations of disclosed information may include determining:
(a)
(b)
(c)
(d)
(e)
(f)

Completeness;
Conformity to standardized forms and formats;
Accuracy of factual information;
Substantive validity of conclusions reached;
Conformity to declarations and documentary information; and
Substantive legality of access and benefit-sharing.
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Options for incentives for enforcement of disclosure obligations
Different types of incentive measures exist to induce compliance with mandatory
disclosure of origin requirements. These include various types of sanctions and positive
incentives that do not have a sanctioning effect. The wide range of sanctions to address
the failure of applicants to make required disclosures of origin may be mandatory or
facultative; and they may be directly within or external to the intellectual property law
system. Options for direct or indirect mandatory or facultative sanctions may include:
(a)
(b)
(c)
(d)
(e)
(f)

Curable or incurable, temporary or permanent bars to the
processing of applications;
Administrative fines, civil liability or criminal penalties;
Termination, or full or partial transfer of entitlements to apply for
or own intellectual property;
Curable or incurable, temporary or permanent, full or partial
unenforceability, revocation, narrowing of the subject matter, or
invalidation of granted intellectual property;
Return or transfer of benefits received from intellectual property;
and
Enforcement of existing or new obligations that provide for
equitable benefit-sharing.

Any measures to induce compliance regarding disclosures of origins must provide an
effective deterrent to non-compliance, and must ensure that the intellectual property
system is not misused to further inequitable conduct. Also, incentive measures should
minimize burdens on applicants that might generate perverse results, and should provide
flexibility to respond to a wide variety of disclosure failures. Sanctions may be applied
sequentially or in combination, rather than as exclusive alternatives.
Implications for WIPO-administered treaties
Although most of the proposed forms of disclosure of origin requirements are legally
compatible with existing WIPO-administered treaties, those treaties were not adopted
with disclosure of origin requirements in mind. Moreover, even if some forms of
mandatory disclosure of origin obligations were deemed incompatible with existing
WIPO-administered treaty provisions, the disclosure of origin obligations (as laterenacted treaty obligations) would take precedence for parties to both sets of treaties.
Nevertheless, the rules, forms and procedures adopted pursuant to WIPO-administered
treaties may need to be changed in order to more effectively implement mandatory
disclosure of origin obligations.
Analysis of the PCT regime identifies a number of issues that need to be addressed in
effectuating disclosure of origin requirements within the international system of
intellectual property applications. These include:
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(a)
(b)

(c)

(d)

Revising rules, forms and administrative instructions to address the
types of information to be supplied, including use of standardized
formats and wording for the provision of information;
Adopting procedures (including the use of electronic documents)
for duplicating, evaluating and transmitting the different types of
information supplied, taking into account the costs involved and
the uses to which the information will be put;
Revising the fees charged to applicants to reflect the type of
information submitted and the costs incurred in processing and
evaluating the information at the international and national stages
of application procedures; and
Addressing the timing and need for translation of required
information and documentation.

Intellectual property-related issues for international certificates of origin
International certificates of origin not only may assist in tracing flows of genetic
resources and associated traditional knowledge, but also attest to the legal provenance to
provide access to such resources and knowledge under specified conditions for their use.
Thus, certificates of origin could assist in demonstrating compliance with CBD access
and benefit-sharing requirements and in complying with mandatory disclosure of origin
requirements. However, the use of certificates of origin raises the same considerations
previously discussed regarding substantive and procedural triggers for disclosure,
evaluations of submitted information and consequences for disclosure failures. In
addition, the use of certificates of origin raises other issues regarding ex-ante verification
of information by certifying entities, the consequences of errors of certification, ex-post
tracking of certified information to assure its continuing validity, and misuse of
certificates by persons to whom they are issued and by others. Moreover, determining
what entities have authority to issue certificates may require complex considerations.
Like other types of certification documents, international certificates of origin may be
issued erroneously, falsified or put to improper uses. Consideration must be given to
what standards should apply to issuing certifications, whether to mandate or to facilitate
use of certificates of origin in satisfying disclosure of origin requirements, how to address
errors of certification and improper uses of certificates, and what consequences should
attach to false, deceptive or confusing uses of certificates. Additional consideration must
be given to whether and how ownership of certificates of origin may be transferred.
Conclusion
In summary, there is a need for new international treaty provisions that would mandate
disclosure of origin requirements in applications for intellectual property. The most
appropriate treaty regime for adopting such requirements is the TRIPS Agreement.
Numerous benefits could be derived from disclosure of origin requirements, although
care should be taken to minimize the administrative costs and burdens of implementation.
The treaty provisions will need to specify the substantive and procedural triggers for
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making required disclosures, the types and timing of evaluations of disclosed
information, the mandatory or facultative consequences of various types of disclosure
failures, and whether to mandate or facilitate the use of international certificates of origin
in making required disclosures. Although disclosure of origin requirements are consistent
with existing intellectual property treaties, such requirements may be facilitated by
revising existing rules, forms and procedures for implementing those treaties.
Additional research and evaluation would help to inform policy choices regarding the
contents of mandatory disclosure of origin requirements to be included in new
international treaty provisions. In particular, additional analysis would be beneficial
regarding: the relationship of existing national laws governing misappropriation with
entitlements to apply for and own intellectual property; and the recognition and
enforcement of national access and benefit-sharing laws and contractual provisions that
impose disclosure of origin requirements, and their relationship with the intellectual
property law system.
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I. Introduction and background
1.
This analysis has been commissioned by the secretariat of the United Nations
Conference on Trade and Development (UNCTAD) in response to an invitation from the
Conference of the Parties (COP) of the Convention on Biological Diversity (CBD) in
Decision VII/19, adopted at its Seventh Meeting in 2004.1 The views in this document are
solely those of the authors and do not necessarily reflect the views of UNCTAD or the
authors’ institutions.
2.
CBD, Bonn Guidelines, WIPO Technical Study and CBD COP Decision
VII/19
Article 15.5 of the CBD provides for access to genetic resources subject to the prior
informed consent of the Party providing those resources. Articles 15.4 and 15.7 of the
CBD subjects any granted access to genetic resources to mutually agreed terms, and
requires Parties to take measures to share in a fair and equitable way with the Party
providing the genetic resources the results of research and development and the benefits
deriving from their commercialization and other uses. Article 8(j) of the CBD encourages
respect for and preservation of traditional knowledge, and the equitable sharing of
benefits arising from the utilization of traditional knowledge that is relevant for the
conservation and sustainable use of biological diversity. These requirements of prior
informed consent and mutually agreed terms with regard to the provision of access to
genetic resources, and for equitable benefit-sharing of genetic resources and traditional
knowledge, are generically referred to as the “access and benefit-sharing” requirements.
3.
In 2002, the sixth COP of the CBD adopted voluntary guidelines (the Bonn
Guidelines) to address access to genetic resources and fair and equitable benefit-sharing
arising from use of those resources.2 In the Bonn Guidelines, the CBD COP invited
Parties and governments to encourage applicants for intellectual property to disclose the
country of origin of genetic resources and the origin of traditional knowledge,
innovations and practices of indigenous and local communities embodying traditional
lifestyles (traditional knowledge), when the subject matter of the application concerns or
makes use of genetic resources or traditional knowledge in its development.3 Such
disclosure requirements are generically referred to as “disclosure of origin” requirements.
In adopting the Bonn Guidelines, the CBD COP noted that disclosure of origin
requirements could contribute to tracking compliance with prior informed consent and
the mutually agreed terms (including provisions for equitable sharing of the benefits of
research and commercialization) on which access to those resources was granted.4

1

UNEP/CBD/COP/7/21, Article 15, available at: http://www.biodiv.org/doc/meetings/cop/cop07/official/cop-07-21-part2-en.pdf
2
UNEP/CBD/COP/6/20, ¶ 3 and Annex, available at: http://www.biodiv.org/doc/decisions/COP-06-decen.pdf.
3
UNEP/CBD/COP/6/20, Decision VI-24.C. and ¶¶ 1, 2, available at
http://www.biodiv.org/doc/decisions/COP-06-dec-en.pdf
4
Id., ¶ 1.
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4.
In the Bonn Guidelines, the CBD COP also urged consideration of measures
aimed at preventing the misappropriation of genetic resources obtained without the prior
informed consent of the Contracting Party providing such resources. Specifically, it
suggested measures to support compliance with access and benefit-sharing requirements,
including disclosure of the country of origin of genetic resources and the origin of
traditional knowledge, measures to prevent use of genetic resources obtained without
prior informed consent, and measures discouraging unfair trade practices.5 The CBD
COP further suggested that national governments monitor applications for intellectual
property relating to the material supplied, recognized that verification of compliance with
access and benefit-sharing requirements may involve systems of voluntary certification,
and authorized Parties to adopt appropriate, effective and proportional measures to
address violations of national requirements for implementing the CBD.6
5.
The CBD COP invited the World Intellectual Property Organization (WIPO) to
submit for the Seventh Meeting an analysis of disclosure of origin requirements in patent
applications and consistency with WIPO-administered treaties.7 Specifically, it requested
analysis relating to the disclosure of:
(a)
(b)
(c)
(d)
(e)

Genetic resources used in developing claimed inventions;
The country of origin of such genetic resources;
Associated traditional knowledge used in such development;
The source of such associated traditional knowledge; and
Evidence of prior informed consent.8

WIPO responded by submitting a detailed technical study on disclosure of origin issues.9
The study analysed various disclosure of origin requirements in patent applications10
under the WIPO-administered Paris Convention for the Protection of Intellectual Property
(Paris Convention),11 the Patent Law Treaty (PLT)12 and the Patent Cooperation Treaty

5

Id., VI-24 A., Annex, ¶¶ 16(d)(ii), (iii) and (vi).
Id., VI-24.A. Annex, ¶¶ 55, 58, 61. Such measures also would help to accomplish the United Nations’
Millennium Development Goals, specifically Goal 7 (to ensure environmental sustainability) and Goal 8 (to
develop a global partnership for development). See UN Millennium Development Goals, available at:
http://www.un.org/millenniumgoals/; UN General Assembly document no. A/Res/55/2, 2000, at:
http://www.un.org/millennium/declaration/ares552e.pdf; UN General Assembly document no. A/56/326,
pp. 33-34 (adopting a goal to press for full implementation of the CBD), available at:
http://www.un.org/documents/ga/docs/56/a56326.pdf.
7
UNEP/CBD/COP/6/20, Decision VI-24. C, ¶ 4, UNEP/CBD/COP/6/20.
8
Id.
9
UNEP/CBD/COP/7/INF/17, also referred to as WO/GA/30/7 Add.1, available at:
http://www.biodiv.org/doc/meetings/cop/cop-07/information/cop-07-inf-17-en.pdf.
10
Id, ¶¶ 161–181.
11
Concluded March 20, 1883 at Paris, effective 1884, as revised through July 14, 1967 at Stockholm and as
amended Sept. 28, 1979 at Stockholm, available at: http://www.wipo.int/clea/docs/en/wo/wo020en.htm
12
Concluded June 1, 2000 at Geneva, effective April 28, 2005, available at:
http://www.wipo.int/documents/en/document/pt_dc/doc/pt_dc47.doc.
6
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(PCT),13 as well as those of the World Trade Organization (WTO) Agreement on TradeRelated Aspects of Intellectual Property Rights (TRIPS Agreement).14
6.
In Decision VII/19, the CBD COP sought to further existing efforts at developing
an international regime to effectively implement access and benefit-sharing and
disclosure of origin requirements. Decision VII/19 directs two CBD Working Groups to
elaborate and negotiate an international regime on access to genetic resources and
benefit-sharing, with the aim of adopting international instruments to effectively
implement the relevant CBD provisions. Of particular relevance here, the CBD COP
recognized the need for further analysis of issues identified in the WIPO Technical Study
and elsewhere regarding disclosure of origin requirements and international certificates of
origin/source/legal provenance, generically referred to as “certificates of origin.” The
CBD COP thus invited WIPO and UNCTAD to identify and analyse issues raised by
disclosure of origin requirements and certificates of origin, including five specific
issues.15 The box below provides the text of the invitation identifying these issues.

13

Concluded June 19, 1970 at Washington, as amended Sept. 28, 1979 and modified Feb. 3, 1984 and Oct.
3, 2001, effective April 1, 2002, available at: http://www.wipo.int/pct/en/texts/pdf/pct.pdf.
14
Annex 1C of the Marrakesh Agreement Establishing the World Trade Organization, concluded April 15,
1994, effective Jan. 1, 1995, available at: http://www.wto.org/english/tratop_e/trips_e/t_agm0_e.htm.
15
UNEP/CBD/COP/7/21, CBD COP 7 Decision VII-19, ¶¶ 7-9.
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CBD Decision VII/19 – Request and Invitation
7. Requests the Ad hoc Open-ended Working Group on Access and BenefitSharing to identify issues related to the disclosure of origin of genetic resources and
associated traditional knowledge in applications for intellectual property rights, including
those raised by a proposed international certificate of origin/source/legal provenance, and
transmit the results of this examination to the World Intellectual Property Organization and
other relevant forums;
8. Invites the World Intellectual Property Organization to examine, and where
appropriate address, taking into account the need to ensure that this work is supportive of
and does not run counter to the objectives of the Convention on Biological Diversity, issues
regarding the interrelation of access to genetic resources and disclosure requirements in
intellectual property rights applications, including, inter alia:
(a) Options for model provisions on proposed disclosure requirements;
(b) Practical options for intellectual property rights application procedures with
regard to the triggers of disclosure requirements;
(c) Options for incentive measures for applicants;
(d) Identification of the implications for the functioning of disclosure requirements
in various World Intellectual Property Organization-administered treaties;
(e) Intellectual property-related issues raised by proposed international certificate
of origin/source/legal provenance;
and regularly provide reports to the Convention on Biological Diversity on its work, in
particular on actions or steps proposed to address the above issues, in order for the
Convention on Biological Diversity to provide additional information to the World
Intellectual Property Organization for its consideration in the spirit of mutual
supportiveness;
9. Invites the United Nations Conference on Trade and Development and other
relevant international organizations to examine the issues in, and related to, the matters
specified in paragraphs 7 and 8 in a manner supportive of the objectives of the Convention
on Biological Diversity and prepare a report for submission to the ongoing process of the
work of the Convention on Biological Diversity on access and benefit-sharing;

7.
In January 2005, WIPO published a first draft analysis in response to the CBD
COP’s invitation in Decision VII/19.16 In May 2005, following receipt of comments on
the first draft, WIPO published a second draft analysis on these issues (hereafter referred
to as the 'WIPO Examination').17 The WIPO Examination contains useful discussions of
the identified issues (building on its earlier Technical Study), and summarizes the various
country submissions to WIPO for purposes of developing its response to the CBD COP’s
invitation. Additional analyses and discussions of options to implement disclosure of
origin requirements and certificates of origin have been developed for and by other
intergovernmental organizations (e.g. the WTO, the United Nations Environment

16

WIPO/IP/GR/05/01, available at:
http://www.wipo.int/tk/en/genetic/proposals/first_draft_examination_cbd_invitation.pdf.
17
WIPO/IP/GR/05/03, available at:
http://www.wipo.int/edocs/mdocs/tk/en/wipo_ip_gr_05/wipo_ip_gr_05_3.pdf.
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Programme (UNEP) and UNCTAD).18 Groups of countries, non-governmental
organizations (NGOs), and academics also have provided detailed suggestions for
elements of an international disclosure of origin requirements regime. For example,
various developing countries have proposed that the TRIPS Agreement be amended to
require applicants for patents to disclose the source and country of origin of genetic
resources and associated traditional knowledge used in inventions relating to biological
materials or traditional knowledge, along with documentary information regarding legal
access and required benefit-sharing.19 This analysis builds upon the prior analyses.
8.
In accordance with the CBD invitation, this analysis is organized in five sections.
Part II discusses options for model provisions on disclosure of origin requirements that
could be mandated by new international treaty provisions. Part III examines practical
options relating to the procedural and substantive triggers for disclosure of origin
requirements. Part IV addresses incentive measures for such requirements, focusing in
particular on enforcement mechanisms within the intellectual property law system. Part
V discusses implications for the functioning of disclosure requirements within WIPOadministered patent law treaties. Prior work of the authors and WIPO, briefly
summarized in Part II,20 has demonstrated that most of the relevant forms of disclosure of
origin requirements (including refusal to grant intellectual property or sanctions that
include invalidation or unenforceability) are fully consistent with existing WIPO patent
law treaties, with the TRIPS Agreement, with the Union for the Protection of New
Varieties of Plants (UPOV),21 and with the International Treaty on Plant Genetic
Resources for Food and Agriculture (ITPGRFA).22 Accordingly, Part V does not repeat
the legal analysis, but rather focuses on practical aspects of implementation of disclosure
of origin requirements within the relevant treaty regimes. It analyses the PCT and the
PLT to illustrate issues at the international stage of application processing in a
coordinated international system of national intellectual property application procedures,
and at the national stage of application processing. Finally, Part VI analyses intellectual
property law issues raised by international certificates of origin.
18

See, for example, WTO, Article 27.3b, traditional knowledge, biodiversity (secretariat webpage listing
relevant submissions through 2004), available at:
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm; WIPO-UNEP, Gupta A.K. (2004), available
at:
http://www.wipo.int/tk/en/publications/769e_unep_tk.pdf;
UNU-IAS
(2003),
available
at:
http://www.ias.unu.edu/news/details.cfm/articleID/458; UNCTAD, TD/B/Com.1/EM.13/3, available at:
http://www.unctad.org/fr/docs/c1em13d3.fr.pdf. Also, see papers and reports from UNCTAD workshops
in February 2004 jointly with the Commonwealth Secretariat, and in April 2002 with the Government of
India, at: http://r0.unctad.org/trade_env/test1/meetings/tk2.htm and
http://r0.unctad.org/trade_env/test1/meetings/delhi.htm.
19
For example, see WTO, IP/C/W/356, ¶ 10; WTO, IP/C/W/403, ¶ 1; WTO, IP/C/W/404, pp. 5-6, (all
available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm).
20
For example, see Sarnoff, J.D. (2004), pp. 31–37, 51, available at: http://www.piipa.org/library.asp;
WIPO, WO/GA/30/7, ¶¶ 148, 153, 175, 183.
21
Concluded Dec. 2, 1961 at Paris, entered into force Aug. 10, 1968, as revised at Geneva Nov. 10, 1972,
Oct. 23, 1978, and Mar. 19, 1991 (entered into force Apr. 1998), available at:
http://www.upov.int/en/publications/conventions/index.html.
22
Concluded Nov. 3, 2001 at Rome, entered into force June 29, 2004, available at:
http://www.fao.org/ag/cgrfa/itpgr.htm#text.
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9.
Before addressing the specific issues identified by the CBD, however, this
analysis discusses the need for an international system of mandatory disclosure of origin
requirements and for greater clarity, defines relevant terminology and defines the scope
of the analysis.

A.

Mandatory disclosure of origin requirements

The need for an international system of mandatory disclosure of origin requirements
10.
As stated elsewhere by developing countries and in a growing body of literature,
an international system of mandatory disclosure of origin requirements is needed to
prevent misappropriation, promote compliance with CBD access and benefit-sharing
requirements, and prevent misuse of the intellectual property law system.23 As recognized
by the Bonn Guidelines,24 disclosure of origin requirements for intellectual property
applications are an important element of the CBD access and benefit-sharing regime,
reflecting the interrelationship of the CBD regime and the international intellectual
property law system.25 Intellectual property applicants should not be rewarded with rights
or privileges that convey commercial benefits, when the subject matter of the applications
was obtained or derived from genetic resources or traditional knowledge acquired in
violation of CBD prior informed consent requirements and conditions of access for
genetic resources. Similarly, intellectual property owners should not retain such
commercial benefits in violation of CBD benefit-sharing requirements.
11.
Disclosure of origin requirements could fulfil important traditional functions
within the intellectual property system.26 Specifically, such requirements may: improve
the substantive examination of patents and other subject matter for which rights or
privileges are sought; enhance determinations of inventorship and other entitlements to
apply for intellectual property; and facilitate or permit use of the subject matter. The
United States, however, has taken the position that erroneously granted patents “are the
rare exception rather than the rule”, and thus that disclosure of origin requirements are
not needed to assist such traditional determinations in regard to patents.27 The factual
basis for this assertion is not apparent, and has been called into question by the United
States Federal Trade Commission and in other analyses of the United States patent

23

See, for example, TRIPS Council Meeting, 14 June 2005, Agenda Items C-E, Statement by India (TRIPS
Council India Statement), p. 2 (noting “transboundary implications” of commercial exploitation of
erroneously granted patents contrary to CBD objectives); WTO, IP/C/W/447, p. 2 (suggesting
establishment of an international obligation under the TRIPS Agreement “and another binding international
instrument”), available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm; Correa C.M.
(2003), pp. 2-3, available at: http://www.iprsonline.org/resources/trips.htm; CIEL (2005), ¶¶ 22–26,
available at:
http://www.ciel.org/Publications/WIPO_CBD%20Request_1Apr05.pdf.
24
UNEP/CBD/COP/6/20, CBD COP Decision VI-24.C, ¶¶ 1, 2,.
25
See, for example, CBD Art. 16.5 (obligating Parties to cooperate “to ensure that [intellectual property]
rights are supportive of and do not run counter to” CBD objectives).
26
See, for example, Correa C.M. (2003), pp. 2–3.
27
WTO, IP/C/W/449, p. 2, available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm.
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system.28 As a result, numerous measures to revise the United States Patent Act to
remedy perceived, widespread issuance of erroneously granted patents are under
consideration.29 Thus, even if not required to assure the proper application of intellectual
property laws, disclosure of origin requirements certainly may assist in making the
relevant determinations and thereby enhancing the integrity of the intellectual property
law system.30
12.
In addition, disclosure of origin requirements may promote compliance with CBD
access and benefit-sharing legislation (by, inter alia, reducing opportunities and
incentives for misappropriation), and they may assist in tracking the commercial
exploitation of genetic resources and traditional knowledge in order to ensure equitable
benefit-sharing. The United States, however, has taken the position that a contract-based
access and benefit-sharing regime requiring disclosures of commercial applications of
genetic resources or traditional knowledge “provides a more effective means” of
monitoring CBD access and benefit-sharing objectives, particularly as commercial
benefits may be obtained from the use of genetic resources or traditional knowledge
without inventing subject matter that qualifies for patent protection.31 However, a
contractual system would not address improper commercialization through issuance of
erroneously granted patents or other intellectual property,32 and it is unclear how such a
system would assure the achievement of CBD objectives in the absence of concluded
contracts.33
13.
Even if intellectual property was properly granted under applicable intellectual
property laws, such rights or privileges may convey commercial value before being used
to obtain commercial benefits by excluding commercial competition or maintaining
commercial monopoly market power. For example, commercial benefits may result from
higher stock prices or through the sale of intellectual property as an asset.34 Denying or
invalidating intellectual property obtained in violation of CBD access and benefit-sharing
principles thus may be necessary to prevent misappropriation of genetic resources or
28

See, for example, TRIPS Council India Statement, p. 2; US Federal Trade Commission (2003), pp. 4–13
(noting concern over questionable patents and recommending adoption of an opposition system,
elimination of the strong presumption of patent validity, revision of the obviousness standard, and increases
in Patent Office funding), available at: http://www.ftc.gov/opa/2003/10/cpreport.htm; National Research
Council, National Academy of Sciences, Merrill S.A., Levin, R.C. and Myers M.B. (eds.) (2004), pp. 61–
62 (noting the contention of legal scholars that changes in patentability standards have resulted in issuance
of patents on obvious inventions and expressing concern about the United States Patent and Trademark
Office’s application of those standards), available at: http://www.nap.edu/html/patentsystem/.
29
See, for example, H.R. 2795, Patent Reform Act of 2005, available at: http://thomas.loc.gov/; H.R. 2791,
United States Patent and Trademark Fee Modernization Act of 2005, available at: http://thomas.loc.gov/.
30
See, for example, TRIPS Council India Statement, p. 4; WTO, IP/C/W/443, ¶¶ 12, 17, available at:
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm.
31
WTO, IP/C/W/449, ¶¶ 18, 22, available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm.
32
See, for example, TRIPS Council India Statement, pp. 2 and 3 (noting the need to employ costly
revocation proceedings to limit use of erroneously granted patents).
33
See, for example, WTO, IP/C/W/446, p. 3, available at:
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm.
34
See, for example, id. p. 3; Long, C. (2002), pp. 625–628 (discussing various valuable market information
functions served by obtaining patents); Kieff, F.S. (2001), pp. 707–710 (explaining how exclusionary rights
facilitate social ordering and bargaining).
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traditional knowledge that results in commercial benefits obtained directly from
acquiring, owning or transferring intellectual property.
14.
Various national laws prevent such misappropriation by limiting the conditions
that define the validity of intellectual property or entitlements to own or retain benefits
deriving from intellectual property.35 This is true even when the relevant genetic
resources or traditional knowledge have been misappropriated from countries that have
not established national access and benefit-sharing legal regimes under the CBD.36 For
example, trade secrecy laws in the United States might prohibit applications for patents
when access to genetic resources or traditional knowledge was obtained in another
country without appropriate authority, even though the other country may not have
appropriate national legislation regarding conditions for access and benefit-sharing.37
15.
The United States, however, has raised concerns that new disclosure of origin
requirements “would cause the additional uncertainty that may lead to invalidation” of
intellectual property.38 On the contrary, rather than cause uncertainty, new international
treaty provisions addressing disclosure of origin requirements may help to make more
coherent existing and future national laws regarding misappropriation, including their
recognition and enforcement in other countries. At least such an instrument may make
existing uncertainties more transparent and predictable with regard to national access and
benefit-sharing and to intellectual property laws that are applicable to transboundary
resource and information flows.39 The relationships between national laws addressing
misappropriation and intellectual property have not been adequately studied. Additional
analysis of national laws that addresses the relationship between misappropriation of
genetic resources or traditional knowledge and their effect on the validity of or
entitlement to own or retain benefits from intellectual property would significantly assist
future discussions on disclosure of origin requirements.40
16.
The present analysis focuses on the need for and the significant features of new
international treaty provisions that would mandate requirements for disclosure of origin
with regard to genetic resources and associated traditional knowledge. As noted in a
recent multi-country submission to the WTO, contractual arrangements alone cannot
35

See, for example, WTO, IP/C/W/447, pp. 8-9 (citing the Second Supplementary Provision of Andean
Community Decision 391, which provides that “Member Countries shall not acknowledge rights, including
intellectual property rights, over genetic resources … obtained or developed through an access activity that
does not comply with … this Decision,” and providing authority to request nullification and other actions in
countries that have conferred rights or granted “protective title documents”).
36
See, for example, id. ¶ 23 (noting the absence of national legislation in the majority of member
countries).
37
See, for example, Restatement (3rd) of Unfair Competition, American Law Inst. (1995), ch. 4, §§ 39, 40
(defining trade secrets and misappropriation under state laws).
38
WTO, IP/C/W/449, ¶ 25.
39
See, for example, WTO, IP/C/W/443, ¶ 9 (an “internationally established and enforced [disclosure of
origin] system” would promote “transparency and predictability [that] cannot be established through a
fragmented nation-to-nation system”).
40
Cf. WTO, IP/C/W/446, pp. 2, 3 (requesting clarification of the circumstances that would warrant
revoking patents or requiring full or partial transfer of rights in inventions, and how benefit-sharing would
be determined to be equitable).
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ensure monitoring and enforcement of CBD requirements in third countries. Obligatory
and enforceable requirements are needed to address the broad range of intellectual
property applications that relate to genetic resources and associated traditional
knowledge.41 The appropriate controls may be obtained by requiring disclosures of origin
in patent and other intellectual property applications to include information on prior
informed consent and equitable benefit-sharing.42 Although the Bonn Guidelines invited
governments to encourage applicants to disclose the country of origin based on broad
substantive triggers relating genetic resources and associated traditional knowledge in
intellectual property applications,43 and although national legislation imposing disclosure
of origin requirements already exists in some countries, such requirements have yet to be
adopted in many countries where intellectual property may be sought. New international
treaty provisions are therefore required to assure worldwide implementation of disclosure
of origin requirements.44
Suggested outline of an international system of mandatory disclosure of origin
requirements
17.
The following principles may provide the outline for more detailed consideration
of the contents of mandatory disclosure obligations. Such obligations could be included
in new international treaty provisions that would also specify the relationship between
required disclosures and mandatory and facultative sanctions. To be effective in deterring
violations of access and benefit-sharing requirements and in preventing misappropriation,
disclosure of origin requirements may stipulate denial of the entitlement to apply for, own
or enforce intellectual property, and may permit delays in the processing of applications,
or consider applications withdrawn if required information is not provided initially or in a
timely manner after a request is initiated. In order to assure the availability of information
on which the integrity of the requisite intellectual property law determinations are to be
made, mandatory disclosure of origin requirements should be imposed at the international
stage of any application procedures, where relevant, and otherwise at the national stage of
application procedures. These requirements should obligate applicants to disclose the
source of genetic resources and associated traditional knowledge, the country providing
the genetic resources, available documentary information regarding compliance with
access and benefit-sharing requirements, and (following a specified level of effort at
inquiry) information known to the applicant regarding persons involved and the country
41

See WTO, IP/C/W/441 Rev.1, available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm
(identifying numerous applications for patents made in regard to subject matter apparently obtained or
developed using biological resources of Peruvian origin and/or traditional knowledge of indigenous
Peruvian peoples without securing the prior informed consent of Peru or of those indigenous peoples). See
also Berglund, M. (2005), p. 255 (discussing the need for “a concerted, global approach incorporating
internationally enforceable minimum standards” to protect traditional knowledge associated with genetic
resources “which originates in a third country”), available at: http://www.law.ed.ac.uk/ahrb/script-ed/vol22/TK.asp.
42
WTO, IP/C/W/438, ¶ 7, available at:
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm.
43
UNEP/CBD/COP/6/20, CBD COP Decision VI-24.C. ¶¶ 1, 2,
44
Dinwoodie, G.B. (2004), p. 1, (noting that “international initiatives are essential, given the need to adopt
similar provisions in different jurisdictions or to recognize foreign requirements across jurisdictions), draft
available at: http://r0.unctad.org/trade_env/test1/meetings/tk2/UCNTAD%20Paper(0129).pdf.
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of origin of genetic resources and associated traditional knowledge. Required disclosures
should be based on a broad set of substantive triggers that relate the subject matter of the
application to the genetic resources and associated traditional knowledge.
18.
Required disclosures of origin should be reviewed at the international and
national stages of application proceedings for completeness and for formal compliance
with specified procedures, but should not ordinarily be reviewed for substantive validity
or legality (unless such review is already required under intellectual property laws or
other laws relating to the validity of the subject matter of the application and entitlements
to apply for and own the intellectual property). Rather, substantive reviews of such
disclosures should occur principally in a judicial action, or in a pre-grant or post-grant
administrative challenge proceeding in which an initial showing is made that
demonstrates the lack of compliance with disclosure requirements or with other legal
requirements that would affect validity of or entitlements to apply for or own intellectual
property.
19.
Opportunities should be provided to rectify failures to disclose required
information at the international and national stages of application procedures, in the
absence of indications of bad faith or a showing that any required inquiries were not
performed. However, opportunities for redress should be more limited following the
granting of intellectual property.
20.
Remedies for disclosure failures should, where possible and where appropriate,
transfer full or partial ownership of intellectual property or impose benefit-sharing
conditions in preference to invalidating the intellectual property at issue. Also, remedies
should be tailored, where possible and in the absence of bad faith, to the scope and nature
of the disclosure failure.45
B.

Terminology and scope of the analysis

21.
In order to evaluate options for disclosure of origin requirements, it is necessary
to determine what actions and materials are to be addressed. A detailed discussion of
mandatory obligations for disclosure of origin requirements and of substantive and
procedural “triggers” for disclosure is provided in parts II and III. However, to ensure a
common understanding of the analysis, it is necessary to clarify the terminology used.46
The analysis adopts terminology from the CBD, supplementing that terminology as
necessary. Some of the definitions adopted differ from those used in prior analyses or in
country submissions regarding disclosure of origin and certificate of origin issues.
22.
“Genetic resources” are defined in Article 2 of the CBD as “genetic material of
actual or potential value,” and “genetic material” is defined as “any material of plant,
45

UNEP/CBD/COP/7/INF/17, ¶155 (describing the “general trend” of existing sanctions provisions under
national laws as “a tendency for the consequences of failure to comply to correspond to the nature of the
information that is not supplied”).
46
WTO, IP/C/W/446, pp. 2-3 (requesting clarification of terms used in various developing-country
submissions).
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animal, microbial or other origin containing functional units of heredity.” In contrast,
“biological resources” “includes genetic resources, organisms or parts thereof,
populations, or any other biotic component of ecosystems with actual or potential use or
value for humanity.” Thus genetic resources are a subset of genetic material, which in
turn is a subset of biological resources, and these are a subset of all biological materials.
Although disclosure of origin issues could therefore address a broader category of
biological materials,47 the focus of this analysis is on “genetic resources.”
23.
“Country of origin of genetic resources.” Article 2 of the CBD defines the
“country of origin of genetic resources” as “the country which possesses those genetic
resources in in-situ conditions.” “In-situ conditions" is defined as “conditions where
genetic resources exist within ecosystems and natural habitats, and, in the case of
domesticated or cultivated species, in the surroundings where they have developed their
distinctive properties.” A country of origin, therefore, is any country where such
resources are now located in in-situ conditions, whether or not that country is where the
resources historically originated. Further, there may be more than one country of origin
for any particular genetic resource.
24.
“Country providing genetic resources.” The access and benefit-sharing
requirements of the CBD do not apply to the “country of origin,” but rather to the
“country providing genetic resources.” This is defined in Article 2 of the CBD as “the
country supplying genetic resources collected from in-situ sources, including populations
of both wild and domesticated species, or taken from ex-situ sources, which may or may
not have originated in that country.” Article 15.5 requires that any access to genetic
resources in a Contracting Party providing genetic resources be subject to the prior
informed consent of that Party, unless it determines otherwise. Similarly, Article 15.7
requires Contracting Parties to adopt “legislative, administrative or policy” measures
“with the aim of sharing in a fair and equitable way the results of research and
development and the benefits arising from the commercial and other utilization of genetic
resources with the Contracting Party providing such resources.” However, Article 15.3
states that “the genetic resources being provided by a Contracting Party … are only those
that are provided by Contracting Parties that are countries of origin of such resources or
by the Parties that have acquired the genetic resources in accordance with this
Convention.”
25.
Significantly, genetic resources may be supplied from a country providing genetic
resources that is not a country of origin of those resources. This is particularly likely to
occur with ex-situ genetic resources that are maintained in various worldwide collections.
Unless the subject matter of an intellectual property application requires repeated inputs
of the same genetic resource in its development, however, only one country is likely to be
the country providing that specific resource. In contrast, the subject matter may require
the input of many different genetic resources supplied from different countries.

47

See, for example, WTO, IP/C/W/443, ¶ 13 (discussing disclosures of origin with regard to “biological
material and/or associated traditional knowledge”).
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26.
Considerations relating to disclosure of the country of origin and the country
providing genetic resources.
Because the mandatory access and benefit-sharing requirements of CBD Article 15 relate
directly to the “country providing genetic resources,” disclosure of origin requirements
that are tied to that Article’s provisions may not necessarily disclose the country of
origin of the genetic resources in question. Determining the country (or countries) of
origin may be a complex undertaking for genetic resources obtained from countries that
are not themselves a country of origin (for instance, when supplied by gene banks,
botanical gardens, or other sources that conserve biological materials in ex-situ
conditions). It may be particularly difficult to determine the country of origin of plant
varieties that have acquired distinctive characteristics in different countries.48
27.
In cases where intellectual property is sought for genetic resources that relate to
the multilateral access and benefit-sharing system of the ITPGRFA,49 disclosure of origin
requirements may be addressed by providing information that the relevant genetic
resources have been obtained from the multilateral system under the standard Material
Transfer Agreement (to be adopted by the Governing Body of the Treaty).50 Further, if
disclosure of origin requirements are tied to the access and benefit-sharing requirements
of the CBD, disclosures in intellectual property applications may not necessarily be
required when genetic resources are provided from countries that are not Parties to the
CBD, or when the subject matter does not relate to genetic resources. In such cases,
mandating disclosure of origin requirements in intellectual property applications would
extend beyond CBD considerations, but would still be relevant in other contexts, such as
in the WTO.
28.
Requiring applicants for intellectual property to disclose the country of origin
may force them to search for or to generate information that may not readily be available
or that may be difficult to obtain or produce. To avoid such burdens, requirements could
be limited to disclosing only the country providing genetic resources, which information
should be readily known. Alternatively, requirements for disclosing the country of origin
could be limited to knowledge already in the possession of applicants. Between these
two positions, applicants could be required to exert a specified level of effort to search for
or generate country of origin information.
29.
In some cases, existing traditional intellectual property laws may require
disclosure of the country of origin in applications, even if this means that applicants must
search for or generate the required information. Such disclosure may be required, for
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See, for example, Correa, C.M. (2003), p. 5.
The ITPGRFA prohibits applications for intellectual property on PGRFA in the form in which they are
received from the multilateral system, but does not clearly prohibit applications when the subject matter is
derived from or uses such resources in its development. See ITPGRFA, Art. 12.3(d) (“Recipients shall not
claim any intellectual property or other rights that limit the facilitated access to the plant genetic resources
for food and agriculture, or their genetic parts or components, in the form received from the Multilateral
System”).
50
ITPGRFA, Art. 12.4.
49
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example, to enable the public to use an invention for which a patent is sought.51 In
addition, national access and benefit-sharing laws of the country providing genetic
resources or of the country of application (or contracts pursuant to such laws imposing
the terms and conditions of access and benefit-sharing) may require disclosure of the
country of origin in any international or national intellectual property application.52 In
such cases, any new international treaty provisions that would require applicants to
disclose the country of origin in intellectual property applications would not impose any
additional burdens on applicants. Rather, such provisions might facilitate disclosures that
already are required under intellectual property laws, and would lead to the removal of
obstacles to disclosures under national laws when required by other countries’ laws or
contractual provisions. This analysis thus focuses on disclosure of origin requirements
that are not already mandated by intellectual property laws, national access and benefitsharing laws and/or contracts signed pursuant to such laws.
30.
“Source” of genetic resources. The CBD does not define the “source” of genetic
resources, or of associated traditional knowledge (discussed below). Although the
Preamble to the CBD reaffirms that “States have sovereign rights over their own
biological resources,” genetic resources may be owned by private persons or entities,
which may have rights to control access to and use of owned genetic resources. The CBD
access and benefit-sharing requirements must therefore address not only the Contracting
Party providing such resources or materials, but also national legislation defining
ownership and use of rights to control conditions of access and benefit-sharing. As
recognized by the WIPO Technical Study, “[t]here may be a specific legal framework for
access to genetic resources, or access may be regulated indirectly through laws
concerning rights attached to land ownership or leasehold, through the conditions that
apply to access to and exploitation of State-owned land and resources, or through the
effect of the law of contract. Government agencies and access providers have used
contracts (such as material transfer agreements), licenses and permits, to establish and
enforce the conditions of access to genetic resources and associated [traditional
knowledge].”53 Further, various levels of government approval may be required in order
to provide access to or establish conditions for equitable benefit-sharing.54
31.
A “source” of genetic resources may be defined as any person or entity (whether
private or governmental) directly providing access to genetic resources that relates in any
relevant way to the subject matter of intellectual property applications. Because more
than one genetic resource may be involved, there may be more than one source of genetic
resources to be disclosed in any given application for intellectual property. A source may
or may not possess the authority to provide access (based on the applicable legal
requirements) under specified conditions of use and equitable benefit-sharing.
51

The WIPO Technical study (UNEP/CBD/COP/7/INF/17), ¶¶ 39-87 provides useful discussions (not
repeated here) of obligations to disclose the country of origin under intellectual property laws, and
summarizes some national or regional laws requiring such disclosure as part of legislation implementing
CBD access and benefit-sharing requirements.
52
Id., Cf. TRIPS Council India Statement, p. 3 (discussing a United States proposal for a “national
contract-based system with an ‘international outlook’”).
53
UNEP/CBD/COP/7/INF/17, ¶ 15.
54
Id., ¶¶ 16–19.
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32.
“Authority” to provide access and to establish conditions for an equitable
share of benefits. It is often difficult to determine who has the legal authority to provide
access to genetic resources and to establish conditions for equitable benefit-sharing
deriving from such access. Whether any person or entity possesses such authority will
depend upon national laws and norms of the country providing resources (and in some
cases may trigger international laws relating to peoples of different nations),55 including
legal relationships regarding indigenous or local communities.56 In order for an
international system of disclosure of origin requirements to assist in ensuring compliance
with access and benefit-sharing requirements, however, the issue of authority must be
addressed.
33.
Authority reflects the application of all laws and required determinations by all
relevant government entities (administrative and judicial) that are competent to authorize
the source to provide access and to determine the legality of the conditions established for
access and for equitable benefit-sharing (including laws defining misappropriation).
Authority also reflects the application of laws relating to public or private ownership and
use of the resources in question. “Authority” thus may be understood as a legal condition
of public or private entities, rather than solely as a government entity that is competent to
determine whether the source has authority. In some cases, government entities may be
sources that possess authority to provide access to genetic resources. In others,
government entities may need to approve the provision of access by private persons (or
other government entities). Authority to provide access to genetic resources may require
the approval of more than one individual, community, or private or government entity.
Persons or entities that receive genetic resources from a source with authority and comply
with specified conditions of access and benefit-sharing possess the legal provenance to
use those resources according to the authorized conditions.57
34.
“Legal provenance” means possession of or other access to genetic resources for
use under specified conditions, pursuant to legal authority. The term “legal provenance”
is frequently employed with reference to certificates of legal provenance, which would
document and attest to the provision of genetic resources from a source vested with the
appropriate authority.58 As used in that context, legal provenance may reflect application
55

Tobin, B. (1997), p. 4, available at: http://www.ias.unu.edu/research/details.cfm/ArticleID/520.
See, for example, WIPO, E:\6-12, p. 2 (noting the “general element” of national treatment and mutual
recognition of indigenous customary laws and national legislation), available at:
http://www.wipo.int/tk/en/igc/ngo/afn_igc6.pdf; UNCTAD, Twarog, S. and Kapoor, P. (eds.) (2004), pp.
83 and 217–218 (discussing recommendations of indigenous groups for strengthening their customary laws
with regard to traditional knowledge and the constitutional status and rights of indigenous peoples of
Bolivia), available at: http://p166.unctad.org/file.php/12/ditcted10_en.pdf.; Riley, A.R. (2005), pp. 69, 86–
91, 118–123 (discussing conflicts of approach between indigenous and national legal regimes, and limits to
indigenous groups’ legal jurisdiction, in regard to cultural property issues).
57
WTO, IP/C/W/447, p. 1, (pointing out that “the concept of legal provenance presupposes the existence of
prior informed consent (PIC) and of fair and equitable benefit-sharing”).
58
Cunningham D., Tobin B. and Watanabe K. (2004), p. 3 (“A certificate of legal provenance would
document evidence that the resources had been obtained from a legally entitled provider. In the face of
continuing uncertainties regarding legal rights over resources and absent a binding international regime on
ABS, legal provenance would fall to be decided by the laws of the country where the resources were
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of and compliance with the law of “the country of origin or of other legal source,” and is
“ill-defined in many cases.”59
35.
“Biopiracy” and “misappropriation.” There are no authoritative definitions for
the term “biopiracy”. Biopiracy may be defined as the effect of obtaining access to
genetic resources without appropriate authority.60 It also may be defined more broadly to
involve unauthorized commercialization resulting from access, derivation of unjustified
benefits, or failure to provide for equitable benefit-sharing.61 In contrast,
misappropriation has legal significance in many jurisdictions, which includes the concept
of taking the value of the intellectual or other property through use.62 Accordingly,
misappropriation may be defined as the consequence of biopiracy, of violating authorized
conditions of access, or of using the genetic resources to derive unjustified or inequitably
shared benefits.63 Misappropriation may be remedied by many different legal doctrines,
including, but not limited to, those relating to unfair competition, trade secrecy and unjust
enrichment.64
36.
“Traditional knowledge.” Article 8(j) of the CBD requires, “as far as possible
and as appropriate” that a Contracting Party “subject to its national legislation, respect,
sourced, potentially providing an opportunity for circumvention of the rights of countries of origin.”),
available at:
http://www.ias.unu.edu/binaries2/Certificates_of_origin_backgr_paper.doc.
59
UNU-IAS (2003), p. 38.
60
Smith S. (2004), p.1 (treating biopiracy as unauthorized use of biological resources or traditional
knowledge, unequal shares of benefits, or patenting without respect to substantive patent law criteria),
available at: http://www.canmexworkshop.com/documents/papers/I.3d.1.pdf; Dutfield, G. (2004), p. 2
(treating biopiracy as “theft, misappropriation of, or unfair free riding” or “unauthorized and
uncompensated collection for commercial ends”), available at:
http://www.canmexworkshop.com/documents/papers/I.3.pdf.
61
Correa, C.M. (2002), § VI, Conclusions, available at:
http://www.southcentre.org/publications/traditionalmedicine/traditionalmedicine.pdf.
62
See, for example, Restatement of Unfair Competition (3rd), American Law Institute (1995), ch. 4, § 38,
(discussing appropriation of another’s “intangible trade values” under United States law); id. § 44
(discussing injunctions to prohibit the appropriation of trade secrets for unauthorized uses). Cf. WTO,
IP/C/W/434, ¶ 8 (limiting misappropriation to “improper collection and/or use,” without addressing use to
obtain intellectual property), available at:
http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm.
63
Cf. WTO, IP/C/W/443, ¶ 12 (describing misappropriation as use in developing the subject matter of
applications and of applying for intellectual property without obtaining prior informed consent or providing
for equitable benefit-sharing); WIPO/GRTKF/IC/7/5, Annex I, ¶ B.2. (defining as an act of
misappropriation any “acquisition or appropriation of traditional knowledge by unfair or illicit means”),
available at:
http://www.wipo.int/edocs/mdocs/tk/en/wipo_grtkf_ic_7/wipo_grtkf_ic_7_5-annex1.pdf.
64
See, for example, Paris Convention Art. 10bis; TRIPS Agreement Arts. 22.2(b), 39.1; Restatement of
Unfair Competition (3rd), American Law Institute (1995), ch 4, §§ 38, 44 (United States law); Beatson, J.
and Schrage, E. (eds.) (2003), pp. 524–530, 544–548 (discussing restitutionary claims and disgorgement or
royalty remedies for tortuous or delictual behaviour and for breach of contract under United Kingdom
common law and German civil law); Ultra-Precision Mfg. Ltd. v. Ford Motor Co., 411 F.3d 1369, 1377-82
(Fed. Cir. 2005) (discussing unjust enrichment claims – grounded on implied-in-law contractual provisions,
breaches of confidential relationship, misappropriation of trade secrets, or conferral of an incremental
benefit other than accessing information in the public domain – that are not preempted by United States
patent law).
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preserve and maintain knowledge, innovations and practices of indigenous and local
communities embodying traditional lifestyles relevant for the conservation and
sustainable use of biological diversity and promote their wider application with the
approval and involvement of the holders of such knowledge, innovations and practices
and encourage the equitable sharing of the benefits arising from the utilization of such
knowledge, innovations and practices.” However, Article 2 of the CBD does not define
“traditional knowledge, innovations and practices.” Traditional knowledge can serve
several functions, and thus may take many forms.65 The WIPO secretariat has proposed
to define traditional knowledge, in relevant part, as “the content or substance of
knowledge resulting from intellectual activity in a traditional context, and includes knowhow, skills, innovations, practices and learning that form part of traditional knowledge
systems, and knowledge embodying traditional lifestyles of indigenous and local
communities, or contained in codified knowledge systems passed between generations.”66
37.
The language of Article 8(j) suggests that traditional knowledge must be “relevant
for the conservation and sustainable use of biological diversity” in order to be subject to
CBD requirements for equitable benefit-sharing.67 Article 2 of the CBD defines
“biological diversity” (to which Article 8(j) refers) as variability among living organisms
from all sources including … ecological complexes of which they are part.” Biological
diversity is therefore broader than and different from genetic resources to which the
obligations of Article 15 apply. Biological diversity also is broader than the Article 2
definition of biological resources. The relationship of traditional knowledge to biological
diversity thus may be broader than the relationship of traditional knowledge to genetic
resources, genetic material or biological material.
38.
Article 8(j), however, does not impose any clear-cut mandate for national
measures for prior informed consent for access to traditional knowledge. Rather, it
promotes the wider application of traditional knowledge with the approval and
involvement of the relevant indigenous/local communities, and encourages equitable
benefit-sharing. Thus the CBD does not appear to regard the respect or preservation of
traditional knowledge as an end in itself.68 Nevertheless, the CBD COP has attempted to
develop guidelines and mechanisms for prior informed consent and for the equitable
sharing of benefits arising from the use of traditional knowledge,69 and has encouraged
consideration of “a process and set of requirements governing prior informed consent,
mutually agreed terms and equitable sharing of benefits with respect to traditional
65

See, for example, WIPO-UNEP, Gupta, A.K. (2004), p. 26 (identifying semiotic, institutional,
configurational, utilitarian, situational, and religious/spiritual forms of traditional knowledge).
66
WIPO/GRTKF/IC/8/5, Annex, p. 20, available at:
http://www.wipo.int/edocs/mdocs/tk/en/wipo_grtkf_ic_8/wipo_grtkf_ic_8_5.doc.
67
See, for example, UNEP/CBD/TKBD/1/2, ¶ 30, available at:
http://www.biodiv.org/doc/meetings/tk/wstkbd-01/official/wstkbd-01-02-en.pdf (noting the connections
between genetic resources and traditional knowledge warrant implementing Article 8(j) in conjunction with
Article 15).
68
Correa, C.M. (2004), p. 2, available at:
http://www.southcentre.org/publications/workingpapers/paper18/wp18.pdf.
69
UNEP/CBD/COP/5/23, CBD COP Decision V/16, Annex III, element 4, task 7, available at:
http://www.biodiv.org/doc/decisions/COP-05-dec-en.pdf.
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knowledge, innovations and practices associated with genetic resources and relevant for
the conservation and sustainable use of biological diversity.”70 Similarly, all of the
submissions to the TRIPS Council regarding disclosure of origin obligations in the CBD
context suggest including traditional knowledge associated with biological materials or
genetic resources.71
39.
Accordingly, “traditional knowledge” may be defined for this analysis as any
form of knowledge resulting from the intellectual activity of indigenous or local
communities, part of traditional knowledge systems, or embodying traditional lifestyles
of indigenous or local communities that is associated with genetic resources and that
leads to the development of, is incorporated in, is used with, or is otherwise relevant to
the subject matter of intellectual property applications. The CBD COP invited WIPO to
examine “the disclosure of origin of relevant traditional knowledge in intellectual
property applications,” and invited Parties and governments to encourage such
disclosures “where the subject matter of the application concerns or makes use of such
knowledge in its development”. It also urged Parties and governments to examine CBD
provisions “with respect to prior informed consent and mutually agreed terms where
traditional knowledge is used in its original form or in the development of new products
and/or new applications”.72 The principles developed in this analysis, however, may be
relevant to a broader range of traditional knowledge that relates to the subject matter of
intellectual property applications.73 In particular, the principles may have relevance for
efforts to develop a sui generis system of protection and equitable benefit-sharing of
traditional knowledge.
40.
Requirements for disclosures of the origin of traditional knowledge associated
with genetic resources may assist in ensuring prior informed consent and equitable
benefit-sharing with regard to both the traditional knowledge and the associated genetic
resources. They may also assist in preventing misappropriation of the traditional
knowledge associated with genetic resources. For example, the draft provisions for the
protection of traditional knowledge considered by the WIPO Intergovernmental
Committee on Intellectual Property, Genetic Resources, Traditional Knowledge and
Folklore require measures to protect against misappropriation by acquisition,
appropriation or utilization of traditional knowledge by unfair or illegal means.74
41.
As with disclosures relating directly to genetic resources, disclosure of origin
requirements may address the country of origin of the traditional knowledge, the country
70

UNEP/CBD/COP/7/21, CBD COP Decision VII/16, Annex, Some potential elements to be considered in
the development of sui generis systems for the protection of traditional knowledge, innovations and
practices of indigenous and local communities, ¶ 5, 2004, available at:
http://www.biodiv.org/doc/decisions/COP-07-dec-en.pdf.
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Id. p. 12.
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UNEP/CBD/COP/6/20, CBD COP Decision VI/10, ¶¶ 31, 46, 47, available at:
http://www.biodiv.org/doc/decisions/COP-06-dec-en.pdf.
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For example, traditional knowledge might lead to inventions that would help to preserve biological
diversity, but would not use genetic resources in developing the invention, as components of the invention,
or when using the invention.
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WIPO/GRTKF/IC/8/5, ¶¶ 1-2.
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providing traditional knowledge, the source of traditional knowledge and the authority of
the source that provides access to traditional knowledge based on specified conditions of
use and equitable benefit-sharing. In this context, the terms “source,” “country of origin,”
“country providing” and “authority” have the same meaning as defined above, but have
as their referent traditional knowledge associated with the relevant genetic resources.
Thus, disclosure of the country of origin of associated traditional knowledge may require
applicants to search for or to generate relevant information. Further, establishing whether
the source possesses authority to provide access under the specified conditions may
require complex determinations. As recognized by Article 8(j) of the CBD, traditional
knowledge is located in “indigenous and local communities.” Such communities may
have customary laws and norms that govern ownership and use rights that differ from and
are in addition to those established by national legislation.75 Authority to provide access
to traditional knowledge within such communities may be heterogeneously dispersed
among community members.76 Also, such communities may extend across national
boundaries, giving rise to complex issues regarding the legal relations of nations with the
different members of those communities. Moreover, because knowledge may be readily
communicated and transmitted, traditional knowledge may be more easily transferred
than associated genetic resources by the source to a recipient in a different country.
42.
“Intellectual property applications.” There are many different forms of
intellectual property that vest only after some form of application and review procedure.
For example, intellectual property may vest based on registration that requires
government review only to record or issue relevant documents, or it may be based on
detailed examination of the substantive validity and compliance with formalities of the
contents of applications. Disclosure of origin requirements applicable to intellectual
property applications thus must address a wide variety of application and review
procedures. “Intellectual property applications” may be defined as applications that
require some degree of government registration or examination before the relevant rights
or privileges vest. Although the primary focus of this analysis is on patents and plant
breeders’ rights, intellectual property applications may also be required for utility models,
petty patents, trademarks, industrial designs and sui generis protections, requiring
registration or examination.77 In contrast, some forms of intellectual property vest
without the requirement to file applications, based on status or conduct in relation to the
subject matter of the rights or privileges. This analysis does not address such intellectual
property (although many of the principles of the analysis may apply), because the CBD
invitation was limited to consideration of disclosure of origin requirements only with
regard to intellectual property applications.
43.
“Applicant” for intellectual property. Intellectual property often is sought by
applicants who did not themselves develop the subject matter of the application. For
75

Lettington R.J.L. and Nnadozie K. (2003), ¶ 24, available at:
http://www.southcentre.org/publications/occasional/paper12/paper12.pdf.
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WIPO-UNEP, Gupta, A.K. (2004), pp. 27, 40 (noting the lack of homogeneity of interests of the
members of many local communities and that not all prevalent community knowledge is communal or
traditional in nature).
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UNEP/CBD/COP/7/INF/17, ¶ 73.
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example, applications for patents may be filed (often by or with the assistance of an
attorney or agent) on behalf of inventors, assignees of inventors in the inventors’ names,
or assignees in their own names. National patent laws may require applicants to disclose
the names of and information regarding each person who is considered an inventor of the
subject matter or has some other basis (such as assignment) for the entitlement to apply.
The failure to disclose the requisite information may result in substantive invalidity of the
patent.78 The TRIPS Agreement and other treaties addressing patents, plant breeders’
rights and other intellectual property did not harmonize national laws regarding
ownership of intellectual property or the relation of creative entities to substantive
entitlements to apply for intellectual property.79 In the Havana case, the WTO Appellate
Body unequivocally affirmed the ruling of the dispute settlement Panel that the TRIPS
Agreement does not regulate the issue of ownership of trademarks, leaving entirely to
national legislation the conditions regarding who is entitled to apply for and own
intellectual property.80 Accordingly, an “applicant” for intellectual property is defined for
this analysis as a person or entity entitled or required to apply for or to register an interest
in intellectual property under the national law of the country where such rights or
privileges are sought.81
44.
“Persons involved” in intellectual property applications. Sources of genetic
resources and associated traditional knowledge, and persons or entities obtaining access
directly from those sources, may not necessarily qualify as inventors or applicants under
national intellectual property laws.82 In such cases, additional disclosures may be needed
to identify those persons or entities and their relationship with the subject matter of the
application. For this analysis, “persons involved” in applications are defined as all
persons who were involved in the development of the subject matter of the application for
the intellectual property, or whose involvement may have a bearing on the entitlement of
the applicant to apply for and receive benefits of intellectual property. Persons involved
in applications thus may have a direct or remote relationship with the applicant or with
the source of genetic resources and associated traditional knowledge. The definition of
persons involved is broader than, for example, the definition of “individuals associated
with the filing or prosecution” of a patent application who are required to supply to the
United States Patent Office known “information material to patentability.”83
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Id., ¶ 50 (citing European Patent Convention Art. 81), ¶ 51.
Sarnoff, J.D. (2004), p. 35 and nn.173 and 174 (citing WTO, WT/DS176/AB/R, United States – Section
211 Omnibus Appropriations Act of 1998, Report of the Appellate Body, ¶ 189 (2002), available at:
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WTO, WT/DS176/AB/R, ¶¶ 155–165, 189.
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45.
“Certificate of origin.” The CBD COP’s referral addressed the “proposed
international certificate of origin/source/legal provenance.” Although the CBD does not
define certificates of origin, source or legal provenance, these concepts were developed in
the context of intergovernmental and regional efforts to implement the CBD.84 Some
prior analyses have discussed “voluntary” or third-party certification schemes, where
individuals or entities may certify conformity to various types of standards in a single
step or progressively (step-by-step). Others have suggested that certificates of origin
could be issued by owners of the genetic resources or traditional knowledge.85 This
analysis considers international certificates of origin to be documents issued by a
competent entity that assures the integrity of the contents of the certification.86 A
certificate of origin also may, but need not necessarily, contain a sworn declaration of a
source or of a recipient of genetic resources or associated traditional knowledge. Thus
certificates of origin differ from certifications or declarations that may be required of or
made by applicants when applying for or owning intellectual property.
46.
An international “certificate of origin” may be defined for this analysis as a
document issued by a competent entity, which identifies the source, attests to the
authority of the source to provide the relevant resources and knowledge for specified
conditions of use, and attests to compliance with equitable benefit-sharing requirements
(pursuant to contractual arrangements or other mechanisms). This definition varies from
some other formulations of certificates of origin, source and legal provenance.87 In
particular, “certificate of origin” differs from the common use of the term which denotes
a certificate that identifies the country of origin, although such information may also be
included. Because certificates of origin must identify the authority of the source, they
also document the legal provenance of the genetic resources and associated traditional
knowledge, in the absence of misappropriation. “Certificate of origin” thus corresponds
more closely to common usage of the terms certificates of source and certificates of legal
provenance.88 Monitoring may be needed to assure ex-post compliance with conditions
of access and equitable benefit-sharing once a certificate of origin is issued. The analysis
in Part VI focuses on the use of international certificates of origin in relation to disclosure
of origin requirements.
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UNEP/CBD/WG-ABS/3/INF/5, Tobin, B., Cunningham, D. and Watanabe, K. (2004), p. 8, available at:
http://www.biodiv.org/doc/meeting.aspx?mtg=ABSWG-03&tab=1; Tobin, B. (1997), p. 7 and n.16; UNUIAS (2003), p. 38.
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See, for example, UNU-IAS (2003), p. 23; de la Cruz, R. (2004), p. 8, available at:
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II.

Model provisions for disclosure of origin requirements

47.
In general terms, three different sets of issues exist for adopting model provisions
of an international regime to implement disclosure of origin requirements. The first set
relates to whether to impose disclosure of origin requirements as mandatory treaty
obligations or just facilitate such disclosures within the existing intellectual property law
system. The second set relates to the nature of the disclosure obligations and the
mandatory or facultative consequences to be prescribed for failures of applicants or
parties to comply with requirements or obligations. The third set relates to the treaty
regime in which to locate the obligations. Because the nature of the disclosure obligations
and the consequences of disclosure failures overlap with the second and third set of issues
posed for analysis by the CBD COP, these issues are more comprehensively addressed in
Parts III and IV.
A.

Mandatory or facilitated disclosure of origin obligations

Foreign recognition and enforcement of existing mandatory disclosure of origin
obligations
48.
As noted in numerous submissions to WIPO and the WTO, various national laws
already require applicants for intellectual property to disclose the source and country of
origin of genetic resources and associated traditional knowledge, along with relevant
documentary information regarding compliance with access and benefit-sharing
requirements.89 Similarly, contracts providing for compliance with access and benefitsharing requirements, and adopted under national laws implementing CBD obligations,
may also require such disclosures (including copies of the contracts), even when the
national laws do not.90 In theory, national laws and contracts may mandate such
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WIPO/GRTKF/IC/Q.3, Part I, Annex, (country submissions in response to WIPO question 3, regarding
specific requirements to disclose the source and geographic origin of genetic resources or traditional
knowledge
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requirements),
available
at:
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disclosures of origin in intellectual property applications filed in foreign jurisdictions.91 If
recognized and enforced in those jurisdictions, under legal principles such as comity,
these legal and contractual requirements already impose an international system of
mandatory disclosure of origin obligations.92
49.
National or contractual requirements for disclosures of origin in foreign
intellectual property applications, however, are not uniform in scope, and may potentially
conflict with intellectual property and other laws in the foreign jurisdictions. Complex
legal rules regarding conflict of laws and legislative and judicial jurisdictions may
sometimes preclude such national requirements from being effectuated.93 Not only are
determinations regarding recognition and enforcement unpredictable, they also increase
the burdens and costs of enforcing such requirements. As noted in a recent WTO
submission suggesting an amendment to the TRIPS Agreement to require mandatory
disclosure of origin requirements, “it would be more cost-effective to establish an
internationally accepted solution … to prevent biopiracy than to divert national resources
to expensive judicial processes for the revocation of patents that include illegal genetic
resources…. Developing countries, in particular, do not have the resources to follow
each and every patent issued outside their territories on the use of their resources.”94
Similarly, indigenous and local communities typically lack the resources to effectively
enforce patents and other rights relating to genetic resources and traditional knowledge.95
New international treaty provisions imposing mandatory disclosure of origin obligations
would reduce uncertainties regarding recognition and enforcement of such national
disclosure requirements in foreign intellectual property applications, and would thereby
reduce the burdens and costs of preventing and remedying biopiracy and
misappropriation. Additional analysis of the recognition and enforcement of existing
national access and benefit-sharing laws and contractual provisions imposing disclosure
of origin requirements, and their relation to intellectual property laws, would significantly
assist future discussions of disclosure of origin requirements.
Treaty consistency of existing disclosure obligations
50.
Prior analyses have demonstrated that most forms of national disclosure of origin
requirements for domestic and foreign patent applications (including requirements under
existing national laws) are consistent with WIPO- and WTO-administered intellectual
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property law treaties,96 including the TRIPS Agreement, the PCT and the PLT. Such
consistent requirements may preclude the granting of rights or privileges when
submission of required documentation has not been made in a timely manner, or they
may invalidate intellectual property ownership if requisite information or documents
were accidentally or intentionally omitted, or if false or fraudulent information or
documents were submitted.97 One potential inconsistency with existing patent law treaties
would arise if an inadequate disclosure resulted in the denial of an effective filing date for
an application from the initial date of submission, if the application otherwise met
specified requirements. However, these treaty requirements may not supersede additional
requirements for the further processing of applications, and problems may easily be
avoided simply by according a filing date before additional consequences ensue (such as
abandonment or refusal to process the application).98 Another potential inconsistency
could arise if there were inadequate opportunities for prior comment and for judicial
review of any invalidation of rights or privileges.99 The prior analyses were premised in
part on the fact that existing international intellectual property treaties have not sought to
regulate national laws that determine entitlements to apply for or own intellectual
property. Thus, parties to those treaties remain free to limit substantive entitlements to
apply for or to own intellectual property, as well as to condition such entitlements on
disclosure obligations and to sanction disclosure failures.100 The relevant substance of the
prior analyses is summarized briefly below.
51.
The PCT does not prohibit national disclosure of origin requirements at the
national stage of processing international PCT applications, regardless of whether these
requirements are considered to be “formal” or “substantive.”101 Nor does the PLT
prohibit such requirements for national applications filed through the PCT system or
initially in national patent offices.102 Although PCT Article 27(1) and PLT Article 6(1)
limit the ability to require compliance with additional requirements relating to the “form
96
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and contents” of applications, these requirements do not apply to disclosure of origin
requirements as substantive conditions of entitlement.103 Both the PCT and PLT
expressly state that they do not regulate substantive patentability rules, and they permit
the imposition of requirements for additional documentation in that regard.104 But even if
disclosure of origin requirements were to constitute prohibited formalities, the PCT
would not preclude imposing disclosure obligations at the national stage. Further, there
were only 10 countries party to the PLT as of April 2005.105 Countries with disclosure of
origin requirements either would not ratify the PLT, or the PLT might be amended to
permit such disclosure requirements. Additional discussion of implementation within the
PCT and PLT treaty regimes is provided in Part V below.
52.
The TRIPS Agreement does not prohibit countries from imposing additional
substantive conditions of entitlement and requirements for applicants to demonstrate their
entitlement to apply for or own intellectual property. Article 29.1 of the TRIPS
Agreement specifies mandatory and facultative patent application disclosure
requirements. But that Article does not preclude countries from imposing additional
disclosure requirements for national applications, particularly when effectuating
substantive conditions of entitlement.106 Nor do the TRIPS Agreement, the PCT or the
PLT prohibit countries from refusing to grant or from invalidating patents or plant
breeders’ rights when substantive criteria for entitlement have not been met or when
required disclosures have not been provided.107
53.
Assuming for analysis that disclosure of origin requirements were to constitute
formalities, Article 62.1 of the TRIPS Agreement expressly authorizes members to
impose “reasonable procedures and formalities” for acquisition and maintenance of
intellectual property (such as copyright formalities and evidence of use for registered
marks). Thus disclosure of origin requirements would need to be evaluated for
reasonableness under Article 62.1. Requirements to disclose the source, the country
providing genetic resources and associated traditional knowledge, the country of origin,
persons involved, and documentary information regarding access and benefit-sharing
may entail varying degrees of burden for applicants. If properly tailored to minimize
unnecessary burdens, disclosure of origin requirements should be considered
“reasonable.” In contrast, requirements for intellectual property application offices to
evaluate such disclosures of origin may entail significant administrative burdens,
particularly if the national application offices are required to assess compliance with
access and benefit-sharing requirements imposed by different countries’ laws or by
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contracts.108 However, TRIPS Article 62.1 would not prohibit such requirements, as it
does not regulate the reasonableness of administrative procedures per se.109
The Swiss proposal to facilitate disclosure obligations
54.
Because it views PCT Article 27(1) and PLT Article 6(1) as precluding disclosure
of origin requirements for PCT at the international and national stage and for PLT at the
national stage of applications, Switzerland has proposed amendment of the PCT to
expressly authorize disclosure of origin requirements for national applications. The PCT
amendments would apply also to the PLT for national and regional applications, as PLT
Article 6(1) incorporates by reference PCT requirements relating to the form and contents
of an international application.110 The Swiss proposal would not mandate national
disclosure of origin requirements. Rather, it would authorize PCT and PLT parties to
impose disclosure of origin requirements at the national stage of application processing,
and it would permit (but would not require) applicants to include such disclosures at the
international stage of PCT applications. If such disclosures were voluntarily included at
the international stage, the PCT would require receiving offices to publish them.111 The
Swiss proposal would apply only to declaring the “source” of genetic resources, which is
defined broadly to include both the source (as defined for this analysis) and the country
providing genetic resources or traditional knowledge. The proposal would not require
disclosure of more than the “primary source” (but would permit disclosure of additional
sources if known), defined as the country providing genetic resources or traditional
knowledge.112 Furthermore, the proposal would not require disclosure unless the
invention that is the subject of the patent application was “directly based” on genetic
resources or traditional knowledge.113 Thus the Swiss proposal would adopt a very
narrow substantive trigger for requiring disclosures of origin in patent applications.
55.
The Swiss proposal, however, would not by itself permit applicants to declare the
source of genetic resources or traditional knowledge at the international stage, unless the
declaration was relevant to the national application of at least one designated country. Of
potentially greater significance, this proposal would prevent designated countries from
requiring applicants to provide additional documentation regarding the disclosure of
source in national patent applications, in the absence of reasonable doubt as to the
veracity of the declaration made in the prescribed form (which would be adopted by
108
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amendment of the Administrative Instructions).114 Designated offices could request
applicants to correct defective declarations (where reasonable doubt exists) or missing
declarations, and could refuse the application or consider it withdrawn after at least two
months from notice. But the failure to comply with disclosure obligations would not
provide grounds for revocation of issued patents (under PLT Article 10(1) if applicable),
unless the failure reflected fraudulent intent.115 The Swiss proposal thus might preclude
nations from imposing more substantial disclosure of origin requirements on nationalstage PCT applications and on national applications subject to the PLT. It would prohibit
requirements to disclose additional sources and the country of origin, as well as
documentary information regarding compliance with CBD access and benefit-sharing
requirements.116 If adopted, countries currently requiring such disclosures at the national
stage would have to change their laws in order to conform to the PCT or the PLT.
Mandatory disclosure of origin obligations
56.
Authority currently exists for countries to require disclosures of origin in patent
applications. Authority also exists for countries to deny intellectual property during the
application process if a failure to make required disclosures is recognized, and to
invalidate intellectual property if required disclosures were not made or were improperly
made. None of the existing intellectual property law treaties, however, mandates that
parties impose disclosure of origin requirements on intellectual property applicants. Nor
do these treaties obligate parties to impose any specific consequences for failures to
comply with national disclosure of origin requirements, or to recognize and enforce other
countries’ access and benefit-sharing laws and contracts requiring applicants to make
such disclosures.117 Thus, although disclosure of origin requirements may be imposed at
the national level, there is no coherent international system in place to assure that such
requirements are effectuated on a worldwide basis. Concerns have been raised that
114
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adoption of proposed mandatory requirements “would lead to significant
uncertainties,”118 but these concerns are misplaced. Uncertainties already exist, and they
cannot be resolved without an agreed solution through new international treaty provisions
or other agreements directly addressing disclosure of origin requirements.
57.
Some developed countries and many developing countries have identified the
need for a mandatory international system to address disclosure of origin issues.119 As
noted by several developing countries, most of the proposals to improve patent
examination relating to genetic resources and traditional knowledge (so as to deter
biopiracy and to prevent misappropriation) are unlikely to address the full scope of prior
art. Further, to the extent that they are voluntary measures, those proposals would
“provide no guarantee” that information on the source and country of origin will be
considered in order to prevent the improper issuance of patents.120 Enforcement
mechanisms external to the intellectual property law system or reliance on contractual
measures are inadequate, because there is no obligation to legislate for such measures or
to enforce such contracts. Moreover, such contracts are unlikely to be entered into unless
they are obligatory and enforceable.121 On the other hand, mandatory disclosures in
intellectual property applications would continue to be useful after the application stage,
and would reduce the need for costly administrative or judicial challenges to the validity
of the patent or the entitlement of the applicant or owner. Developing countries in
particular lack adequate resources to undertake such challenges on a worldwide scale.122
58.
Numerous benefits from adopting mandatory disclosure obligations have been
identified for both the CBD regime and the intellectual property law system. These
include: improving the substantive examination of applications; providing greater
certainty regarding the validity of granted rights and privileges; reducing the need for
revocation of improperly granted intellectual property; improving identification of
possible cases of misappropriation; facilitating actions to challenge the validity of
wrongly issued intellectual property; improving determinations of inventorship or other
relationship to the subject matter, thereby assisting identification of persons who should
participate in equitable benefit-sharing; facilitating abilities to use the subject matter of
the intellectual property; promoting compliance with access and benefit-sharing
legislation; and tracking commercialization to promote more effective benefit-sharing.123
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Of course, disclosure obligations should be seen as only one of many elements of an
international system to prevent biopiracy and misappropriation.124
59.
Objections to disclosure of origin requirements have been raised based on
concerns that such requirements will not necessarily prevent misappropriation (even if
misappropriation is understood only by reference to lack of authority to grant access and
lack of prior informed consent for access).125 Additional objections are based on concerns
that invalidation of intellectual property will not necessarily assure, and may even
prevent, equitable benefit-sharing.126 In response, it has been noted that disclosure of
origin requirements seek not to replace but to supplement other methods for enforcing
prior informed consent and benefit-sharing regimes.127 These objections appear to be
based on the controversial view that such measures are unduly burdensome to applicants
and administrative offices, and unduly costly to other interests (such as the certainty of
patent validity) when compared to the benefits to be obtained.128 Furthermore, such
objections do not take account of the need to monitor intellectual property once validity is
granted under applicable intellectual property law requirements (and the associated costs
of doing so), so as to deter and remedy misappropriation (e.g. by violating contractual
conditions under which rights or privileges were to be obtained or equitable benefits
shared).129 Nor do these objections take account of the need to prevent misuse of the
intellectual property system itself.130 Objections that disclosure of origin requirements
would not prevent misappropriation when applications for intellectual property are not
filed131 are similarly misplaced. However, they do imply the need for effective
international measures that directly protect against improper access and misappropriation
of genetic resources and traditional knowledge.132
60.
It bears noting that many countries are still in the process of enacting legislation
to effectuate CBD access and benefit-sharing requirements. Determining compliance with
CBD prior informed consent and equitable benefit-sharing principles in such situations
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may be a complex undertaking. Such determinations may need to take account of legal
principles that have not been incorporated into legislation, and may raise complex issues
that have not previously been addressed or adequately resolved. For example, authorized
access may depend on common law or on traditional rules of property, as well as on
inchoate sovereign interests over their resources and on complex principles of
international law.133 Equitable benefit-sharing may need to be determined in the absence
of contractual or other agreements that reflect mutually approved terms.134 Additional
analysis of CBD access and benefit-sharing obligations and of disclosure of origin
requirements in such circumstances would be helpful.
61.
For the reasons articulated above, this analysis concludes that mandatory
international obligations to impose disclosure of origin requirements are both necessary
and appropriate. Such obligations should be adopted within an appropriate intellectual
property law treaty regime. The treaty provisions should address what disclosures should
be required, whether to recognize and apply the access and benefit-sharing requirements
of countries providing the genetic resources and associated traditional knowledge, and
how international and national intellectual property application offices and national
judiciaries should evaluate the adequacy of such disclosures. The treaty also may need to
address whether to recognize and enforce contracts that require disclosures that differ
from or add to the mandatory treaty obligations or national laws.
B.

Specification of mandatory disclosure obligations and consequences

62.
The investigatory burdens and costs to applicants of providing disclosures of
origin and documentary information regarding access and benefit-sharing, as well as the
administrative burdens and costs of evaluating such information, should be limited to
what is necessary to attain the intended objectives of the disclosure obligations.135
Various options are explored below concerning the scope of the disclosures and the
administrative burdens they may entail. Unless and until new international treaty
provisions are adopted, the scope of required disclosures and consequences of disclosure
failures will vary across countries.136 Similarly, the failure to disclose required
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information may result in different legal consequences, such as punitive sanctions and/or
invalidation of granted rights or privileges. Objections have been made to mandating
invalidation of intellectual property for disclosure failures, as the absence of intellectual
property might in some circumstances jeopardize or prevent commercialization that could
lead to appropriate benefit-sharing.137 However, some flexibility in the mandatory
obligations may be warranted to permit the consequences of disclosure failures to be
tailored to the circumstances. The goals of such tailoring would be, where appropriate, to
encourage the correction of unintentional disclosure errors and to permit the transfer
(rather than invalidation) of intellectual property or the return of unjustly obtained
benefits in cases of fraudulent conduct, unauthorized access or inequitable benefitsharing.138
63.
Because these issues overlap with the discussions of procedural triggers in Part III
and of incentive measures in Part IV, the analysis in this section is limited to an overview
of various administrative and post-administrative options.
Disclosures in application submissions and their evaluation
64.
In order to promote compliance with CBD access and benefit-sharing
requirements, disclosure of origin obligations must provide useful information, but
should not impose undue costs and burdens on applicants or administrative offices.
Significantly, information contained in intellectual property applications may be used
after the application process, for example in administrative or judicial proceedings to
invalidate improperly granted intellectual property or to seek remedies for
misappropriation. Requiring applicants to disclose information on the source of and
country providing genetic resources and associated traditional knowledge, the authority
of the source, the country of origin, and compliance with access and benefit-sharing
requirements not only may help to assure proper entitlements to apply for and own
intellectual property, but also may assist compliance with CBD access and benefitsharing requirements, even when such information is not evaluated in the application
context.139 When specifying what disclosure of origin requirements to mandate by treaty,
consideration should be given to what information must be disclosed during the
application process, what evaluations should be made of the information, how the
information may otherwise be used, and whether and when information should be
supplemented or corrected.
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65.
There are several contexts in which information provided by mandatory
disclosure of origin requirements may be evaluated. These include:
•
•
•
•
•

International applications;
National applications;
Pre-grant administrative opposition or other challenges;
Post-grant administrative re-examination, interference, revocation,
opposition or other challenges; and
Judicial proceedings (including enforcement actions and separate legal
actions addressing validity, ownership or misappropriation).

66.
There are also numerous options regarding what information and documentation
should be disclosed by applicants, and whether and when it should be supplemented or
corrected at a later period. These include:
•
•

•

•

Disclosures of information only (which may be required in prescribed
forms or content);
Disclosures of information accompanied by various declarations by
applicants (e.g. declarations of adequate investigation, declarations of the
accuracy of submitted information, and declarations of compliance with
access and benefit-sharing requirements);
Disclosures of information accompanied by documentary information
regarding access and benefit-sharing (e.g. submission of contracts
providing conditions for access and benefit-sharing; evidence of
compliance with contractual requirements); and
Disclosures of information accompanied by international certificates of
origin.

Obviously, these different options may be combined in various ways, and the information
may be put to different uses in different contexts. Requiring information to be provided
at entry to the international stage (if any) or the national stage of the application process
would assure that such information (if transmitted and retained) would be available for
consideration at later stages. So long as transmission of the information does not impose
significant burdens, analysis can focus on whether it would be useful to provide the
information at earlier stages (e.g. requiring submission at the international stage to assure
efficient transmission to multiple national stage application offices), even if the
information is evaluated only at later stages.
67.
Further, there are numerous options concerning the scope of evaluations of
information submitted pursuant to mandatory disclosure obligations. These include:
•
•
•

Evaluations for completeness of submitted information, declarations and
documents;
Evaluations for substantive adequacy of disclosed information;
Evaluations of relevance and accuracy of declarations;
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•
•

Evaluations of relevance and accuracy of documentary information
regarding access and benefit-sharing; and
Evaluations of validity of international certificates of origin.

Different evaluations may occur in different procedural contexts.
68.
National intellectual property offices seldom scrutinize demonstrations of
entitlement to apply for or to own intellectual property (e.g. recorded assignment
documents) for their substantive validity, unless those documents (and thus the right to
apply for or to own intellectual property) are suspect or are otherwise challenged in a pregrant or post-grant administrative proceeding.140 Nevertheless, such documents are
routinely required to be filed, and reference is required to be made to those documents in
intellectual property applications.141
Consequences of disclosure failures, fraudulent conduct, lack of authority and
inequitable benefit-sharing
69.
Various options have been proposed for the consequences of providing
incomplete, incorrect or fraudulent disclosures of origin. These include:
•
•
•

Leaving decisions on sanctions to contracting States (including
recognition and enforcement of other States’ laws, where applicable);142
Relying on “effective, proportionate and dissuasive [external] sanctions,”
without affecting the validity or ownership of intellectual property (so as
to provide greater certainty regarding validity and ownership);143
Imposing civil liability or criminal penalties for violation of contractual
obligations;144

140

Under United States law, 37 Code of Federal Regulations (C.F.R.) § 1.48(g), the United States Patent
and Trademark Office (US PTO) may require additional information, as needed, to correct inventorship;
and 37 C.F.R. § 3.73(b) requires documentation of assignee ownership “to the satisfaction of the Director”
of the US PTO, including relevant chain of title information. See also 37 C.F.R. §§ 1.171, 1.175, 1.324,
1.634 (United States law addressing correction of inventorship in reissue applications, issued patents and
interferences).
141
See, for example, United States laws 35 U.S.C. § 261, ¶ 4 (requiring recording of assignments, grants or
conveyances of patents to be valid against subsequent purchasers), 37 C.F.R. § 1.76(b)(1) (requiring for
voluntary application data sheets inclusion of information demonstrating authority of assignees to apply for
patents, pursuant to 37 C.F.R. § 1.46, which authorizes issuance of patents to assignees), 37 C.F.R. §
3.11(a) (providing for recording of assignments and other documents affecting title to applications, patents,
or registrations), 37 C.F.R. § 3.21 (requiring registered assignments to cross-reference related applications),
and 37 C.F.R. § 3.56 (treating conditional assignments as absolute unless withdrawn, because the Office
does not evaluate or determine whether conditions have been met).
142
See, for example, WIPO (2005), Provisional Compilation, p. 56, Submission of the European
Communities.
143
WIPO (2005), Provisional Compilation, p. 56, Submission of the European Communities. See also
WTO, IP/C/W/434, ¶ 3 (viewing “with the utmost caution” proposals that “would add uncertainties in
patent rights”), and ¶ 14 (sanctions that include invalidation “would create a ‘cloud’ of uncertainty over the
patent right”).
144
For example, WTO, IP/C/W/434, ¶ 26; WIPO (2005), Provisional Compilation, p. 50, Submission of the
United States; Correa, C.M. (2005), pp. 8–9 (summarizing the positions of a US PTO presentation).
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•
•

•

•

•
•

Using unfair competition rules and other legal regimes to address
violations of access and benefit-sharing requirements;145
Addressing the failure to provide required information or the submission
of false or fraudulent statements or documents by imposing administrative
fines or criminal penalties internal or external to the intellectual property
system (depending on the effect of the information on the applications);146
Requiring evaluations of various forms of disclosure and refusing to
process applications or to grant rights or privileges where required
information is not submitted (potentially subject to opportunities for
correction) or where information is falsely or fraudulently submitted;147
Requiring revocation or invalidation of intellectual property following
determinations that various forms of required information were not
submitted (potentially subject to opportunities for correction) or where
information was falsely or fraudulently submitted;148
Requiring full or partial transfer of rights or privileges in the subject
matter of intellectual property, so as to promote fair and equitable benefitsharing;149 and
Requiring the return of any unjustified benefits conferred in violation of
access and benefit-sharing requirements.150

These options for mandatory disclosure obligations are not mutually exclusive, and there
may be reasons for resorting to multiple options so as to assure adequate deterrence,
enforcement and compensation.
Conflict of laws and jurisdictional rules
70.
Mandatory disclosure of origin obligations will assist in effectuating a number of
existing legal regimes, such as laws implementing CBD access and benefit-sharing
requirements and specifying the consequences of failure to comply with those
requirements; laws addressing entitlements to apply for intellectual property; and laws
relating to misappropriation and to the return of unjustified benefits. In the absence of
mandatory disclosure of origin obligations specified by new international treaty
provisions, these and other laws will continue to apply and to impose the various
consequences listed above. New international treaty provisions addressing mandatory
sanctions thus may assist in clarifying the applicable legal framework, and in establishing
more uniform conditions for recognition and enforcement of the various sets of
potentially applicable legal requirements.151 Alternatively, an international agreement
could assure that national disclosure of origin requirements take precedence over national
145

For example, WTO, IP/C/W/434, ¶ 11.
For example, WTO, IP/C/W/442, ¶¶ 13, 14.
147
For example, id. ¶¶ 13.
148
For example, id. ¶ 14.
149
For example, id.
150
For example, CIEL (2005), ¶ 24.
151
Dinwoodie, G.B. (2003), pp. 202, 206 (discussing ways that substantive treaty law may affect or
constitute choice of law rules and may affect harmonization); UNEP/CBD/COP/7/INF/17, ¶ 157
(discussing choice of law and recognition of judgment issues).
146

48

intellectual property laws that otherwise might preclude recognition and enforcement of
disclosure of origin requirements.152 Mandatory disclosure of origin obligations thus may
help to make the international system of national laws requiring disclosures of origin
more coherent.
71.
Consideration should also be given to including mandatory provisions regarding
jurisdiction, recognition and enforcement of judgments (such as mutual recognition,
application of mandatory rules, and jurisdiction that cannot be declined)153 or less strict
obligations to adjudicate disputes (such as forum non-conveniens principles that would
permit national agencies and courts to decline jurisdiction)154 relating to compliance with
national access and benefit-sharing laws and with mandatory, treaty-based or additional
disclosure obligations. Similarly, consideration should be given to whether and under
what conditions compliance issues should be referred to an appropriate intergovernmental
organization or to the courts or agencies of other countries (e.g. for definitive
interpretations of CBD access and benefit-sharing requirements or of CBD implementing
legislation of the country providing genetic resources and associated traditional
knowledge).155
152

WIPO/GRTKF/IC/8/6, ¶¶ 27-29 (discussing jus cogens and other means to ensure national effect of
international obligations), available at:
http://www.wipo.int/edocs/mdocs/tk/en/wipo_grtkf_ic_8/wipo_grtkf_ic_8_6.doc.
153
Drahos, P. (2004), pp. 27–28 (discussing mutual recognition principles), available at:
http://r0.unctad.org/trade_env/test1/meetings/tk2/drahos.draft.doc; Convention on the law applicable to
contractual obligations, concluded June 19, 1980 at Rome, Art. 7(1) (Rome I Convention) (authorizing
application of mandatory rules of law of other countries “with which the situation has a close connection”
for contractual disputes), available at: http://www.rome-convention.org/instruments/i_conv_cons_en.htm;
Dinwoodie, G.B. (2003), p. 202 (discussing universal jurisdiction); European Union, Council Regulation
(EC) No 44/2001 of 22 December 2000 on jurisdiction and the recognition and enforcement of judgments
in civil and commercial matters, O.J. L 12/1 (Jan. 16, 2001) (adopting complex rules for when courts have
jurisdiction and must recognize and enforce judgments rendered in other jurisdictions), available at:
http://europa.eu.int/eur-lex/pri/en/oj/dat/2001/l_012/l_01220010116en00010023.pdf.
154
See, for example, United States Department of State (2001) (noting that the forum non conveniens
doctrine in United States law permits courts to decline jurisdiction where the forum is inconvenient and
adequate alternative forums exist), available at: http://www.state.gov/www/global/legal_affairs/us_annexc.html; Altman v. Republic of Austria, 317 F.3d 954, 972 (9th Cir. 2002) (noting that the forum non
conveniens doctrine authorizes district courts in the United States to decline to exercise jurisdiction based
on the convenience of the parties and the interests of justice, subject only to abuse of discretion review),
affirmed on other grounds, 541 U.S. 677 (2004).
155
See, for example, Handelskwekerij G.J. Bier B.V. v. Mines de Potasse d'Alsace S.A., Case 21/76, [1976]
E.C.R. 1735, 1745 (referring from a national appellate court to the European Court of Justice a question of
interpretation under the European Convention on Jurisdiction and Enforcement of Judgments in Civil and
Commercial Matters, Art. 2, done at Brussels, Sept. 27, 1968, 33 O.J. Eur. Comm. (C189/1) 1 (July 28,
1990)); Dinwoodie, G.B. (2004), pp. 14–15 (discussing concerns over judicial competence that might
“counsel in favor of input from courts in countries with developed bodies of traditional knowledge law,”
noting concerns of developed countries over deference to foreign institutions in the contexts of negotiation
of the Hague Convention on Jurisdiction, Recognition and Enforcement of Foreign Judgments in Civil and
Commercial Matters, Working Document No. 110E (Revised) (27 April 2004), and suggesting use of
international institutions to determine compliance issues). Cf. United States law 28 U.S.C. §§ 1781, 1782
(discussing authority to receive letters rogatory and to compel assistance to foreign and international
tribunals); European Convention on Transfer of Proceedings in Criminal Matters, opened for signature May
15, 1972, entered into force March 30, 1978 (delineating principles for transfer to courts with concurrent
jurisdiction).
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72.
Finally, mandatory disclosure of origin treaty provisions will likely need to be
translated into domestic legislation and administrative rules, because such obligations
may need to be phrased in general terms and because some national legal systems do not
permit adoption of self-implementing treaty provisions. An obvious principle underlying
the drafting of such treaty provisions is that the language of mandatory disclosure of
origin obligations should be made as clear as possible so as to avoid disputes regarding
their meaning and to facilitate their translation into national laws and rules. Further,
attention should be given in the text to how failures by parties to fully implement those
requirements should be addressed. Provisions for dispute resolution among parties
already exist for the TRIPS Agreement,156 which appears to be the most appropriate
treaty regime in which to locate provisions on mandatory disclosure of origin obligations.
C.

Choice of treaty regime to implement mandatory disclosure obligations

73.
Numerous countries have suggested amending the TRIPS Agreement’s patent
provisions (specifically TRIPS Article 29) to include mandatory disclosure of origin
obligations.157 Applying such disclosure obligations only in the context of patents,
however, would not affect other intellectual property applications whose subject matter
implicates CBD access and benefit-sharing requirements.158 Of particular relevance, such
a limitation would not apply mandatory disclosure obligations to the subject matter of
plant breeders’ rights, if such rights were not provided by patents but rather by plant
breeders’ certificates under the UPOV Convention (as is permitted by Article 27.3(b) of
the TRIPS Agreement). The UPOV Convention’s 1978 and 1991 texts addressing plant
breeders’ rights might need to be amended to assure mandatory disclosure of origin
obligations in applications for those rights. However, there are many fewer parties to the
UPOV Convention than to the TRIPS Agreement. Thus, if such obligations were
provided only in the UPOV Convention, they would not apply directly to countries that
are not signatories to that Convention.
74.
Without regard to the political economy of the choice of treaty regime in which to
locate mandatory disclosure of origin obligations,159 the most appropriate seems to be the
TRIPS Agreement (without limiting those obligations to patent applications). The main
reasons for this are: the large membership of the WTO; the recognized expertise of the
WTO in intellectual property issues; the comprehensive approach of the TRIPS
Agreement to the intellectual property system; the obligation of the WTO to address the
relationship of the TRIPS Agreement to the CBD, pursuant to paragraph 19 of the Doha
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See generally, WTO, Marrakesh Agreement Establishing the World Trade Organization, Annex II,
Understanding on rules and procedures governing the settlement of disputes, concluded April 15, 1994,
effective Jan. 1, 1995, available at:
http://www.wto.org/english/tratop_e/dispu_e/dsu_e.htm.
157
WTO, IP/C/W/356, § 10 (proposing to amend the TRIPS patent provisions); WTO, IP/C/W/403, § 1
(same); WTO, IP/C/W/404, p. 6 (proposing to amend Art. 29).
158
Again, application of disclosure of origin requirements to utility models, petty patents, trademarks,
industrial designs and other sui generis protections is not addressed here, but is implicated by the analysis.
159
Helfer, L.R. (2004), Yu, P.K. (2004), p323
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Declaration;160 the provision in the TRIPS Agreement for a review procedure;161 and the
existence of the WTO’s binding mechanism for dispute settlement to address violations
of requirements.162 Because the WTO does not implement many intellectual property law
treaties, however, appropriate measures would need to be included in the TRIPS
Agreement to ensure the application of new mandatory disclosure of origin treaty
provisions to other intellectual property treaty regimes.163 Those regimes might then need
to be amended to effectively incorporate the relevant obligations to be effectuated.164
Provision might also be made to assure a continuing role for the CBD to provide
assistance and coordination in developing and implementing disclosure of origin
requirements.
75.
On the other hand,, including new mandatory disclosure of origin treaty
provisions in the CBD would more readily allow linkage and continuing coordination of
disclosure of origin obligations with CBD access and benefit-sharing requirements. The
CBD secretariat also has substantial technical expertise regarding genetic resources and
associated traditional knowledge associated with the subject matter of intellectual
property applications, as well as substantial legal expertise regarding the CBD and
national access and benefit-sharing requirements. Nevertheless, the CBD would be a less
appropriate location than the TRIPS Agreement for such new treaty provisions. Locating
such provisions within the CBD regime would not incorporate disclosure requirements
directly into the intellectual property law system, and thus would complicate efforts to
assure that disclosure obligations are adopted within intellectual property treaty regimes.
Further, disclosure of origin obligations mandated within the CBD would not directly
apply to the intellectual property systems of countries that are not Parties to the CBD,165
but which may be Parties to the TRIPS Agreement. The CBD COP could make a
contribution to possible negotiations on the contents of disclosure obligations to be
adopted within the TRIPS Agreement, either within the context of the ongoing review of
the TRIPS Agreement and WTO Doha Round negotiations or of CBD COP efforts to
develop international treaty provisions for further addressing access and benefit-sharing
requirements.

160

WTO, WT/MIN(01)/DEC/1, p. ¶ 19, 2001, available at:
http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_e.pdf.
161
TRIPS Agreement, Art. 71.1.
162
WTO, IP/C/W/447, p. 13 (the TRIPS review process and binding mandates “makes this the ideal forum
for incorporating requirements concerning disclosure of origin and legal provenance in the text of the
TRIPS Agreement”).
163
See, for example, TRIPS Agreement, Arts. 2, 27.3(b) (requiring compliance with specific provisions of
the Paris Convention, and limiting the effects of the Agreement on existing obligations under other
Conventions; requiring protection for plants under patent requirements regulated by the TRIPS Agreement
or under the UPOV Convention or a sui generis protection system).
164
Under the Vienna Convention, later-enacted treaties control in the event of conflict. Vienna Convention
on the Law of Treaties, May 23, 1969, Arts. 31(2) and (3), 1155 U.N.T.S. 331 (Vienna Convention). Thus,
it may not be necessary to amend those treaties to permit effectuation, but coordination and any necessary
amendment would be preferable.
165
Notably, although the United States is a signatory to the CBD, it has not ratified the Convention. See
Parties to the Convention on Biological Diversity/Cartagena Protocol on Biosafety, available at:
http://www.biodiv.org/world/parties.asp.
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76.
Given the comprehensive nature of the TRIPS Agreement and other relevant
features of the WTO regime, WIPO would not appear to be the most appropriate choice
of forum for developing new international treaty provisions to effectuate disclosure of
origin requirements. The TRIPS Agreement is part of a set of WTO agreements that
address not only intellectual property but other concerns as well; it may therefore more
readily integrate CBD access and benefit-sharing considerations within the intellectual
property law system. In contrast, WIPO has a narrower focus on the intellectual property
law system. Although WIPO possesses a wealth of expertise regarding intellectual
property concerns and the mechanics of intellectual property applications and their
processing, it lacks relevant expertise relating to biological diversity and to issues of
access and benefit-sharing.166 Further, although the Paris Convention addresses a broad
range of intellectual property issues,167 it does not generally establish comprehensive
minimum standards as does the TRIPS Agreement and neither does it relate its
requirements to other intellectual property treaty regimes. New treaty provisions adopted
within a WIPO-administered treaty context, moreover, would be subject to voluntary
ratification, and would not be able to take advantage of the dispute settlement mechanism
that the WTO provides.

166
167

CIEL (2005), ¶¶ 5–8.
Paris Convention Arts. 4–11.
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III.

Options for application procedure triggers

77.
Disclosure of origin obligations may require submission of various types of
information that may be subjected to different kinds of evaluations during and after the
process of applying for intellectual property. The analysis below first identifies how
genetic resources and associated traditional knowledge may substantively relate to the
subject matter of applications for intellectual property, the types of evaluations that may
be performed, and the types of information that may be submitted. This is followed by a
discussion of the different procedural triggers for submitting and evaluating disclosure of
origin information and a brief description of various consequences that might result from
disclosure failures.
A.

Substantive triggers

78.
One of the most basic issues for disclosure of origin obligations is when the
subject matter of the application for intellectual property is sufficiently related to genetic
resources and associated traditional knowledge as to require the disclosure of relevant
information.168 Prior analyses have noted that evaluations pursuant to traditional patent
law doctrines – such as understanding the scope of the claimed subject matter,
determining whether it constitutes prohibited subject matter, evaluating the adequacy of
written descriptions and enablement, examining prior art, and assessing inventorship and
entitlement to apply for or own patents – already may require applicants to disclose the
source and country of origin of genetic resources and traditional knowledge and to list
some persons involved in developing the subject matter.169 Deposits of source materials
or other biological materials may also be required.170 Material transfer agreement
contracts also may specify the relationship between source materials and “derivatives,”
and such relationships may, in some cases, impose ownership or disclosure obligations
that extend beyond traditional patent law doctrines such as inventorship.171 Thus the
relationships of genetic resources and associated traditional knowledge to the subject
matter of applications under traditional patent law doctrines cannot be reduced to simple
formulations.172
79.
Numerous proposals have been made to require disclosures of origin in regard to
genetic resources under various conditions, when such information is not already
specifically required under national patent laws. For example:

168

WTO, IP/C/W/429 Rev. 1, ¶ 7.
See, for example, WTO, IP/C/W/429 Rev. 1, ¶¶ 4–6, 8; UNEP/CBD/COP/7/INF/17, ¶¶ 32–52, 57–64.
170
See, for example UNEP/CBD/COP/7/INF/17, ¶¶ 32(a), 102–105; Budapest Treaty on the International
Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure (1977), concluded Apr.
28, 1977, effective Aug. 19, 1980, amended Sept. 26, 1980, effective May 24, 1984, available at:
http://www.wipo.int/treaties/en/registration/budapest/pdf/trtdocs_wo002.pdf;
and
WIPO
(2005),
Provisional Compilation, Submission of Japan, pp. 23–24 (noting that disclosures cannot substitute for
deposits).
171
UNEP/CBD/COP/7/INF/17, ¶¶ 107–109.
172
Id., ¶¶ 92–109, 112–114.
169
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•
•

•

The Bonn Guidelines suggest the need for such disclosures when “the
subject matter of the application concerns or makes use of genetic
resources [or traditional knowledge] in its development”;173
The Swiss proposal would require disclosures only when the subject
matter of the patent application is “directly based” on genetic resources or
traditional knowledge, by making immediate use of the genetic resources
and by having sufficient contact with the traditional knowledge to identify
relevant properties;174 and
Various national or regional laws, such as those of the Andean
Community, require extensive disclosures (including contracts for access
and documentary information on legal provenance for access to traditional
knowledge) based on much broader relationships to the subject matter of
the applications (e.g. for products or processes that are developed or
obtained from genetic resources or traditional knowledge).175

Consideration must therefore be given to the purposes to be accomplished by disclosure
requirements and the benefits or burdens such disclosures would provide or impose.
1.

Substantive triggers and the purposes of disclosure requirements

80.
The appropriate linkage for disclosure of origin requirements of genetic resources
and associated traditional knowledge to the subject matter of an intellectual property
application will depend on the reasons for making the disclosures and on the types of
information to be disclosed and evaluated.176 Broader reasons for making disclosures
entail correspondingly broader substantive relations between the subject matter and the
applicant on one hand and the kinds of information that may become relevant for
disclosure on the other. The following paragraphs present a non-comprehensive list of
determinations that would constitute reasons for requiring disclosures of origin, which
gives an indication of the breadth of information that may be relevant. In general, the
applicant should already know at the time the application is filed what genetic resources
and associated traditional knowledge are involved, and the sources and countries
providing such resources and knowledge.177 However, the applicant may not necessarily
173

UNEP/CBD/COP/6/20, CBD COP Decision VI/24, Annex, C, ¶¶ 1, 2.
WTO, IP/C/W/423, ¶¶ 27-28.
175
Andean Community, Decision 486, Common intellectual property regime, concluded Sept. 14, 2000 at:
Lima, Arts. 26(h) and (i), available at: http://www.comunidadandina.org/ingles/treaties/dec/D486e.htm.
See also Andean Community, Decision 391, Common regime on access to genetic resources, concluded
July 2, 1996 at Caracas, Complementary provisions (second provision which prohibits recognition of
intellectual property obtained in violation of access requirements, and authorizing member countries to
request
nullification
of
granted
rights
or
privileges),
available
at:
http://www.comunidadandina.org/ingles/treaties/dec/d391e.htm.
176
Various countries have implicitly identified these purposes as the underlying premises to be explored for
disclosure of origin obligations, asking how such requirements would help in various contexts, for example,
improving examination, ensuring a “harmonious relationship” between the CBD and the TRIPS
Agreement, and achieving the objectives of the CBD; WTO, IP/C/W/420 and Add.1, II. Checklist of Issues,
¶¶ 1–3 available at: http://www.wto.org/english/tratop_e/trips_e/art27_3b_e.htm.
177
Two notable exceptions are when the subject matter was developed without the applicant realizing that
such resources, materials or knowledge were used in or otherwise related to the development, or when the
174
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know all persons involved, the countries of origin, what authority the source possessed to
transfer the resources, materials or knowledge under the applicable conditions, and
whether use of the resources, materials or knowledge leading to or incorporated in the
subject matter of the application conforms to applicable legal requirements. Such
determinations sometimes may require legal judgments that the applicant cannot itself
perform, such as judicial determinations of unfair competition or unjust enrichment. In
such cases, disclosures of information nevertheless may facilitate the identification of the
persons involved, the country of origin and the authority of the source, which may also
facilitate required legal determinations.
Determinations relating directly to intellectual property laws
81.
Because national intellectual property laws differ, existing requirements for
disclosure of origin in intellectual property applications also differ. For patent
applications, genetic resources and associated traditional knowledge typically are
required to be disclosed to the extent they constitute known prior art relevant to
examination, or when they are needed to enable those skilled in the art to practice the
claimed subject matter. In some jurisdictions, national patent laws also require applicants
to disclose their status as inventors,178 and to disclose the source of genetic resources and
associated traditional knowledge if the source is a joint inventor or holds a sufficient
interest to be treated as an applicant or owner. Further, national patent laws may impose
requirements for applicants and owners to share the commercial benefits of the invention
with other persons involved.179 The applicant also may disclose the country of origin
when identifying the sources and countries providing genetic resources and associated
traditional knowledge, the inventors, co-applicants and co-owners, and other persons
involved. On the other hand, the applicant may not know or be required to disclose
whether the source had authority to transfer genetic resources and associated traditional
knowledge, whether benefits have been equitably shared, or the identity of the original
source and country providing resources or knowledge where improvements are made to
derivatives of the original resources. However, disclosures may be required even though
the subject matter is not “directly based” on such inputs, as the scope of information
relevant to substantive validity and entitlement determinations may extend beyond what
the applicant did with the inputs.180
82.
Because intellectual property laws do not exhaust the laws governing ownership
interests or rights to equitable benefit-sharing (including the law of contracts181), the
applicant has not fully described those aspects of the resources, materials or knowledge of which use was
made.
178
In many jurisdictions, applicants must file in the name of the inventor. Under the Paris Convention, the
inventor is entitled (but not required) to be identified. Paris Convention, Art. 4ter.
179
For example, Japanese Patent Law Art. 35 requires the provision of reasonable remuneration to
inventors who transfer their rights or otherwise enable their employers to obtain patents on their inventions.
180
For example, UNEP/CBD/COP/7/INF/17, ¶¶ 98–100 (describing various uses of inputs in relation to the
subject matter of applications).
181
Id., ¶¶ 74–79 (discussing licences and material transfer agreements containing shared ownership
requirements for derived subject matter, and varying consequences of failures to record ownership interests
relating to transfers and enforceability of intellectual property).
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category of determinations relating to intellectual property laws is not self-contained.
National intellectual property laws may require applicants to provide declarations and
supporting documentation regarding their entitlements to apply for and own intellectual
property; they may also require supporting documentation regarding declared information
(at least to the extent that the national office “may reasonably doubt the veracity” of the
applicant’s declaration).182 Accordingly, disclosures of origin required by intellectual
property laws may include, by reference, disclosures required by laws governing
entitlements and equity.
Determination of entitlements and equity under other laws
83.
Numerous laws, including those defining misappropriation and unjustified
enrichment, define who may qualify as an applicant for or owner of intellectual property
and who may possess beneficial interests in intellectual property that would require
equitable benefit-sharing. Various submissions have noted the need for disclosures of
origin to: assist in deterring, identifying and remedying misappropriation; prevent misuse
of the intellectual property law system for advancing and providing benefits in cases of
inequitable conduct; and ensure equitable sharing of the commercial benefits of genetic
resources and associated traditional knowledge.183 Accordingly, laws addressing
entitlements and equity may require disclosure of the authority of the source to provide
access to genetic resources and associated traditional knowledge for the uses leading to
the subject matter of the intellectual property application, documentary information
regarding equitable benefit-sharing, or identification of the original source and country of
origin in the case of derivatives. Moreover, failure to disclose such information may
affect the validity or enforceability of the intellectual property. For example, failure to
disclose unauthorized acquisition of genetic resources and associated traditional
knowledge might qualify as inequitable conduct or “unclean hands”, which would
prevent enforcement of patents.184 Such legal and equitable concerns may apply even in
the absence of bad faith (e.g. where a source unknowingly lacked authority to provide
access to those inputs).185
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Id., ¶ 177 (quoting PCT Rule 51bis.2(a) and (b)).
For example, WTO, IP/C/W/443, ¶ 3; CIEL (2005), ¶ 25 and n.54, ¶ 26 and n.55.
184
For example, Precision Instrument Mfg. Co. v. Automotive Maintenance Mach. Co., 324 U.S. 806, 809–
810, 815, 819–820 (1945) (case under United States law upholding the dismissal of an action to enforce
patents that were obtained based on fraudulent statements in an interference regarding the date of invention
– and probably also involving incorrect inventorship); Seismograph Service Corp. v. Offshore Raydist, 135
F. Supp. 342, 347-48, 353-56 (E.D. La. 1955) (case under United States law invalidating on prior art
grounds a patent that was based on misappropriated information and possible false inventorship, and
suggesting that an equitable remedy of a royalty free licence would have been appropriate had the patent
been valid), affirmed in pertinent part, 263 F.2d 5, 22 (5th Cir. 1959).
185
Many ex-situ repositories and depositories exist for genetic resources and biological materials.
Although ITPGRFA Art. 12.3(d) prohibits intellectual property or other rights or privileges that would
restrict access to materials obtained through the multilateral system in the form received, the ITPGRFA
may not prevent application of equitable principles to derivatives for which intellectual property may be
sought.
183
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Determination of compliance with CBD legislation and contracts
84.
Legislation implementing CBD access and benefit-sharing obligations, and
contracts adopted pursuant to such legislation or to effectuate access and benefit-sharing
requirements, also may require disclosures of origin. Disclosing the source or country
providing genetic resources and associated traditional knowledge and the country of
origin may assist countries and indigenous or traditional communities to identify
unauthorized access or use and inequitable benefit-sharing. Such disclosures may be
particularly helpful in the absence of CBD-implementing legislation in the country
providing genetic resources and associated traditional knowledge, or in the absence of
contracts establishing conditions for access and equitable benefit-sharing.186 Conversely,
CBD-implementing legislation or contracts concluded in the country providing genetic
resources and associated traditional knowledge, or the country of application, could
require disclosures of any relevant information. Such disclosure requirements raise
recognition and enforcement issues.187
Other motivations for requiring disclosures
97.
Various other motivations have been identified for requiring disclosures of origin,
which would suggest different substantive triggers and the submission of different types
of information. For example, disclosure of the source, the country providing genetic
resources and associated traditional knowledge, and the country of origin may provide a
more predictable environment for governments, investors, traditional communities and
researchers to enter into transfers of such resources or knowledge.188 Further, prior
informed consent for access and equitable benefit-sharing principles are not limited to
genetic resources and associated traditional knowledge regulated by the CBD.
Accordingly, mandatory disclosure of origin requirements could extend beyond the CBD
context.
2.

Types of information to be disclosed

98.
In many cases, the level of effort involved in developing and submitting various
types of information may not be significant if the applicant already possesses such
information. Relevant information may need to be known in order to ground the
applicant’s belief in its entitlement to apply for and to own the relevant intellectual
property. Intellectual property laws may require the presentation of known information,
although it may not be required in a format that would distinctly identify it as a disclosure
of origin.189
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For example, WTO, IP/C/W/368, ¶ 24 (citing IP/C/M/32, ¶ 128 and IP/C/M/28, ¶ 158).
For example, Colombia has proposed that the text of a Swiss proposal to amend the PCT refer to
national law applied by any Member State, rather than to the designated office, to assure that the disclosure
obligation is mandatory in all PCT Members even when the country of origin is not designated by the
applicant. See WIPO (2005), Provisional Compilation, Submission of Colombia, p. 15.
188
For example, WTO, IP/C/W/368, ¶ 24 (citing WTO, IP/C/W/228).
189
WTO, IP/C/W/429 Rev. 1, ¶¶ 9-10 (noting the need to “cull out” relevant information from that “usually
collected and recorded in the process of invention”).
187
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99.

For each of the substantive relationships that might trigger disclosures, there are
at least three non-exclusive categories of information that could be submitted:
•
•

•

The required information only;
The required information along with a declaration by the applicant, which
may address adequacy of any required investigation, accuracy of any
disclosed information, or compliance with applicable access and benefitsharing requirements; and
The required information along with supporting documents.

In addition, required information may be submitted along with an international certificate
of origin issued by a competent entity attesting to compliance with authorization and
benefit-sharing requirements.190 Issues relating to certificates of origin are discussed in
Part VI below.
100.

For each of the categories of information to be disclosed, disclosure of origin
requirements may require disclosure of specified contents and the use of specified
formats. These include:
•
•
•
•
•

Presenting information on standardized forms using standardized terms;
Addressing specified mandatory contents;
Describing specified levels of effort and documenting investigations
performed;
Listing a specified set of conclusions reached and explaining the bases
therefore; and
Providing indications of levels of confidence.

Disclosure of information only and level of effort
101.
Mandatory disclosure obligations may require applicants to disclose relevant
information already known to the applicant,191 similar to existing patent laws that require
disclosure of known, relevant information.192 For some types of disclosures of origin,
however, it may be necessary to specify the level of effort to be imposed on the applicant
to identify and disclose the relevant information. For example, the applicant should
normally know the source and country providing genetic resources and associated
traditional knowledge, and ought to know the authority of the source to provide access on
the specified conditions of use (or at least should have good reason to believe in that
authority, when legal judgments are required that the applicant is not qualified to make).
However, the applicant may not necessarily know the country of origin, persons involved
and the original country of origin for improvements to derived genetic resources.
Mandatory disclosure obligations thus may need to specify the extent of investigation
190

Correa, C.M. (2003), p. 9.
Id., p. 6.
192
For example, United States laws, 37 C.F.R. § 1.56(a) and (c), require disclosure of all information
material relevant to patentability known by a variety of persons involved in applying for patents.
191
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required of applicants to obtain such information based on the uses to which that
information may be put during or after application.
Declarations of applicants
102. Sworn oaths or declarations by applicants for intellectual property may be a useful
addition to the disclosure of information only, particularly in cases where the applicants
know that they have obtained and used the relevant genetic resources and associated
traditional knowledge from a source with authority and have provided or arranged for
equitable benefit-sharing. They could also be useful for applicants who know whether
and to what extent they have made investigations to identify information and to
determine that the information is correct and complete. However, such declarations may
be difficult to provide in the absence of clear rules identifying the level of effort required
or of transparent standards for determining prior informed consent for access and
equitable benefit-sharing. And they may not be possible when they require legal
judgments that the applicant is not qualified to make. Moreover, declarations may impose
substantial burdens on applicants to verify the accuracy of the information on which the
declarations are based. Nevertheless, declarations could prove useful as a preventive
measure to assure conformity to applicable requirements and as a deterrent to
unauthorized conduct, particularly where fraudulent declarations may result in significant
civil or criminal sanctions.
Documentary information
103. Documentary information may also be a useful addition to the disclosure of
information only or to such disclosure supplemented by declarations. Various countries
have suggested including in mandatory disclosure of origin requirements evidence of
compliance with access and benefit-sharing requirements (including submission of
contracts for access and benefit-sharing).193 However, it may be impossible to provide
complete documentation regarding compliance with equitable benefit-sharing obligations,
as such obligations may extend to future commercial benefits, the generation of which the
application for intellectual property is intended to enable. Furthermore, documentary
information regarding entitlements to apply for, own or receive benefits from intellectual
property, and regarding compliance with laws implementing CBD access and benefitsharing requirements, may involve complex legal determinations that intellectual
property application offices are not well suited to make. As a result, the application
offices would not readily be able to evaluate such documentary information, although
evaluation may already have been required to determine the substantive validity of or
entitlements to apply for or own intellectual property.194
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For example, WTO, IP/C/W/356, ¶ 10; WTO, IP/C/W/403, ¶ 1; WTO, IP/C/W/404, pp. 5–6.
WTO, IP/C/W/433, ¶¶ 21–22 (noting that proposals to include such evidence have not argued for
substantive evaluation of the documents by national patent offices, when there is no challenge to the
validity of a patent in a pre-grant or post-grant opposition or revocation proceeding); Correa, C.M. (2003),
p. 9 (noting the lack of technical preparation for national intellectual property offices to assess such
requirements of foreign laws).
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Trade secrecy of disclosed information
104. Trade secrecy concerns may be triggered by disclosures where the information is
not itself part of the subject matter of the intellectual property application, and is not
required to be disclosed under the relevant intellectual property laws. These concerns
could be addressed by subjecting such information to protection from public disclosure
upon an adequate showing of trade secret status.195
3.

Relationships establishing substantive triggers

105. Disclosed information may relate to many different types of substantive
evaluations that are relevant to determinations during and after the process of applying
for intellectual property. Substantive triggers may include those:
•
•
•
•
•

Relating the source to the subject matter of the application;
Relating the source to the applicant.
Relating the applicant to persons involved;
Disclosing the country of origin; and
Disclosing documentary information regarding compliance with access
(including prior informed consent) and benefit-sharing requirements.

Consideration must be given to whether and to what extent to require information relating
to these different substantive triggers.
Relationship of the source with the subject matter
106. The source of genetic resources and associated traditional knowledge may relate
to the subject matter of intellectual property applications in a variety of ways. These may
include:
•
•
•
•
•
•

Forming part of the subject matter for which intellectual property is sought
(including as a required disclosure to enable others to use or replicate the
subject matter);
Use during the process of developing the subject matter;
Use as a necessary prerequisite for developing the subject matter;
Use to facilitate development of the subject matter;
Use as necessary background material or information for development of
the subject matter; and
Forming part of the prior art relevant for examination of the application.196
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For example, United States law, 40 C.F.R. Part 350, requires assertion and documentation of claims to
trade secrecy status of information submitted in regard to emergency planning information disclosure
requirements.
196
WTO, IP/C/W/429 Rev.1, ¶ 8; WTO, IP/C/W/404, p. 6; UNEP/CBD/COP/7/INF/17, ¶¶ 92-101;
WIPO/IP/GR/05/03, ¶ 83.
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In addition, the importance of the genetic resources and associated traditional knowledge
to the subject matter may vary, ranging from essential (e.g. as a component of the subject
matter or integral to its development) to marginal (e.g. as providing prior art disclosures
of how others had failed to develop the subject matter, without suggesting the subject
matter).
107. Determining whether and what disclosures to require in all of these situations
should depend not only on whether such information is required under traditional
intellectual property law principles, but also on the additional purposes to be
accomplished and on the importance of the input to the subject matter. A broad approach
to triggering disclosure of such information should be adopted, because it may be
difficult to determine by generic category and in advance what types of relationships to
the subject matter will exist, and how those relationships may affect entitlements to apply
for or own the intellectual property sought. The applicant should normally possess
information regarding the source of genetic resources and associated traditional
knowledge,197 so that little effort would be required to submit such information or
declarations of the source or documents identifying the source. Yet the potential use of
such information may be substantial.
108. Where information regarding the source is known, information on the country
providing the genetic resources and associated traditional knowledge should also be
known. A broad approach to triggering disclosure of such information should be adopted.
Disclosure of the country providing genetic resources and associated traditional
knowledge is critical to ensuring that applicable access and equitable benefit-sharing
requirements have been complied with under the laws of countries implementing the
CBD. In contrast, more complicated evaluations are needed regarding the benefits and
burdens of disclosing additional information relating to the country of origin, persons
involved, and authority to use the genetic resources and associated traditional knowledge.
109. So-called negative declarations may help ensure that the applicant has performed
an adequate investigation before concluding that genetic resources and traditional
knowledge were not involved in the development of the subject matter of the application,
and thus that no additional disclosures of origin are required. By the same token, positive
declarations may help to ensure the integrity of submitted information and documents
regarding the source, the country providing genetic resources and associated traditional
knowledge, the country of origin, persons involved, and the legal authority for access and
benefit-sharing. Documentary information regarding the source or country providing
genetic resources and associated traditional knowledge may be unnecessary if
declarations are required, although such documentation could help to prevent or detect
fraudulent declarations.
197

Brazil has proposed the disclosure of information on the source and (subject to reasonable efforts) the
country of origin “even where the use was only incidental … if the disclosure were relevant” for
substantive patentability, to understand or use the invention, or for inventorship or entitlement
determinations. WIPO (2005), Provisional Compilation, p. 11, Submission of Brazil. Even if substantial
effort is required, such information may need to be obtained and disclosed in order for the application
office to determine whether or not it is relevant.
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Relationship of the source with the applicant
110.
Both intellectual property laws and other laws define the relationship of the
source with the applicant. Applicants in some jurisdictions are routinely required to
disclose their relationship with the subject matter (e.g. as an inventor, an assignee, or
some other person having a beneficial interest). Applicants normally should know these
relationships in order to ground their belief in their entitlement to apply for or own the
intellectual property. In contrast, it may be more difficult to know of persons involved
who may possess a beneficial interest in the subject matter of the application, and in some
cases entitlement issues may require legal judgments that the applicant is not authorized
to make. In such cases, it may nevertheless be useful for the applicant to identify the
issues that give rise to uncertainties.
111. Accordingly, a broad approach to triggering disclosures of relevant information
also should be adopted in regard to the relationship of the source with the applicant.198
Much of the information should be readily available to the applicant, and thus should not
require substantial effort to disclose. This is true even though such disclosures may not
normally be reviewed by national intellectual property offices (except when they are
clearly lacking in relevant content or when they are subjected to a third-party challenge).
112. Declarations of applicants also may be appropriate in regard to the relationship of
the source with the applicant. For example, inventors of patentable subject matter (and
assignees in the event the inventor is deceased or unwilling) are routinely required to sign
oaths or declarations of inventorship of the subject matter for which patents are
claimed.199 Such declarations could be appropriately limited in the event of legal
uncertainty (e.g. by statements such as “to the extent of the applicant’s knowledge” or
“subject to a contrary legal determination”). Submission of documentary information
regarding the relationship of the source with the applicant may be more appropriate in
this context, as intellectual property laws may already require such information to be
submitted ; it may also be required in order to comply with CBD access and benefitsharing legislation.
Relationship of the applicant with persons involved
113. It may be difficult to determine which other persons may be involved in the
application, as well as the relationship of those persons with the applicant. Information
regarding persons involved may not readily be available to the applicant. For example,
the source or the country providing genetic resources and associated traditional
knowledge may owe equitable benefit-sharing obligations to indigenous or local
198

In the rare case where the source is unknown, disclosure of the genetic resources and associated
traditional knowledge could be made along with a statement that the source is unknown. Cf. WIPO (2005),
Provisional Compilation, p. 14, Submission of Colombia (discussing declarations that the origin is
unknown).
199
For example, United States laws, 35 U.S.C. §§ 115, 117, 118, require an oath or declaration, authorizing
filing in the event of death, and authorizing filing by assignees of unwilling inventors along with
documents proving the relevant facts.
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communities living in different countries. Confirming the existence and scope of such
obligations would likely require legal judgments that applicants may not be qualified to
make, even if they possessed the relevant information. Investigating such issues could
involve significant expenditures of time and resources, without leading to definitive
conclusions.
114. Accordingly, careful evaluation should be made as to whether the potential
existence of persons involved should trigger mandatory disclosure of origin obligations.
To the extent the applicant is aware of such information, disclosure may more readily be
required. Such disclosure will help ensure that the persons involved know of the applicant
and the application. Thus consideration also should be given to mandating a specified
level of effort to identify persons involved, so as to better assure appropriate access and
benefit-sharing. The investigatory burden should not be so great as to discourage the use
of genetic resources and associated traditional knowledge, which would defeat the
purpose of facilitated access and benefit-sharing.200
115. Requirements for disclosure or investigation of persons involved should not
“create uncertainties” with regard to the application process, or generate unnecessary
additional litigation.201 Such uncertainties may already exist if there are persons involved
who possess interests in the application or in equitable benefit-sharing that the applicant
has not recognized. It is the fact that persons are involved, and not the disclosure of their
relationship per se, that may call into question the validity of the intellectual property or
the entitlement of the applicant. Disclosure of information relating to persons involved
may thus help to identify and resolve such existing uncertainties. Because abusive use of
challenge procedures or litigation can be dealt with adequately, the fear of such abuses is
not sufficient reason to reject disclosures of origin relating to persons involved.
116. Consideration should also be given to requiring declarations from applicants
identifying known persons involved and specifying a level of effort to investigate
whether persons are involved; they could also provide negative declarations that no other
persons are involved. Performing exhaustive searches may be unduly burdensome.
Although applicants may not be able to specify the relationship of persons involved that
require legal judgments that applicants may not be qualified to make, applicants may
identify those issues, and thus may assist identification and resolution of existing
uncertainties. Documentary information might be required to demonstrate the relationship
of persons involved with the applicant, particularly when required to demonstrate
compliance with CBD access and benefit-sharing requirements.
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For example, WIPO (2005), Provisional Compilation, p. 25, Submission of Japan.
For example, WIPO (2005), Provisional Compilation, pp. 42, 47 and 50, Submission of the United
States. The contractual approach suggested by the United States (including disclosures to “appropriate
authorities” regarding applications of genetic resources or traditional knowledge, pp. 48–49) does not
remove any such uncertainties. Rather, contracts only add to the types of relevant information that must be
evaluated in regard to whether applicants are entitled to seek intellectual property and whether they specify
additional terms for access and equitable benefit-sharing. Further, contracts may require that the contracts
and other information be disclosed in intellectual property applications.
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Disclosure of the country of origin
117. Disclosure of the country of origin may also involve complex determinations, and
may require extensive investigations to obtain information that applicants may not
routinely possess. For example, it may be difficult to identify the country of origin of
plant varieties, particularly as plant varieties may acquire distinctive characteristics in
different countries.202 Similarly, it may be difficult to identify traditional knowledge that
constitutes prior art,203 and thus to identify the country of origin when such knowledge
formed part of the background to the invention. Because of concerns over sovereign
rights and for other reasons, some countries have suggested that a duty to investigate the
country of origin is warranted.204
118. Accordingly, careful evaluation should be made as to whether a disclosure of the
country of origin should be required. Such information should likely be disclosed when
it is already known by applicants, and consideration should be given to imposing
investigatory obligations to identify countries of origin. This will help with notifying
countries of origin of the use of the resources and of the application for intellectual
property when they are not the country providing the genetic resources and associated
traditional knowledge.
119. Careful evaluation should also be made as to whether to require applicants to
provide declarations of the country of origin and that required investigations were made,
or negative declarations that no unidentified country of origin is involved. Documentary
information relating to the country of origin or to the level of effort of the declaration also
might be required, and could assist in assuring the validity of the information and the
integrity of the declarations.
Disclosure of documentary information on access and benefit-sharing
120. Applicants should normally possess information regarding and documents
(including contracts) demonstrating their compliance with prior informed consent for
access and equitable benefit-sharing obligations imposed by the CBD and by national
legislation implementing the CBD. If they do not have such information and documents,
they may be in violation of the relevant laws. Accordingly, a broad approach to triggering
disclosure of such information and documents should be required, at least for information
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Correa, C.M. (2003), p. 5. In the case of plant genetic resources for food and agriculture obtained from
the Multilateral System set forth by the ITPGRFA, the benefits are multilaterally shared. ITPGRFA, Art.
13. Hence, it might suffice for disclosure obligations to provide an indication that the relevant plant genetic
resources have been obtained from the multilateral system under the standard Material Transfer Agreement,
so long as the purpose and conditions of access are limited solely to the utilization and conservation of the
resources for research, breeding and training for food and agriculture, not including chemical,
pharmaceutical and/or other non-food/feed industrial uses. ITPGRFA, Art. 12.3(a).
203
WIPO, Compilation, Submission of Belize, p. 8.
204
WIPO, Compilation, Submission of Colombia, p. 15 (noting that declaration that the origin of a genetic
resource is unknown “would not suffice for fully satisfying the disclosure requirement”).
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already in the applicant’s possession.205 In some cases, applicants may lack documentary
information, for example when countries have not adopted legislation to implement CBD
requirements. However, applicants risk biopiracy and misappropriation when they are not
qualified to make legal judgments that the source has authority to provide the genetic
resources and associated traditional knowledge for uses leading to intellectual property
applications or that benefit-sharing arrangements will be equitable. Requirements to
disclose information and documents relating to access and benefit-sharing would
therefore help to identify such cases and the issues they raise. Such disclosures would
strengthen incentives that already exist for applicants to investigate the authority of the
source to provide access on specified conditions and ensure the equity of benefit-sharing
arrangements.
121. Moreover, documentary information on access and benefit-sharing will normally
relate directly to entitlements to apply for and own intellectual property or to impose
obligations to restrict use or to share commercial benefits. Such information and
documents may not routinely be reviewed by national intellectual property offices, except
when they appear to be insufficient or when they are subjected to a third-party challenge.
122. Declarations by applicants may also be appropriate with regard to compliance
with access and benefit-sharing requirements. Applicants should know the legal status of
their use of genetic resources and associated traditional knowledge, and of the retention
of benefits deriving from that use. Thus any investigatory burdens associated with
making such declarations should be justified. Such declarations also may assist in
ensuring the integrity of the disclosed information and documents, as well as compliance
with CBD-implementing legislation, as false or fraudulent declarations typically may
invoke substantial liability or civil or criminal penalties. However, where access and
benefit-sharing requirements are not clear, it may be difficult for applicants to provide
declarations. Thus requirements for declarations might need to identify legal
determinations that the applicant in good faith has sought but has been unable to resolve.
B.

Procedural triggers

123. Requirements for disclosures of origin may be triggered at various times, so as to
be of use at different procedural stages during and after application for intellectual
property. Procedural triggers must define the opportunities for required disclosures and
evaluations, the format in which information is to be submitted, and the types of
evaluations that are to be made. They may be imposed by national access and benefitsharing legislation, by contracts and by new treaty requirements. Various non-exclusive
procedural triggers exist for requiring disclosures of origin. Salient times during and after
application for intellectual property to require such disclosures include:
•

The international stage of application processing (in a coordinated
international system of national intellectual property application
procedures);
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WIPO, Compilation, Submission of Brazil, p. 12 (suggesting declarations of source and country of
origin accompanied by relevant evidence of access and benefit-sharing).
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•
•
•

The national stage of application processing;
Pre-grant and post-grant administrative challenge proceedings; and
Judicial proceedings.

For each of the triggers, it is important to consider: the form, prescribed formats and
timing for submission of any required disclosures; whether and to what extent the
disclosed information may be evaluated at the time of the disclosure or at a later stage;
and whether and when to require or permit applicants or owners to supplement or
correct disclosures during or after the application process.
124. When form, prescribed formats, timing and supplementation are evaluated at any
of the relevant times, it also becomes necessary to consider the consequences for failure
to conform to procedural requirements. A brief discussion of the consequences of
disclosure failures is provided here in respect of procedural triggers, and a more extensive
analysis is provided in Part IV.
1.

CBD-related sources of disclosure requirements

Disclosure requirements of CBD- implementing legislation
125. As noted in the WIPO Technical Study, disclosure of origin requirements in
intellectual property applications may “have [their] roots in the laws and regulations of
the source country that relevantly govern access and benefit-sharing.”206 These laws and
regulations thus may become an integral part of the intellectual property law system to
the extent they require disclosures to (and evaluations by) national application offices or
other entities within the intellectual property system. For example, national access and
benefit-sharing legislation could require disclosures regarding genetic resources and
associated traditional knowledge to be made not only to the competent access and
benefit-sharing authorities of the country providing genetic resources and associated
traditional knowledge,207 but also to all jurisdictions (if recognized and enforced in other
countries) where applications for intellectual property are filed that relate in relevant
substantive ways to such resources and knowledge.
126. National access and benefit-sharing laws could impose the same types of
procedural triggers for disclosures of origin as could be imposed pursuant to mandatory
obligations under new international treaty provisions. These include disclosures made at
the time of filing or during the processing of international or national applications, during
pre-grant or post-grant challenge proceedings, or during various forms of judicial
proceedings. Thus, procedural triggers imposed pursuant to national access and benefitsharing laws are not discussed separately below, but rather are subsumed within the
general discussion of procedural triggers.
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UNEP/CBD/COP/7/INF/17, ¶116.
For example, WTO, IP/C/W/400 Rev.1, ¶ 11 (discussing potential reference of disclosures of origin in
PCT applications to a list of “competent government agencies”).
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Access and benefit-sharing contract-imposed disclosure requirements
127. Provisions of contracts entered into pursuant to national access and benefitsharing laws also may require disclosures of origin to competent access and benefitsharing authorities and in intellectual property applications throughout the world.208 The
existence of such contractual disclosure obligations raises “complex question[s] of
private international law.”209 Because such contracts could impose the same procedural
triggers for disclosures of origin relating to intellectual property applications as national
access and benefit-sharing laws, or as mandatory treaty requirements, they are not
discussed separately below.
2.

Procedural triggers for disclosures

Disclosure requirements at the international stage
128. Various countries have suggested that disclosures of origin should be made at
some point during the international phase of patent applications filed under the PCT. 210
The PCT establishes a coordinated international system of national application filing
procedures. Under that treaty, applicants for patents may file a single, initial application
in one country that designates multiple countries in which patents may ultimately be
sought. Applicants thereby obtain the benefit of the international filing date when they
ultimately prosecute patent applications in regional or national patent offices around the
world.211 These suggestions (which can be broadened to address the international stage of
any coordinated international system of national intellectual property application
procedures) have the advantage of ensuring that disclosures of origin would be
transferred to all national offices of countries to which applications are made for
intellectual property through the international system. However, these suggestions do not
provide detailed discussions of options for required disclosures at the international stage,
for evaluations that might be performed at that stage, or for the consequences of
disclosure failures.212
208

UNEP/CBD/COP/7/INF/17, ¶ 107 (noting that contracts may result from standard material transfer
agreements stipulated by law or regulations implementing CBD requirements). A discussion of various
issues to be addressed in contracts is provided in WIPO/GRTKF/IC/7/9, available at:
http://www.wipo.int/edocs/mdocs/tk/en/wipo_grtkf_ic_7/wipo_grtkf_ic_7_9.pdf. For example, contractual
terms to be negotiated by parties include who will decide whether to apply for what types of intellectual
property(Id., Annex, ¶ 33).
209
UNEP/CBD/COP/7/INF/17, ¶118 and ¶¶ 108, 129.
210
WIPO/IP/GR/05/01, ¶ 52 (discussing the Swiss proposal of WTO, IP/C/W/433, WTO, IP/C/W/423, and
WTO, IP/C/W/400/Rev.1, which would authorize, but not require, disclosure at the time of filing an
international application “or later during the international phase”); WIPO/IP/GR/05/01, p. 58, Box,
Summary of triggers for disclosure requirements; Procedural options (noting procedural triggers include
initial filing, specific deadlines after filing, formal or substantive examinations, prior to grant or sealing of
patents, during opposition or revocation proceedings, or when patents are asserted or enforced); WTO,
IP/C/W/442, ¶ 9 (discussing provision of evidence of benefit-sharing “at the time of applying for the grant
of a patent”).
211
For example, PCT Art. 3 (international application); PCT Art. 11 (filing date); PCT Art. 20
(communication of international application to designated offices).
212
In the case of the Swiss proposal to amend the PCT, if disclosures of origin are required by the national
law of a designated office, PCT Rule 51bis.3(a) would require the designated office to provide an invitation
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129. Disclosures of origin at the international stage could include the same categories
of information (i.e. disclosures of information only, disclosures with declarations by the
applicant and disclosures with documentary information) pursuant to the same
substantive triggers discussed above. Although the legal consequences of treating these
required information disclosures as “formal” or “substantive” may vary under existing
international intellectual property law treaties, this distinction is not particularly helpful
in terms of specifying alternatives for inclusion as mandatory treaty obligations.213 More
relevant questions relate to the timing, contents and format of the disclosures, the level of
effort required, the nature of any required evaluations at the international stage, and
whether any failures to conform to disclosure requirements will trigger opportunities for
correction or supplementation and will result in mandatory or facultative sanctions.
130. Disclosures may be required initially upon filing of applications or at other stages
of international intellectual property application procedures. Because many disclosures of
origin will directly relate to entitlements to apply for and own intellectual property, they
should be required at filing. However, opportunities should be provided (in the absence
of bad faith or fraudulent intent) to rectify disclosure failures and to supplement initial
disclosures.
131. Different options exist for whether and how evaluations of disclosed information
are to be performed at the international stage. Evaluating disclosures of origin at the
international stage may be efficient if it results in termination of application processing,
which would avoid duplicating evaluations in multiple national application offices. On
the other hand, international stage evaluations may be inefficient if evaluations are
inevitably duplicated at the national stage.
132. Consideration also needs to be given to the competence of international
intellectual property application offices to make various types of evaluations. For
example, disclosures of origin might be evaluated at the international stage for
substantive compliance by applicants with national access and benefit-sharing legislation
of the country providing genetic resources and associated traditional knowledge.
However, international application offices may be poorly qualified to perform such
evaluations, which may require the intervention of authorities of the countries providing
the genetic resources and associated traditional knowledge. The outcome of such
determinations should not vary with the receiving office in which the international
application is filed or with the national intellectual property application offices that are
designated. Although international application offices may be better suited to evaluate
disclosures of origin that relate to entitlements to apply for the subject matter, entitlement
determinations may vary depending on the laws of designated countries in which the
to supply any missing disclosure at the beginning of the national phase, within a specified time limit of not
less than two months from the invitation(WTO, IP/C/W/423, ¶ 25). Further, PCT Rule 26ter provides for
correction or addition to declarations before publication, and for the receiving Office or the International
Bureau to invite applicants to correct declarations under PCT Rule 4.17 if “not worded as required” or (for
inventorship) if “not signed as required.” (WTO, IP/C/W/433, p. 10,reprinting Rule 26ter and noting the
ability of applicants to provide or correct declarations at the international stage).
213
See, for example, UNEP/CBD/COP/7/INF/17, ¶¶ 132-35.
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intellectual property is sought. Evaluations of patentability conducted at the international
stage for PCT applications214 typically apply harmonized and restrictive substantive
evaluation criteria that may differ from national patent laws, and thus are preliminary in
nature.
133.

International stage evaluations could review disclosures of origin for:
•
•
•
•
•
•

Completeness;
Conformity to standardized forms;
Accuracy of the factual information presented;
Substantive validity of conclusions reached;
Conformity of the disclosed information with any declarations by
applicants and documents presented; and
Substantive legality of access and benefit-sharing.

Rules may need to be developed to address burdens of proof and standards for rebuttal in
any such evaluations.215
134. The degree of administrative burden of international stage evaluations increases
substantially if evaluations are required of the factual accuracy of information, the
substantive validity of conclusions reached, or the legality of access and benefit-sharing.
However, some such evaluations may already be required within the intellectual property
law system, where disclosed information may call into question entitlements to apply for
intellectual property or the substantive validity of the application.216 Whether or not
evaluations are performed at the international stage, the information submitted at that
stage might need to be transmitted to multiple national application offices. Disclosures at
the international stage thus impose costs on applicants and additional administrative
burdens on the international application offices.
135. There is also the need to consider whether to specify mandatory or facultative
sanctions in regard to disclosure failures or to leave such decisions to the discretion of
countries in which international applications are filed. Various consequences could attend
the failure to provide complete, conforming, accurate or valid disclosures, initially or
following any opportunities provided for rectifying inadequacies. The most basic
consequence could be to delay processing unless or until the appropriate information is
provided.217 Additional consequences might be imposed when disclosures are found to be
214

For example, PCT Art. 18 (international preliminary search report); PCT Art. 33 (international
preliminary examination report); PCT Rule 43bis (written opinion of the international search authority).
UNEP/CBD/COP/7/INF/17, ¶ 137 (discussing prima facie showings in regard to burdens of proof);
WIPO/IP/GR/05/01, ¶ 87 (discussing burdens of proof in evaluating adequacy of disclosures).
216
For example, PCT, Arts. 33 and 34 (discussing substantive evaluations and procedures for international
preliminary examination).
217
For example, WTO, IP/C/W/442, ¶ 12 (suggesting that applications “would not be processed any
further” without disclosure of required information, and could be accompanied by imposing time limits for
making the required disclosures, following which the application “could be deemed withdrawn”); WIPO,
Compilation, p.56, Submission of the European Communities (suggesting that the required disclosures be
made using a standard application form, and that failure or refusal to disclose should trigger the opportunity
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inadequate, including abandonment of applications (thereby terminating rights of
priority), transfer of rights to prosecute applications, abandonment of entitlements to
apply for or to own the intellectual property, and administrative fines, civil liability or
criminal penalties. These consequences may vary depending on consideration of factors
such as the good faith and diligence of the applicants, administrative burdens of
performing repeated evaluations of corrected or supplemented information, costs of
additional evaluations and delays in processing, and whether such costs may be offset by
applicant fees and other factors.218
136. Various sanctions may also be applied to already issued intellectual property if
disclosures are found to be inadequate after the international stage. Whether such
sanctions are imposed may depend on similar factors to those described above. The
consequences of disclosure failures in this context may include:
•
•
•

•

Substantive invalidation of the intellectual property;
Termination or transfer of ownership of the intellectual property;
Imposition of administrative fines, civil liability or criminal penalties
(including for violations of relevant access and benefit-sharing legal and
contractual requirements) within or external to the intellectual property
law system; and
Requiring the return of any unjustified benefits conferred as a result of
disclosure failures or in violation of access and benefit-sharing
requirements.

137. Part IV provides further discussion of these consequences. However, it is useful
to note here that international application offices may not necessarily possess
administrative subpoena powers or other compulsory processes to require applicants to
provide information or to testify, so as to determine good faith or fraudulent intention.219
Similarly, such offices may not be authorized by national laws or constitutional
provisions to impose punitive fines, civil liability or criminal penalties.
138. Because of the administrative burdens of performing evaluations other than for
completeness or consistency, and notwithstanding the potential to avoid duplicative
determinations at the national stage in multiple jurisdictions, it seems unwarranted to
require review of disclosures of origin at the international stage for factual accuracy or
for substantive validity. Intellectual property examiners at the international stage are
unlikely to possess training in applying access and benefit-sharing requirements or
contractual provisions under the laws of foreign jurisdictions. Nevertheless, the
international office should be authorized to require applicants to supplement with
“to remedy the omission within a certain time fixed under” applicable law, and that the application “shall
not be further processed” in the event of continuing failures).
218
For example, WIPO/IP/GR/05/01, ¶¶ 87-88 (discussing good faith and fraudulent intent with regard to
disclosure failures). Cf. United States law, 35 U.S.C. § 41 (addressing extension of time and petition fees);
United States law 35 U.S.C. § 133 (limiting response time to six months, except on a showing that delay
was unavoidable); United States law, 35 U.S.C. § 151 (limiting issue-fee payments to three months).
219
Cf. United States law, 35 U.S.C. § 24 (authorizing district courts to issue subpoenas to compel testimony
relating to contested patent cases in the US PTO).
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additional information and documents any initial disclosures that appear to be inadequate,
inaccurate or invalid, or when disclosed information appears insufficient to support
conclusions reached or to demonstrate entitlements and substantive validity.
Disclosure requirements at the national stage
139. As at the international stage, at least three different categories of information
relating to different substantive triggers may be disclosed at the national stage of the
application process (i.e. disclosures of information only, disclosures with declarations by
the applicant, and disclosures with documentary information). Similarly, these
disclosures could be presented using specified formats (e.g. standardized forms,
mandatory contents, described levels of effort, specified conclusions and indicated levels
of confidence) and may be corrected or supplemented over time. Where disclosures are
required at the international stage, supplementary disclosures may occur upon entry into
the national stage or thereafter.
140. Evaluations at the national stage may be more extensive, may duplicate, or may
rely to some extent upon evaluations performed at the international stage. Similar types
of evaluations of disclosed information may be performed (e.g. for completeness,
conformity to prescribed formats, factual accuracy, substantive validity of conclusions,
conformity to declarations and substantive legality). As at the international stage, because
of the administrative burdens and lack of training to make determinations regarding
national access and benefit-sharing requirements or contractual requirements under the
laws of foreign jurisdictions, it seems unwarranted to require review of disclosures of
origin for factual accuracy or for substantive validity during initial application
processing. However, national application offices are more likely to use such disclosed
information to make determinations regarding substantive entitlements and substantive
validity of applications under relevant intellectual property law standards.
141. At this stage, as at the international stage, various mandatory or facultative
sanctions could result from failures to provide complete, conforming, accurate or valid
disclosures. In addition to delaying processing of applications, following notice and an
opportunity to correct or supplement disclosure failures in the absence of bad faith or
fraudulent intent,220 additional consequences may include abandonment of applications or
abandonment of entitlements to apply for or to own the intellectual property. Following
issuance of intellectual property, consequences may include substantive invalidation,
termination or transfer of ownership, imposition of fines, liability or penalties, and
requiring the return of any unjustified benefits.
Pre-grant and post-grant administrative challenges
142. Pre-grant and post-grant administrative challenges normally address either the
entitlement to apply for or own the intellectual property or the substantive validity of the
220

For example, WIPO, Compilation, Submission of Colombia, p. 15 (suggesting that the “competent
national office” should notify the applicant and avoid continuing to “other phases of the application
procedure” until the requisite disclosure is made).
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issued intellectual property. Unlike during the initial application process, pre-grant and
post-grant administrative re-examination, interference, revocation or opposition
proceedings may involve more substantial administrative procedures and may provide for
the participation of interested third parties.221 Such proceedings therefore may be more
appropriate for conducting more extensive evaluations of the factual accuracy and
validity of conclusions regarding disclosures of origin. Depending upon when such
proceedings are available, they may be considered efficient and low-cost alternatives to
judicial resolution of intellectual property application or ownership disputes.222 The
availability and procedures for such challenges, however, vary across jurisdictions.
143. Mandatory or facultative evaluations of disclosures of origin in pre-grant or postgrant challenge proceedings are unlikely to be limited to reviews for completeness and
for conformity to prescribed formats, because of the inherent potential for such
challenges to link disclosures of origin to substantive entitlements or to the validity of
applications or granted intellectual property. In such challenges, therefore, national
offices may be required to evaluate information regarding the authority of the source to
provide access to genetic resources and associated traditional knowledge, and of the
applicant to provide for equitable benefit-sharing under actual conditions of use. Where
pre-grant and post-grant challenges do not relate to disclosures of origin, however, it may
not be warranted for national offices to evaluate the disclosed information for factual
accuracy or validity of conclusions.
144. Given that pre-grant and post-grant administrative challenges to intellectual
property are typically conducted when prior information and evaluations have been called
into question, different types of or additional disclosures of origin may be required, and
different substantive triggers adopted. Similarly, correction or supplementation of earlier
disclosures and submission of documentary information relating to those disclosures is
more likely to be requested or required. Evaluation of such additional disclosures within
the context of the administrative proceeding may be efficient, limiting the need for
subsequent or duplicate judicial actions to determine relevant issues.
145. The same types of mandatory or facultative sanctions could result from disclosure
failures discovered at the pre-grant or post-grant administrative challenge stage.
However, because such challenges involve more extensive procedures and may be
adversarial, additional burden of proof rules and presumptions may need to be specified.
Unlike during ex parte administrative proceedings, international or national application
offices may need to adjudicate competing evidentiary presentations of opposing
221

For example, United States law, 35 U.S.C. §§ 311-18 (specifying inter partes re-examination
procedures); United States law, 35 U.S.C. § 135 (specifying interference procedures); European Patent
Convention (EPC), Arts. 99–105 (specifying opposition procedures). Cf. United States law, 35 U.S.C. §§
301-07 (specifying ex parte re-examinations, subject to the same procedures as initial examination after a
determination that sufficient cause exists and after the filing of an initial statement and reply).
222
See, for example, EPC Art. 99(1) (limiting oppositions to filing within nine months after publication of
notice of grant); United States Patent and Trademark Office, 21st Century Strategic Plan, Action Paper 40:
Post-Grant Review of Patent Claims,2003 (noting that post-grant review under United States law provides
accused infringers and patent holders with an alternative forum to district court litigation of patent validity
issues”), available at: http://www.uspto.gov/web/offices/com/strat21/action/sr2.htm.
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parties.223 Further, pre-grant and post-grant challenge procedures create the potential for
formal and informal discovery mechanisms, which may assist in addressing information
gaps in regard to the various disclosure issues to be evaluated. In such proceedings,
national application offices may or may not possess administrative subpoena powers.
Judicial proceedings
146. Disclosures of origin may be required and evaluations of disclosed information
may occur in judicial proceedings, giving rise to challenges to the validity of a patent
(e.g. in infringement or declaratory judgment actions). Disclosures may also be required
and evaluations made in other judicial actions that relate to the subject matter, the
applicant, the persons involved, the country of origin, and conformity with access and
benefit-sharing requirements. Thus the range of issues to be addressed in such judicial
proceedings may be broader than in the context of application procedures or pre-grant
and post-grant administrative challenges.
147. Judicial systems also differ with respect to their reliance on adversarial or
inquisitorial procedures to reach determinations.224 These differences may affect not only
how much information and documentation is requested, but also who may participate and
what type of information discovery may be obtained. Participants in judicial proceedings
may include applicants for or owners of intellectual property, accused infringers, persons
involved who may claim various entitlements and other interested third parties. Different
rules regarding burden of proof and presumptions in regard to disclosures of origin may
be appropriate for judicial proceedings. In contrast to international or national stage
examination or administrative challenges, moreover, judicial systems typically possess
subpoena powers and other compulsory process authority to require testimony and the
production of documents that may be needed to make determinations and assess good
faith and fraudulent intention.225
148. Judicial proceedings thus are better suited to reviewing the full range of issues
raised by disclosures of origin. In particular, judges may more readily require disclosure
of (and parties to judicial proceedings may more readily seek to discover) information
relevant to compliance with earlier stage disclosure requirements, contractual provisions,
access legislation, and equitable principles for determining ownership entitlements and
benefit-sharing. Moreover, judges are better equipped to review and evaluate access and
benefit-sharing legislation of foreign countries and contractual provisions.
149. As with international and national application stages and administrative
challenges, mandatory disclosures in judicial proceedings could take various forms and
223

Cf. UNEP/CBD/COP/7/INF/17, ¶ 137 (noting the potential for different burden of proof rules in
litigation).
224
For example, Law Reform Commission of Western Australia, The adversarial system of civil litigation,
in: Review of the Criminal and Civil Justice System: Final Report, ch. 6, ¶ 6.2,2000 (noting distinctions
between inquisitorial and adversarial approaches), available at:
http://www.lrc.justice.wa.gov.au/RevCCJS-p92/finalreport/finalreporthtml/ch6adverscivil.html.
225
For example, Federal Rules of Civil Procedure, 45(a)(1)(C) (authorizing United States district courts to
issue subpoenas to compel testimony or the production of documents).
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could relate to different substantive triggers. In the judicial context, there may be less
need to require prescribed forms or formats for presenting information or to disclose the
level of confidence in various conclusions. On the other hand, there may be a greater
need to evaluate the level of effort previously expended in investigations and to
document the basis for conclusions reached so as to assess good faith, as earlier
disclosures and conclusions are more likely to be called into question. Also, judicial
proceedings are more likely to include persons involved who were not previously
identified, and thus to address considerations of misappropriation and unjustified
enrichment.
150. The same types of mandatory or facultative sanctions could result from disclosure
failures at the judicial proceeding stage, including for determinations that earlier
disclosures were inadequate, false or fraudulent, or based on inadequate investigatory
efforts. However, deferring all evaluations of disclosures of origin until this stage may
not adequately protect the interests of countries of origin or of the persons involved.
Developing countries in particular may lack adequate resources to effectively monitor
and enforce violations of access and benefit-sharing requirements in multiple
jurisdictions following the granting of intellectual property.226 Earlier administrative
evaluations of disclosures of origin could reduce the need for later judicial proceedings,
or could permit countries of origin or persons involved to bring appropriate judicial
actions at an earlier time in order to transfer ownership, invalidate intellectual property,
or establish entitlements at earlier stages of application procedures and at a lower cost.
151. Because of the wide variety of potential judicial proceedings that could trigger
disclosure of origin requirements, careful evaluation is needed to determine what
disclosure of origin obligations should be triggered at the judicial proceedings stage, and
what mandatory or facultative evaluations should be required of such disclosures. For
example, it may not be sufficient in judicial actions that dispute validity or ownership
(even in inquisitorial judicial systems) to rely on the parties to identify and litigate issues
regarding equitable sharing of benefits with countries of origin and persons involved. It
may therefore be appropriate to adopt mandatory provisions authorizing persons involved
to intervene and to participate as full parties in such proceedings.227 This would permit
persons involved to raise additional issues and to seek to obtain an equitable share of any
benefits that are conferred through such an infringement action.228 Similarly, it may be
necessary to mandate new legal claims (rights of action),229 and jurisdiction over such
claims, to allow persons involved or countries of origin to obtain appropriate relief.
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For example, WTO, IP/C/W/356, ¶ 12.
Cf. Federal Rules of Civil Procedure, 24(a) and (b) (describing requirements under United States law for
mandatory and facultative intervention).
228
For example, the person involved might seek to impose a constructive trust over any damages award by
proving a right to an equitable share of the benefits of commercialization of genetic resources and
associated traditional knowledge that was acquired from the person involved.
229
Cf. Cort v. Ash, 422 U.S. 66, 78 (1975) (identifying four requirements for implying private rights of
action under United States laws); Middlesex County Sewerage Authority v. National Sea Clammers
Association, 453 U.S. 1, 20 (1981) (describing under United States laws conditions for limiting recourse to
a statutory private right of action based on a remedial scheme provided in a different statute).
227
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IV.

Incentives for enforcement of disclosure obligations.

A.

Types of measures

152. Measures relating to compliance with mandatory disclosure of origin obligations
may take different forms, including direct mandatory sanctions, indirect mandatory
sanctions, facultative sanctions and positive incentives.230
153. Direct mandatory sanctions have mandatory consequences that directly affect the
intellectual property law system as a result of disclosure of origin requirements. These
consequences may include:
•
•
•
•
•
•

Curable or incurable, temporary or permanent bars to processing of
applications;
Administrative fines, civil liability and criminal liability imposed within
the intellectual property law system;
Termination or full or partial transfer of entitlements to apply for or own
intellectual property;
Curable or incurable, temporary or permanent, full or partial
unenforceability, revocation, narrowing of the subject matter, or
invalidation of granted intellectual property;
Return or transfer231 of benefits received from intellectual property
ownership; and
Enforcement of existing or new obligations to provide for equitable
benefit-sharing.

Direct mandatory sanctions provide strong “negative” incentives to comply with (and
thus deterrents to avoidance of) disclosure requirements. Such sanctions may apply as a
consequence of existing intellectual property and other laws, but could be mandated
directly by treaty when specifying disclosure of origin requirements.
154. Indirect mandatory sanctions have mandatory consequences external to the
intellectual property law system, but which supplement the consequences of that system’s
requirements. Examples of indirect mandatory sanctions are: administrative fines, civil
liability, or criminal sanctions that are imposed separately from the intellectual property
law system and in addition to any effects that failures to comply with disclosure of origin
requirements may have on inventorship, entitlements to apply for or own intellectual
property, or substantive validity of intellectual property.
230

Cf. Gollin, M.A. (2005), ¶ 1(discussing and adopting different definitions for “direct,” “indirect” and
“voluntary/permissive” requirements), available at:
http://www.iprsonline.org/ictsd/docs/DOO3_Gollin.pdf.
231
In addition to disgorgement remedies based on unjustified enrichment, some jurisdictions provide for
duties to account on co-owners of intellectual property (see, for example, H.R. Rep. No. 1476, 94th Cong.,
2nd Sess. 121 (1976), recognizing the judicially developed duty to account in United States copyright law).
Cf. United States law, 35 U.S.C. § 262 (specifying there is no duty of joint owners of patents to account to
each other).
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155. Facultative sanctions authorize but do not mandate consequences within or
external to the intellectual property law system which supplement or duplicate existing
consequences that may apply as the result of intellectual property and other legal
requirements. Facultative sanctions may include the same types of measures as direct or
indirect mandatory sanctions.
156. Positive incentives are measures to encourage disclosures that do not have
mandatory or facultative sanctioning effects. Examples of such incentives include
reduced filing fees for providing specified disclosures of origin in applications for
intellectual property, as well as reputational or moral benefits of responsible conduct and
equitable benefit-sharing.232
157. The choice of mandatory or facultative sanctions with regard to disclosures of
origin may be the most controversial issue to be resolved in developing an international
agreement. Some countries vigorously oppose any mandatory or facultative sanctions that
would affect entitlements to apply for or own intellectual property or that would
invalidate granted rights or privileges,233 even though disclosure failures and false or
fraudulent submissions already may have such consequences under existing intellectual
property laws and other laws.234 Other countries seek to apply as direct sanctions only
existing sanctions under intellectual property laws (e.g. authorizing revocation or
invalidation of patents only in the case of fraudulent intention, as provided by PLT
Article 10(1)).235 Yet other countries seek to impose a wide variety of mandatory or
facultative sanctions, “the nature of which will depend on whether one is dealing with a
formal or substantive component of the disclosure and on whether it is at the level of preor post-grant.”236

232

For example, WIPO/IP/GR/05/01, ¶ 159 (discussing Submission of Japan regarding “sense of
responsibility and conduct of fair and equitable benefit sharing”), and box following ¶ 164, Summary of
incentives (discussing additional positive incentives); WIPO, Compilation, p. 43, Submission of the United
States (discussing patents as incentives for disclosure of new, useful and unobvious information); WIPOUNEP, Gupta , A.K. (2004), pp. 39–40 (discussing incentives to conserve biological diversity and prevent
knowledge erosion). Although the WIPO Examination discusses “[b]ehavior that may be encouraged by
incentives,” reflecting objectives of the CBD (and other values such as compliance with applicable laws)
and “‘[p]erverse’ or undesirable incentives,” these so-called incentives are better classified as desirable
effects or undesirable behaviour that may result from adoption of various options). WIPO/IP/GR/05/01,
box following ¶ 164.
233
For example, WIPO, Compilation, p. 56, Submission of the European Communities; WTO, IP/C/W/434,
¶ 2.
234
For example, WIPO/IP/GR/05/01, ¶¶ 79, 89; Correa, C.M. (2003), p. 10 (noting the inequitable conduct
doctrine under United States patent law).
235
For example, WTO, IP/C/W/400 Rev. 1, ¶ 29; WTO, IP/C/W/423, p. 3; Addor, F. (2005), pp. 4, 5
(discussing the Swiss Proposal, which would limit sanctions to those under PLT Art. 10(1) and would
require submission and evaluation of documentary information regarding access and benefit-sharing only to
and by “government agencies competent to receive information”), available at:
http://www.iprsonline.org/ictsd/docs/DOO6_Addor.pdf.
236
WTO, IP/C/W/443, ¶ 10. See also WTO, IP/C/W/429/Rev. 1 and Add.1–Add.3, ¶¶ 11-14;
WIPO/IP/GR/05/01, ¶155 (summarizing Submission of Brazil); WIPO, Compilation, p. 16, Submission of
Colombia (also noting reduction of application processing time).
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B.

Considerations for sanction provisions

158. Sanctions for disclosure failures may be based on different substantive and
procedural triggers relating the subject matter of or the applicant for intellectual property
to the source, the country providing genetic resources and associated traditional
knowledge, the country of origin, and access and benefit-sharing legislative requirements.
Careful evaluation of the options is needed, given the many potential sanctions and
substantial disputes over whether particular sanctions are appropriate as mandatory or
facultative requirements. Consideration should therefore be given to the following issues:
•

•

•

Sanctions must provide an effective deterrent to non-compliance with
CBD access and benefit-sharing requirements, ensuring that the
intellectual property is not granted inappropriately and that the intellectual
property system is not misused to further inequitable conduct;237
The burdens imposed in ensuring conformity to disclosure requirements
and the potential fear of sanctions should not deter facilitated access to
genetic resources and associated traditional knowledge where access and
equitable benefit-sharing are likely to occur;238 and
Flexibility should be provided to tailor the sanctions to the conduct
involved (either by leaving their application to the discretion of
Contracting States239 or by specifying requirements or principles for
applying flexibility), so as to ensure that the sanctions are appropriate and
do not result in adverse consequences.240

159. When considering what sanctions to adopt in regard to disclosures of origin, it is
important to note that sanctions may be applied sequentially or in combination, rather
than as exclusive alternatives. Decisions to impose sanctions thus may need to take into
account not only the type of sanctions that are appropriate in relation to the conduct, but
also whether previously imposed sanctions may logically or practically preclude or
render particular additional sanctions inappropriate. This is especially true of sanctions
that already exist under national intellectual property laws, which might preclude
application of more lenient sanctions. To the extent that particular sanctions might
conflict with existing patent law treaties, mandatory sanctions might supersede those
treaty requirements.241 Moreover, mandatory sanctions may make more coherent the
existing international system, requiring recognition and enforcement of national laws that
would impose various sanctions on disclosure of origin failures.
237

For example, WTO, IP/C/W/429/Rev.1 and Add.1–Add.3, ¶¶ 3-6; WTO, IP/C/W/442, ¶¶ 5-8; WIPO,
Examination, ¶ 164 (summarizing Submission of CIEL).
238
WTO, IP/C/W/434, ¶¶ 15, 25-27; WTO, IP/C/W/429/Rev.1 and Add.1–Add.3, ¶¶ 9-10; WTO,
IP/C/W/443, ¶¶ 10–12, 18–23.
239
For example, WIPO, Compilation, p. 56, Submission of the European Communities.
240
For example, id. (discussing “effective, proportionate and dissuasive sanctions outside the field of patent
law”).
241
See Vienna Convention, Arts. 31(2) and (3). For example, mandatory sanction obligations might require
withdrawal and resubmission of applications or invalidation of the right to apply for the subject matter,
even though the applicant had otherwise provided sufficient disclosures to obtain a filing date under PLT
Art. 5(1) or PCT Art. 11(1).
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V.

Functioning of disclosure requirements under WIPO treaties

160. Most of the proposed forms of disclosure of origin requirements are legally
compatible with existing WIPO treaties dealing with patent law (as well as with the
TRIPS Agreement and the UPOV Convention).242 Even if some forms of mandatory
disclosure obligations were incompatible with an existing WIPO-administered treaty
provision, such obligations (as later-enacted treaty provisions) would supersede the
WIPO-administered treaty provisions for parties to both sets of treaty requirements.
Alternatively, the WIPO-administered treaties could be amended to be consistent with
these obligations. This analysis does not repeat the earlier legal analyses, but rather
considers procedures within the WIPO-administered intellectual property law treaty
system for processing applications, focusing on patent law requirements. In doing so, it
identifies various issues that may need to be addressed in any new international treaty
provisions imposing mandatory disclosure of origin requirements.
161. Although existing international treaties would legally permit the imposition of
required disclosure of origin requirements at the national stage, they may not facilitate the
receipt and transmission of any required or voluntarily disclosed information from
international “receiving” intellectual property application offices to national “designated”
offices. Receiving and designated offices may not be prepared to carry out mandatory
disclosure obligations effectively or efficiently without the development of additional
administrative rules, procedures and forms to address reproduction, publication and
transmission of declarations and of supporting evidentiary documentation. Also, both
international and national application offices may need authority to impose appropriate
fees to cover the costs and administrative expenses relating to the processing of such
information. Additional complexities arise with regard to electronic filing and processing
of disclosures. Furthermore, rules, procedures and forms would need to consider the
language of documents, linguistic abilities of officials and translation concerns. Finally,
consideration should be given to the development of necessary administrative expertise,
particularly if substantive evaluations of disclosed information are to be performed
during the application process.

A.

Rules, forms and processing of information at the international stage

162. The basic premise of the PCT system is the creation of a consistent set of
international procedures for the administration of patent applications, which permits the
filing of a single application in a receiving office, thereby having a simultaneous effect
for filing priority purposes in multiple designated countries.243 Although receiving offices
are authorized to require applicants to provide supplementary information for disclosures
242

See generally, Sarnoff, J.D. (2004). Additional discussions of specific provisions of the Paris
Convention, the PLT, and the PCT, focusing on their formal or substantive character, are provided in
WIPO/IP/GR/05/01, ¶¶ 172–190.
243
For example, UNEP/CBD/COP/7/INF/17, ¶¶ 172–173.

78

that appear to be invalid or inadequate,244 they do not routinely evaluate the substantive
adequacy of the disclosed information.245 Following preliminary reviews in the receiving
office, applications may be subjected to various preliminary substantive reviews (e.g. for
preliminary searches and preliminary examinations246) in the receiving office or other
appropriate application offices. Although the PCT system now requires preliminary
reports on patentability,247 the reports (and voluntarily requested preliminary
examinations) are not binding on designated national application offices. The principal
function thus served by the international system is the receipt, processing and transfer of
the application information and preliminary analyses to the designated national offices.
Rules and forms
163. At the international stage, disclosures must be provided through a standardized
application request form in accordance with the PCT Administrative Instructions
mandating the use of “standardized wording” for completing the form.248 PCT Rules
direct the international receiving office to delete information contained in the request
form that is not authorized under the Rules or which the Administrative Instructions do
not expressly permit to be voluntarily disclosed.249 Additional PCT Rules address specific
forms of information relating to genetic resources, such as references to deposits of
biological materials or to the listing of nucleotide or amino acid sequences.250
164. The PCT Rules authorize designated national offices to require additional
disclosures at the national stage of application processing that relate to: (i) inventorship;
(ii) entitlements to apply; (iii) entitlements to claim priority to earlier applications; (iv)
oaths or declarations of inventors; (v) documents relating to “non-prejudicial” (public)
disclosures under national laws; (vi) confirming signatures of additional applicants; and
(vii) missing information regarding applicants.251 As recognized by the Swiss Proposal,
the PCT Rules limit the authority of national offices to require additional formal (but not
substantive) disclosures to those made at the international stage relating to inventorship
244

Under PCT Rule 26ter 2, the receiving office or the International Bureau “may” invite applicants to
correct declarations under Rule 4.17 if the office or Bureau “finds” they are not worded or signed as
required by the Administrative Instructions, but the Rules do not mandate review for such defects.
245
Cf. WIPO/IP/GR/05/01, ¶¶ 170–171 (discussing formal review of disclosure adequacy at the
international stage for purposes of obtaining a filing date, and later substantive review for patentability).
246
PCT Arts. 17, 18, 34 and 35.
247
PCT Rules 44bis and 70 (as in force from April 1, 2005) (establishing an enhanced international search
and preliminary examination system, requiring mandatory “international preliminary reports on
patentability,” whether or not an applicant requests a preliminary examination), available at:
http://www.wipo.int/pct/en/texts/pdf/pct_regs.pdf.
248
See WIPO, PCT/RO/101, Notes to the Request Form, p. 3 (April 2005) (referencing WIPO, PCT/AI/2,
PCT Administrative Instructions §§ 211-15 (as in force Feb. 12, 2004), available at:
http://www.wipo.int/pct/en/texts/pdf/ai.pdf); id. (noting that where the “standardized wordings are not
applicable,” declarations should not be made on the PCT authorized form, but rather should be supplied
only at the national stage).
249
PCT Rule 4.18(a) and (b).
250
PCT Rule 13bis.1, 13bis.2, and 13ter; WIPO, Technical study on disclosure requirements related to
genetic resources and traditional knowledge, 2003, ¶ 178.
251
PCT Rules 4.17, 51bis.1(a).
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and entitlement to apply, unless there is reasonable doubt as to the veracity of the earlier
disclosures at the international stage.252
165. The types of information that may be supplied at the international stage pursuant
to disclosure of origin requirements are likely to vary significantly from the types of
information that were contemplated when creating the PCT Rules, Administrative
Instructions and Request Form. Thus any new international treaty provisions mandating
disclosure of origin requirements may need to address amendments to the rules
implementing various intellectual property treaties, and the creation of appropriate forms
and instructions to assure that required information is included in, transmitted with and
published as part of applications for intellectual property. Mandating the types of
information and documents to be published at the international stage (in full, partial or
summary form) will help ensure that countries of origin and persons involved receive
adequate notice of relevant applications at the earliest time.
Processing of information and fees
166. Specific PCT Rules also address the preparation and recording of the contents of
applications and accompanying disclosures, and transmission of such information to
different international application offices (such as the International Bureau and the
International Search Authority) for various purposes.253 These purposes may include
publication and provision of references to additional disclosures that are provided in the
application, the International Search Report and preliminary amendments to the claims.254
Additional Rules address further transmission of information (including opinions and
examination reports)255 to applicants and to various international and national application
offices (including designated offices for national stage processing).256
167. As with the PCT rules that address information content and forms, those
addressing information processing procedures were established with specific types of
information in mind. Mandatory disclosure of origin obligations may require submission
at the international stage of different kinds of information than are required by existing
application procedures. Such information will need to be transmitted to various
application offices and may be published. Therefore, careful consideration should be
given to the types of information management procedures that will best facilitate
transmission of disclosed information for recording, evaluation and public notice
purposes, without generating undue administrative burdens and costs.

252

PCT Rule 51bis.2(a). As discussed elsewhere, PCT Art. 27(3) (from which Rule 51bis.2 purports to
derive its authority) should not be understood to prohibit additional disclosure requirements relating to
substantive entitlements to apply for patents at the national stage. See Sarnoff, J.D. (2004), p. 48. Rule
changes may be needed, however, to ensure that such information can be required to be processed at the
international stage and transmitted to the national stage.
253
PCT Rules 22 and 23.
254
PCT Rules 43, 46 and 48.2.
255
PCT Rules 43bis, 44, 44bis, 62 and 70.
256
PCT Rules 47, 71, 73 and 93bis.1.
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168. The PCT Rules permit electronic filing, processing and transmission of
applications and associated documents,257which may substantially reduce the costs of
processing information. However, various countries may not be prepared to manage
electronic submissions or transmissions,258 and many applicants may not be able to create
or transmit electronic documents. Additional concerns could arise with regard to:
creating, preserving and ensuring the legibility and integrity of electronic records or
documents;259 ensuring that the information provided uses common formats, and that
electronic information management systems are interoperable and secure;260 and
certifying the authenticity of electronic records or documents.261
169. Regarding fees, current PCT Rules262 were established with specific types of
information in mind. Accordingly, fees may need to be adjusted to take into account the
different types of disclosure of origin information that will need to be processed.
Consideration should be given to ensuring that such fees are not prohibitive for
applicants.
Language concerns
170. Specific PCT Rules govern the requirements for submission of applications in
various languages,263 and specify when translations of information contained in
applications or produced during evaluation of applications may be required.264 Issues
relating to the language of submitted information and the need for translations may occur
with greater frequency for disclosures of origin than for other types of disclosures in
intellectual property applications. Access to genetic resources and associated traditional
knowledge may be provided from countries that either may not be the countries where the
patentable subject matter is developed, or may not be the countries in which international
or national applications are originally filed and subsequently prosecuted. Sources giving
access to genetic resources and traditional knowledge may provide information and
documents in languages (including indigenous languages and local dialects) different
from the official language of the country providing such resources and knowledge.
Information and documents and CBD access and benefit-sharing legislation from such
countries thus may be in languages different from the official language of the
international receiving office or designated offices.
171. Careful consideration therefore should be given to the languages in which
intellectual property applicants must submit required disclosures of origin and
documentary information regarding compliance with access and benefit-sharing, and to
the need for and timing of translations of such information and documents. Applicable
257

PCT Rule 89bis.1(a), 89ter; WIPO, PCT/AI/2, §§ 701–713.
PCT Rules 89bis.1(d) and 89bis.3.
259
For example, WIPO, PCT/AI/2, §§ 706 and 708.
260
For example, WIPO, PCT/AI/2, §§ 703, 710, Appendix F.
261
For example, WIPO, PCT/AI/2, §§ 710(a)(iv), 711(b).
262
For example, PCT Rules 14–16, 19.4(b), 21(c), 26bis.2(c), 31.1(b), 40.1, 40.2, 48.4, 49.1, 57, 58, 58bis,
68.2, 68.3, and 91(f).
263
PCT Rule 12.1.
264
For example, PCT Rules 12.3, 12.4, 45, 48.3, 55.1, 55.2, 62bis.1, 72, 74 and 76.
258
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requirements should reflect the types of mandatory or facultative evaluations of such
information that are to be performed at various stages of international application
processing.
B.

Rules, forms and processing of information at the national stage

172. As with international stage applications, mandatory disclosure obligations will
need to address the rules, forms, procedures and fees at the national stage of processing
applications for intellectual property, in light of the types of evaluations to be performed.
However, such national stage procedures and evaluations may vary dramatically among
different countries, given the wide range of practices and legal requirements that exist for
different types of intellectual property applications. At the national stage additional
documentation or the use of forms different from those employed at the international
stage may be required,265 and translation of information and documents is even more
likely to be required than at the international stage.266 Also, at this stage, different fee
structures will apply depending on the types of information required to be submitted and
the types of evaluations to be performed.267
173. Unlike at the international stage, national application offices may be required to
evaluate the factual accuracy, validity and authenticity of various disclosures,
declarations and documents (at least where the information facially appears to relate to
substantive validity of the application or facially calls into question the entitlement to
apply for intellectual property). Thus, different considerations may be involved with
regard to retaining, processing and transmitting disclosures of origin and accompanying
documentation at the national stage.
Rules, forms, processing and fees
174. Neither the PCT nor the PLT prohibit disclosure of origin requirements at the
national stage of processing PCT applications or for national applications in PLT
jurisdictions. Depending on the degree to which mandatory disclosure of origin
obligations harmonize national application disclosure requirements, different types of
information may be required to be submitted at the national application stage using
different forms and formats and pursuant to different procedures. Consideration therefore
should be given to the degree to which disclosure requirements can and should be made
consistent, so as to minimize information processing burdens on applicants. Particularly
where regional application processing may exist,268 or where national application offices
265

For example, PCT Rule 51bis; PLT Arts. 6(2)(a) and 6(6). See also PLT Art. 2(2) (limiting the Treaty
from restricting any party from “prescribing such requirements of the applicable substantive law relating to
patents as it desires”).
266
For example, PLT Art. 6(3).
267
For example, PLT Art. 6(4).
268
For example, Protocol on Patents and Industrial Designs Within the Framework of the African Regional
Industrial Property Organization (ARIPO), concluded at Harare (Zimbabwe) Dec. 10, 1982, as amended
Dec. 11, 1987, Apr. 27, 1994, Nov. 28, 1997, May 26, 1998, Nov. 26, 1999, and Nov. 30, 2001, §§ 3(3)–
3(7).
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rely on prior evaluations and decisions by other countries’ application offices,269
consistent procedures may greatly facilitate the submission and evaluation of required
disclosures of origin and documentary information regarding access and benefit-sharing.
175. Standardized requirements and forms may be particularly useful to minimize
processing burdens and costs for applicants who file in multiple jurisdictions. As noted
by others in the context of certificates of origin, common procedures and standardized
electronic (paperless) systems and databases that can be adapted for local purposes are to
be preferred, because of the reduction of the need to perform different types of
evaluations under differing legal regimes and because of the high costs of maintaining
and tracking non-electronic information.270
Translation issues
176. Translation issues may be particularly complex with regard to national stage
evaluations of disclosures of origin. Disclosures of origin at the international stage are
unlikely to be made in multiple languages, but may need to be translated so as to be
understood and evaluated at the national stage in all of the various countries for which
intellectual property is sought. Similarly, documents relating to access and benefitsharing requirements may, of necessity, be drafted in multiple languages. Whether
translations are required will depend on the types of evaluations to be made of
information disclosures, declarations and documents. Where translations are required,
significant costs may be entailed and the potential for translation errors may arise. Thus
careful consideration should be given to how disclosure of origin requirements might
facilitate national stage evaluations in various languages.

269

For example, Government of Hong Kong (SAR, China) (2005) (noting that Hong Kong SAR registers
patents granted by the State Intellectual Property Office of the Peoples Republic of China, the European
Patent Office for patents designating the United Kingdom and the United Kingdom Patent Office),
available at: http://www.ipd.gov.hk/eng/intellectual_property/patents/how_to_apply.htm#p3.
270
For example, UNEP/CBD/WG-ABS/3/INF/5, pp. 62, 64–65 and 66. Of course, a substantial investment
of resources may be required to develop and adopt those systems.
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VI.

Intellectual property issues raised by international certificates of
origin

177. International certificates of origin were conceived of in the context of registering
genetic resources and traditional knowledge and tracking their transboundary flows.271
As understood here, international certificates of origin are documents issued by entities
competent to certify that the source of genetic resources and associated traditional
knowledge has the authority to provide access on specified conditions, and also to certify
the existence of ex ante benefit-sharing requirements that are compliant with the CBD
and with relevant laws and equitable principles of the country providing such resources
or knowledge.272 International certificates of origin thus provide documentation of the
legal provenance for the recipient to use the genetic resources and associated traditional
knowledge under the identified conditions of access and benefit-sharing. As a result,
international certificates of origin may provide highly relevant information regarding the
types of disclosures of origin that may be required of intellectual property applicants.
178. Numerous issues are raised by mandatory or facultative disclosures of origin in
intellectual property applications using international certificates of origin. These
certificates may assist applicants to make required disclosures of origin regarding
compliance with access and benefit-sharing requirements of the country providing
genetic resources and associated traditional knowledge. The value of the certificates of
origin in this context will depend on the types of information contained in them and how
they would be verified and tracked to ensure the integrity of their continuing application
to the genetic resources and associated traditional knowledge that are relevant to the
application for intellectual property.273 As with other disclosures of origin, use of
certificates of origin could impose significant burdens of analysis, investigation and
evaluation on applicants, certification entities and intellectual property offices,
particularly if it is necessary to track ex-post compliance with benefit-sharing
requirements identified in those certificates.. These considerations, however, do not differ
significantly from the discussions provided above regarding substantive and procedural
triggers, and thus are not repeated below. Instead, the analysis focuses on how certificates
of origin may relate to existing intellectual property law requirements, and identifies
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For example, UNEP/CBD/WG-ABS/3/INF/5, p. 52 (discussing certificates to “trace the flow of genetic
resources”), and p. 54 (discussing certificates to monitor the “transboundary movement of genetic resources
and potentially traditional knowledge”); WIPO, Compilation, p. 41, Submission of Turkey (noting the
registration of genetic resources in Turkey and supporting an international certification system to register
all genetic resources).
272
See, for example, UNEP/CBD/WG-ABS/3/2, ¶¶ 62, 67, 89 and n.33, 91 and n.43 (discussing a draft
Central American regional agreement that would require competent entities to issue certificates of origin
establishing the legality of access to genetic resources and traditional knowledge, and that would also
require intellectual property authorities to demand presentation of the certificate before registering products
or processes that “may involve the use” of genetic resources and traditional knowledge; also discussing
Philippine
and
Costa
Rican
certification
requirements),
available
at:
http://www.biodiv.org/doc/meetings/abs/abswg-03/official/abswg-03-02-en.pdf. Cf. WIPO/IP/GR/05/01, ¶
204 (noting questions of legal and practical capability of administrative and legal authorities in one
jurisdiction to determine conformity with laws and regulations in other jurisdictions).
273
For example, UNEP/CBD/WG-ABS/3/INF/5, p. 17–18 (citing UNU-IAS (2003)).
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additional intellectual property law issues (in the context of trademark and unfair
competition law) that are raised by such certificates.
A.

Subject matter of the certification and the certification standard

179. Certificates of origin not only may help to track flows of genetic resources and
associated traditional knowledge, they also provide a certification of authority to provide
access to the relevant genetic resources and associated traditional knowledge on specified
conditions of use and ex ante benefit-sharing. Thus, these certificates may require
applicants and certification entities to evaluate the genetic resources and associated
traditional knowledge used at very early stages of developing the subject matter of
intellectual property applications, or that are used as necessary background information
for such development. To ensure the integrity and relevance of certificates of origin,
certification entities also must verify that the uses to which genetic resources and
associated traditional knowledge have been put conform to the authorized conditions.274
The certification standard must therefore address the level of confidence required for
various determinations before certificates of origin can be issued.
180. Certifying authorized access and equitable benefit-sharing may require extremely
complex evaluations. For example, certification may require determinations of how the
source acquired the resources under the national laws of multiple jurisdictions, and
potentially may require determinations of international legal claims of sovereignty over
genetic resources made by different countries. Certificates of origin also may certify
additional information relevant to determinations of authorized access and equitable
benefit-sharing, thereby facilitating additional disclosures of origin in intellectual
property applications. For example, certification entities may perform, or may require
certificate applicants to conduct, investigations to identify countries of origin and persons
involved.275 Careful consideration should therefore be given to the types of information
to be certified, the levels of investigatory effort and of confidence required by the
certification standard with respect to such information, and the burdens and costs of
providing certifications. As with disclosures of origin, the nature of the certifications
relating to intellectual property applications should depend on the types of evaluations to
be performed and the eventual uses for the certificates of origin.
181. Consideration should also be given to the consequences of certification errors by
competent entities, and to misuse of certificates by persons to whom they were issued.
For example, where an applicant for intellectual property obtained a certificate of origin
based on false representations to the certifying body, that applicant might (depending on
the laws and equitable principles involved) lose the right to apply for or own the
intellectual property, might be found to have engaged in inequitable conduct that would
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For example, UNEP/CBD/WG-ABS/3/INF/5, p. 55 (discussing use of certificates to demonstrate both
the origin and the right to use resources for specific purposes).
275
For example, UNEP/CBD/WG-ABS/3/5 (2004), ¶ 96 (noting difficulties of identifying the country of in
situ origin of genetic resources), available at: http://www.biodiv.org/doc/meetings/abs/abswg03/official/abswg-03-05-en.pdf.
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render the intellectual property invalid or unenforceable, or might be required to transfer
ownership or any commercial benefits that have been or will be obtained.
B.

Ex-ante verification and ex-post tracking of certifications

182. Some observers have noted the complexities involved in verifying that certificates
of origin correspond to the genetic resources being certified, initially and later,
particularly with respect to derivative genetic materials.276 These concerns have particular
relevance for certificates of origin relied upon to document compliance with access and
benefit-sharing requirements when applying for intellectual property. Certificates of
origin thus may need to provide traceability of the genetic resources and associated
traditional knowledge in question from the source providing such inputs, through and
including development of the subject matter of the intellectual property application and
any granted rights and privileges.277 Without such traceability, it may be difficult to
determine whether disclosures of certificates of origin are required, and to verify that the
certifications correspond to the subject matter of the application in the relevant ways
disclosed.
183. To ensure the integrity of authorized access and equitable benefit-sharing under
specified conditions of use, it may be necessary to trace genetic resources and associated
traditional knowledge not only from the source to the subject matter of and applicant for
the relevant intellectual property, but also to additional uses to which such resources and
knowledge may be put (and for which intellectual property applications may not
necessarily be sought). For example, genetic resources may lead to the development of
subject matter by the applicant, which in turn may lead to the development of additional
subject matter by other persons or entities who are not subject to contractual provisions
for equitable benefit-sharing. Alternatively, the applicant may use genetic resources not
only to develop the subject matter of the application for intellectual property, but also
additional subject matter for which intellectual property applications have not been filed
(e.g. trade secrets), and which provides unjustified and inequitable commercial benefits.
184. Consideration also should be given to how international certificates of origin
relate to the actual ex-post provision of equitable benefit-sharing based on certification of
ex-ante arrangements for such benefit-sharing. This is particularly relevant in the context
of intellectual property applications, as the premise of such applications is the granting of
276

For example, WIPO/IP/GR/05/01, ¶ 203 (quoting from UNEP/CBD/WG-ABS/3/5, p. 18);
UNEP/CBD/WG-ABS/3/5, ¶ 94 (discussing “check points” for verifying certificates); UNEP/CBD/WGABS/3/7, Annex I, p. 29 (discussing, in the context of additional elements and options for an international
regime on access and benefit-sharing, internationally recognized certificates of legal provenance of genetic
resources which employ standardized codes that accompany biological materials and are “passed to all
extracts, derivatives, or information”), available at: http://www.biodiv.org/doc/meetings/abs/abswg03/official/abswg-03-07-en.pdf; Dedeurwaerdere, T., et al. (2004), p. 2, 4 (discussing change in materials
covered by certificates due to “processing, breeding and refinement” and whether certification would
address the “gene, sample, species, or batch”), available at:
http://www.iddri.org/iddri/telecharge/biodiv/workshop-abs.pdf.
277
Richerzhagen, C. (2004), Part 1 (discussing the “3 T’s: traceability, transparency and tractability” for
certificates of origin), available at: http://www.ias.unu.edu/research/details.cfm/articleID/601.
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exclusive rights or privileges that may subsequently result in commercial benefits.
Tracing certificates of origin to subsequent conduct, however, may entail substantial
levels of effort, administrative burdens and costs.
C.

Authority to certify

185. As noted by others, prior informed consent and mutually agreed terms for access
and benefit-sharing may involve, among other things, “research permits, collecting
permits, export, and import permits. In most countries, different offices, even different
Ministries, have the responsibilities for some or all of these permissions. Research on
lands managed by local and indigenous communities, or on their biodiversity knowledge
can require additional agreements (not formal permits, per se).”278 Accordingly, obtaining
certificates of origin may require interacting with different levels of government and with
multiple agencies or ministries within each level of government.
186. Certificates of origin may need to differentiate between the types of certifications
provided (and the entities authorized to provide them), based on when genetic resources
and associated traditional knowledge were acquired. For example, it has been proposed
to distinguish between access obtained before the CBD (and its recognition of sovereign
rights over genetic resources) and access obtained before and after adoption of CBD
access and benefit-sharing legislation in the country providing genetic resources.279 This
is particularly relevant in regard to ex-situ collections and materials provided under the
multilateral facilitated access system of the ITPGRFA.280 Additional consideration is
needed of how certificates or origin would assist disclosures of origin and demonstrations
of compliance with access and benefit-sharing requirements in such situations.
187. Particularly, given the complexities of determining certification authority and of
making appropriate certifications, careful consideration should be given to whether to
impose mandatory or facultative requirements to obtain and to disclose certificates of
origin in order to meet disclosure of origin obligations. Such evaluations will depend in
part on the robustness and comprehensiveness of the certificate of origin system and on
the degree to which certificates of origin generate the types of information required to be
submitted by mandatory disclosure of origin obligations and how useful they are for
evaluations within or relevant to the intellectual property law system.
278

UNEP/CBD/WG-ABS/3/INF/5, p. 27.
Dedeurwaerdere T., et al. (2004), p. 3.
280
Although facilitated access is subject to strict conditions under material transfer agreements that apply to
subsequent transfers, and either provide for benefit-sharing to an international fund or encourage such
benefit-sharing where products are made available for further breeding, access is supposed to be provided
expeditiously “without the need to track individual accessions.” ITPGRFA, Arts.12.3(b), 12.4, 13.2b(i) and
d(ii). Further, although recipients are not supposed to claim intellectual property or other rights or
privileges in accessed materials “in the form received,” ITPGRFA, Art. 12.3(d), significant disputes exist
regarding application of this provision to isolated and purified genetic sequences. See, for example, Helfer,
L.R. (2002), at § 4.3.2.4, available at: http://www.fao.org/Legal/Prs-OL/lpo31.pdf. Thus benefits may flow
to the international fund without regard to the country of origin, may not be required to be shared under the
ITPGRFA, and may involve materials with a disputed relationship to ITPGRFA restrictions on seeking
intellectual property.
279
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D.

Confusion, false certifications, errors and related concerns

188. International certificates of origin, like other certification documents issued by
competent government entities, may be put to numerous commercial uses, in addition to
enabling access to genetic resources and associated traditional knowledge and
demonstrating prior informed consent and equitable benefit-sharing so as to obtain
intellectual property. For example, certification marks and labelling relating to
certificates of origin may be useful in promoting commercial recognition of the subject
matter of intellectual property and in obtaining benefits for countries and indigenous or
local communities that exercise rights over genetic resources and associated traditional
knowledge. Such uses raise difficult questions regarding the authenticity standards to be
applied.281
189. Furthermore, certificates of origin may be put to false, deceptive and confusing
uses.282 As with consumer confusion regarding the “origin, sponsorship or approval” of
goods or services in trademark law,283 relevant persons (including officials in intellectual
property offices) may be confused as to the referents of certificates of origin and the
authority of the certificate holder to use the certified genetic resources and associated
traditional knowledge. Confusion may also result if certificates of origin fail to identify
the country of origin and other persons involved, in instances where such identification
may be required to demonstrate the legitimacy of access or equitable benefit-sharing.
Similarly, confusion may result when multiple countries issue certificates of origin that
are in conflict regarding claims of authority to use genetic resources or regarding the
equity of the benefit-sharing arrangements.
190. Concerns as to the integrity of certificates of origin arise precisely because
certifications are valuable to commercial relations and may provide unjustified
commercial benefits when they are falsified, contain errors, or are used in a confusing
manner. Applicants for certificates of origin may falsify information submitted to
certification entities in order to obtain improper certifications for use in intellectual
property applications. Applicants for intellectual property also may falsify certificates of
origin themselves.284 Falsification or other improper uses of certificates of origin may
result in improper issuance of intellectual property and other public and private harms,
whether or not access to genetic resources and traditional knowledge was authorized and
281

See, for example, Drahos, P. (2004), pp. 32–34 (discussing failures to accommodate needs of all
indigenous groups and to fund administration of the Indigenous Label of Authenticity and Collaboration
Mark adopted by the National Indigenous Arts Advocacy Association of Australia in 1999), available at
http://www.unctad.org/trade_env/test1/meetings/tk2/drahos.draft.doc
282
Cf. Escudero, S. (2001), p. 9 (discussing the Madrid Agreement for the Repression of False or Deceptive
Indications of Source on Goods of 1891, Art. 1(1) (as revised), requiring seizure of goods bearing a false or
deceptive
indication
of
geographical
origin),
available
at:
http://www.southcentre.org/publications/workingpapers/paper10/wp10.pdf; United States law 15 U.S.C. §
1125(a)(1)(B) (prohibiting false designations of origin or misleading designations of fact that misrepresent
in commercial advertising the geographic origin of goods, services or commercial activities)
283
United States law 15 U.S.C. § 1125(a)(1)(A); and 15 U.S.C. § 1114(a) (addressing infringement of
registered marks).
284
See, for example, Dedeurwaerdere, T., et al. (2004), p. 2 (discussing authorized signatures/seals, special
paper or stamps, electronic systems and security issues).
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equitable benefit-sharing provided. Even when all parties are acting in good faith,
certificates of origin may contain errors.
191. Consideration should be given to ensuring the integrity of certificates of origin, to
correcting errors in certification, and to deterring, identifying and punishing false
statements and falsified certificates. Existing laws may impose mandatory or facultative
sanctions within and external to the intellectual property system for errors in certificates
of origin that are relied on for disclosures in intellectual property applications. For
example, a certificate of origin that fails to name the correct source may result in the
failure to name a joint inventor of the subject matter of the intellectual property
application. Later discovery of the error might entail any of the following remedies under
existing intellectual property laws: correction of inventorship; transfer of ownership;
invalidation or unenforceability of the intellectual property; or the return or transfer of
benefits. Additional consequences within or external to the intellectual property law
system might be imposed, including administrative fines, civil liability, criminal penalties
and additional benefit-sharing obligations. Flexibility may be needed to determine the
sanctions to be employed for various types of certification errors.
192. Finally, consideration should be given to whether and how ownership of
certificates of origin can be transferred. For example, in the United States, trademarks
cannot be assigned separately from the goodwill that the trademarks signify.285
Certificates of origin may need to apply to and be transferred with the relevant genetic
resources and associated traditional knowledge.286 It may not make sense to permit the
transfer of ownership in certificates of origin separately from the relevant genetic
resources and associated traditional knowledge.
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See, for example McCarthy Thomas J. (2005), § 18.2 (citing United States cases).
See, for example, UNEP/CBD/WG-ABS/3/7, p. 29 (discussing passing certification codes to extracts,
derivatives and knowledge); UNEP/CBD/WG-ABS/3/INF/5, p.46, fig. 4 (providing flow diagram of
material entering and leaving biological resource centres).
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Conclusion
193. In summary, there is a need for new international treaty provisions that would
mandate disclosures of origin requirements in applications for intellectual property. The
most appropriate treaty regime to adopt such requirements is the TRIPS Agreement.
Numerous benefits would derive from disclosure of origin requirements, although care
should be taken to minimize the administrative costs and burdens of implementation. The
treaty provisions will need to specify the substantive and procedural triggers for making
required disclosures, the types and timing of evaluations to be performed with disclosed
information, the mandatory or facultative consequences of various types of disclosure
failures, and whether to mandate or facilitate the use of international certificates of origin
in making required disclosures. Although disclosure of origin requirements are consistent
with existing intellectual property treaties, such requirements may be facilitated by
revising existing rules, forms and procedures implementing those treaties.
194. Additional research and evaluation relating to the following issues would help to
inform policy choices regarding the contents of mandatory disclosure of origin
requirements:
•

•

Existing national laws addressing the relationship between
misappropriation of genetic resources or traditional knowledge, and their
effect on the validity of or entitlement to own or retain benefits from
intellectual property; and
Applicable legal principles for the recognition and enforcement of existing
national access and benefit-sharing laws and contractual provisions that
impose disclosure of origin requirements, and their relation to intellectual
property laws.
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for Access and Equitable Benefit-Sharing.
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to genetic resources and disclosure requirements in intellectual property rights
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WIPO/IP/GR/05/03 (2005), Examination of issues relating to the interrelation of access
to genetic resources and disclosure requirements in intellectual property rights
applications: Second draft.
WIPO, Member State proposals and suggestions regarding the invitation to WIPO from
the Conference of the Parties to the Convention on Biological Diversity on access to
genetic resources and disclosure requirements in intellectual property applications
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instruments, on intellectual property in relation to genetic resources and on the protection
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Islanders Commission (ATSIC), Foundation for Aboriginal and Islander Research Action
(FAIRA), Canadian Biodiversity Network, Coordinating Body of the Indigenous
Organizations of the Amazon Basin (COICA), Hokotehi Moriori Trust, Rekohu,
Aotearoa (New Zealand), Indigenous Peoples Caucus of the Creators Rights Alliance, the
Kaska Dena Council, the Saami Council and the International Indian Treaty Council,
submitted to the WIPO Intergovernmental Committee on Intellectual Property and
Genetic Resources, Traditional Knowledge, and Folklore, Sixth Session, March 15-19
2004.
SCP/6/5 (2001), Study on the interface between the SPLT, the PLT and the PCT.
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WIPO (2005), Member State proposals and suggestions regarding the invitation to WIPO
from the Conference of the Parties to the Convention on Biological Diversity on access to
genetic resources and disclosure requirements in intellectual property rights applications.
WIPO-UNEP, Gupta, A.K. (2004), WIPO-UNEP study on the role of intellectual
property rights in the sharing of benefits arising from the use of biological resources and
traditional knowledge, Geneva: WIPO-UNEP.
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on Trade-Related Aspects of Intellectual Property Rights.
Marrakesh Agreement Establishing the World Trade Organization, Annex II,
Understanding on rules and procedures governing the settlement of disputes.
IP/C/W/347/Add.3 (2002), Review of the provisions of Article 27.3, Relationship
between the TRIPS Agreement and the Convention on Biological Diversity and
protection of traditional knowledge and folklore, information from intergovernmental
organizations, Addendum, International Union for the Protection of New Varieties of
Plants (UPOV).
IP/C/W/356 (2002), The relationship between the TRIPS Agreement and the Convention
on Biological Diversity and the protection of traditional knowledge – Submission of
Brazil, China, Cuba, the Dominican Republic, Ecuador, India, Pakistan, Thailand,
Venezuela, Zambia and Zimbabwe.
IP/C/W/368 (2002), The relationship between the TRIPS Agreement and the Convention
on Biological Diversity: Summary of issues raised and points made.
IP/C/W/383 (2002), Review of Article 27.3(B) of the TRIPS Agreement, and the
relationship between the TRIPS Agreement and the Convention on Biological Diversity
(CBD) and the protection of traditional knowledge and folklore, Communication from the
European Communities and their member States.
IP/C/W/400/Rev.1 (2003), Article 27.3(b), the relationship between the TRIPS
Agreement and the Convention on Biological Diversity and the protection of traditional
knowledge, Communication from Switzerland.
IP/C/W/403, (2003), The relationship between the TRIPS Agreement and the Convention
on Biological Diversity and the protection of traditional knowledge, Submission of
Bolivia, Brazil, Cuba, the Dominican Republic, Ecuador, India, Peru, Thailand and
Venezuela.
IP/C/W/404 (2003), Taking forward the review of Article 27.3(b) of the TRIPS
Agreement, Joint communication from the African Group.
IP/C/W/420 (2004), The relationship between the TRIPS Agreement and the Convention
on Biological Diversity (CBD): Checklist of issues, Submission of Bolivia, Brazil, Cuba,
Ecuador, India, Peru, Thailand and Venezuela.
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IP/C/W/423 (2004), Additional comments by Switzerland on its proposals submitted to
WIPO regarding the declaration of the source of genetic resources and traditional
knowledge in patent applications, Communication from Switzerland.
IP/C/W/429/Rev.1 & Add.1-Add.3 (2004), Elements of the obligation to disclose the
source and country of origin of the biological resources and/or traditional knowledge
used in an invention, Submission of Bolivia, Brazil, Colombia, Cuba, the Dominican
Republic, Ecuador, India, Pakistan, Peru, Thailand and Venezuela.
IP/C/W/433 (2004), Further observations by Switzerland on its proposals regarding the
declaration of the source of genetic resources and traditional knowledge in patent
applications.
IP/C/W/434 (2004), Article 27.3(b), relationship between the TRIPS agreement
and the CBD, and the protection of traditional knowledge and folklore, Communication
by the United States.
IP/C/W/438 (2004), The relationship between the TRIPS Agreement and the Convention
on Biological Diversity (CBD) and the protection of traditional knowledge – Elements of
the obligation to disclose evidence of prior informed consent under the relevant national
regime, Submission of Bolivia, Brazil, Cuba, Ecuador, India, Pakistan, Peru, Thailand
and Venezuela.
IP/C/W/441 Rev.1 (2005), Article 27.3(B), relationship between the TRIPS Agreement
and the CBD and protection of traditional knowledge and folklore, Submission of Peru.
IP/C/W/442 (2005), The relationship between the TRIPS Agreement and the Convention
on Biological Diversity (CBD) and the protection of traditional knowledge – Elements of
the obligation to disclose evidence of benefit-sharing under the relevant national regime,
Submission from Bolivia, Brazil, Colombia, Cuba, Dominican Republic, Ecuador, India,
Peru and Thailand.
IP/C/W/443 (2005), The relationship between the TRIPS Agreement and the Convention
on Biological Diversity (CBD) and the protection of traditional knowledge – Technical
observations on issues raised in a communication by the United States, Submission from
Brazil and India.
IP/C/W/446 (2005), The relationship between the TRIPS Agreement and the Convention
on Biological Diversity (CBD) and the protection of traditional knowledge and folklore
and review of implementation of the TRIPS Agreement under Article 71.1,
Communication from Switzerland.
IP/C/W/447 (2005), Article 27.3(b), Relationship between the TRIPS agreement and the
CBD and protection of traditional knowledge and folklore, Communication by Peru.
IP/C/W/449 (2005), Article 27.3(B), Relationship between the TRIPS Agreement and the
CBD, and the protection of traditional knowledge and folklore, Communication by the
United States.
IP/C/W/447 (2005), Article 27.3(B), Relationship between the TRIPS Agreement and the
CBD and protection of traditional knowledge and folklore, Communication from Peru.
IP/C/W/449 (2005), Article 27.3(B), Relationship between the TRIPS Agreement and the
CBD, and the protection of traditional knowledge and folklore, Communication by the
United States.
WT/DS176/AB/R (2002), United States – Section 211 Omnibus Appropriations Act of
1998, Report of the Appellate Body.
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WT/MIN(01)/DEC/1 (2001), Doha Ministerial Declaration.
TRIPS Council Meeting 14 June 2005, Statement by India.
Official Documents by Country
Andean Community, Decision 486, Common intellectual property regime.
Andean Community, Decision 391, Common regime on access to genetic resources,
Law Reform Commission of Western Australia (2003), Review of the Criminal and Civil
Justice System: Final Report.
European Convention on Jurisdiction and Enforcement of Judgments in Civil and
Commercial Matters.
European Convention on Transfer of Proceedings in Criminal Matters.
European Patent Convention.
European Union, Council Regulation (EC) No 44/2001 of 22 December 2000 on
jurisdiction and the recognition and enforcement of judgments in civil and commercial
matters.
Handelskwekerij G.J. Bier B.V. v. Mines de Potasse d'Alsace S.A., Case 21/76, [1976]
E.C.R. 1735, 1745, European Union.
Government of Hong Kong (SAR, China) (2005), Patents: How to apply for grant of
patents in the Hong Kong SAR?, document prepared by the Intellectual Property
Department of the Government of Hong Kong (SAR, China).
Indian Biological Diversity Act (2002).
Japanese Patent Law.
United States Code.
United States Code of Federal Regulations.
Federal Rules of Civil Procedure, United States.
H.R. 2795, Patent Reform Act of 2005, United States.
H.R. 2791, United States Patent and Trademark Fee Modernization Act of 2005, United
States.
H.R. Rep. No. 1476, 94th Cong., 2nd Sess. 121 (1976), United States.
Altman v. Republic of Austria, 317 F.3d 954 (9th Cir. 2002), United States.
Cort v. Ash, 422 U.S. 66 (1975), United States.
Hilton v. Guyot, 159 U.S. 113 (1895), United States.
Precision Instrument Mfg. Co. v. Automotive Maintenance Mach. Co., 324 U.S. 806
(1945), United States.
Middlesex County Sewerage Authority v. National Sea Clammers Association, 453 U.S. 1
(1981), United States.
Seismograph Service Corp. v. Offshore Raydist, 135 F. Supp. 342 (E.D. La. 1955),
United States.
Ultra-Precision Mfg. Ltd. v. Ford Motor Co., 411 F.3d 1369 (Fed. Cir. 2005), United
States.
United States Department of State (2001), The doctrine of forum non conveniens in the
United States.
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United States Federal Trade Commission (2003), To Promote Innovation: The Proper
Balance of Competition and Patent Law and Policy.
United States Patent and Trademark Office (2003), 21st Century Strategic Plan, Action
Paper 40: Post-Grant Review of Patent Claims.
Documents by Institution
Center for International Environmental Law (2005), CBD request to WIPO on the
interrelation of access to genetic resources and disclosure requirements: Observations
from the Center for International Environmental Law (CIEL) on the first draft of the
WIPO Examination of the Issues, Geneva: CIEL.
National Research Council, National Academy of Sciences (2004), A Patent System for
the 21st Century, Committee on Intellectual Property Rights in the Knowledge-Based
Economy, Washington: The National Academies Press (Merrill, S.A., Levin, R.C. and
Myers, M.B. (eds.)).
Restatement of Unfair Competition (3rd Restatement 1995), Philadelphia: American Law
Institute.
South Centre/CIEL (2004), IP Quarterly Update, Fourth Quarter 2004: Intellectual
Property and Development: Overview of Developments in Multilateral, Plurilateral, and
Bilateral Fora, Geneva: South Centre/CIEL.
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Addor, F. (2005), Switzerland’s Proposals Regarding the Declaration of the Source of
Genetic Resources and Traditional Knowledge in Patent Applications and Switzerland’s
Views on the Declaration of Evidence of Prior Informed Consent and Benefit-sharing in
Patent Applications, presentation at the ICTSD/CIEL/IDDRI/IUCN/QUNO Dialogue on
Disclosure Requirements: Incorporating the CBD Principles in the TRIPS Agreement on
the Road to Hong Kong, WTO Public Symposium, Geneva, 21 April 2005.
Beatson, J. and Schrage, E. (eds.) (2003), Cases, Materials and Texts on Unjustified
Enrichment, Oxford: Hart Publishing.
Berglund, M. (2005), The Protection of Traditional Knowledge Related to Genetic
Resources: The Case for a Modified Patent Application Procedure, SCRIPT-ed, 2(2):108.
Correa, C.M. (2002), Protection and Promotion of Traditional Medicine: Implications for
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Correa, C.M. (2003), Establishing a Disclosure of Origin Requirement in the TRIPS
Agreement, Occasional paper No. 12, Geneva: Quaker United Nations Organization
(QUNO).
Correa, C.M. (2004), Update on international developments relating to the intellectual
property protection of traditional knowledge including traditional medicine, TradeRelated Agenda, Development and Equity Working Paper 18, Geneva: South Centre.
Correa, C.M. (2005), The politics and practicalities of a disclosure of origin obligation,
Occasional Paper No. 16, Geneva: QUNO.
de la Cruz, R. (2004), Informal notes: vision of indigenous peoples in the context of the
decisions pertaining access to genetic resources and benefit-sharing (ABS) and Article 8j:
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An analysis of the impacts of CBD/COP Decisions with respect to WIPO’s IGC mandate,
Gland: IUCN.
Cunningham, D., Tobin, B. and Watanabe, K. (2004), Tracking genetic resources and
international access and benefit-sharing governance: The role of certificates of origin,
Tokyo: UNU-IAS.
Dedeurwaerdere, T., et al. (2004), CPDR/Iddri/UNU-IAS Workshop summary,
Roundtable on Practicality, Feasibility and Cost of Certificates of Origin, 2nd Paris
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